
<html lang="en"     class="pb-page"  data-request-id="5506bdc3-90fb-44fb-9424-d9c5abcac4a1"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;issue:issue:10.1021/jmcmar.2020.63.issue-15;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c00130;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay" /></meta><meta name="dc.Creator" content="Thomas  Knoepfel" /></meta><meta name="dc.Creator" content="Pierre  Nimsgern" /></meta><meta name="dc.Creator" content="Sébastien  Jacquier" /></meta><meta name="dc.Creator" content="Marjorie  Bourrel" /></meta><meta name="dc.Creator" content="Eric  Vangrevelinghe" /></meta><meta name="dc.Creator" content="Ralf  Glatthar" /></meta><meta name="dc.Creator" content="Dirk  Behnke" /></meta><meta name="dc.Creator" content="Phil B.  Alper" /></meta><meta name="dc.Creator" content="Pierre-Yves  Michellys" /></meta><meta name="dc.Creator" content="Jonathan  Deane" /></meta><meta name="dc.Creator" content="Tobias  Junt" /></meta><meta name="dc.Creator" content="Géraldine  Zipfel" /></meta><meta name="dc.Creator" content="Sarah  Limonta" /></meta><meta name="dc.Creator" content="Stuart  Hawtin" /></meta><meta name="dc.Creator" content="Cedric  Andre" /></meta><meta name="dc.Creator" content="Thomas  Boulay" /></meta><meta name="dc.Creator" content="Pius  Loetscher" /></meta><meta name="dc.Creator" content="Michael  Faller" /></meta><meta name="dc.Creator" content="Jutta  Blank" /></meta><meta name="dc.Creator" content="Roland  Feifel" /></meta><meta name="dc.Creator" content="Claudia  Betschart" /></meta><meta name="dc.Description" content="Inappropriate activation of endosomal TLR7 and TLR8 occurs in several autoimmune diseases, in particular systemic lupus erythematosus (SLE). Herein, the development of a TLR8 antagonist competition..." /></meta><meta name="Description" content="Inappropriate activation of endosomal TLR7 and TLR8 occurs in several autoimmune diseases, in particular systemic lupus erythematosus (SLE). Herein, the development of a TLR8 antagonist competition..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="July 30, 2020" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c00130" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2020 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00130" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c00130" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c00130" /></link>
        
    
    

<title>Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c00130" /></meta><meta property="og:title" content="Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0019.jpeg" /></meta><meta property="og:description" content="Inappropriate activation of endosomal TLR7 and TLR8 occurs in several autoimmune diseases, in particular systemic lupus erythematosus (SLE). Herein, the development of a TLR8 antagonist competition assay and its application for hit generation of dual TLR7/8 antagonists are reported. The structure-guided optimization of the pyridone hit 3 using this biochemical assay in combination with cellular and TLR8 cocrystal structural data resulted in the identification of a highly potent and selective TLR7/8 antagonist (27) with in vivo efficacy. The two key steps for optimization were (i) a core morph guided by a TLR7 sequence alignment to achieve a dual TLR7/8 antagonism profile and (ii) introduction of a fluorine in the piperidine ring to reduce its basicity, resulting in attractive oral pharmacokinetic (PK) properties and improved TLR8 binding affinity." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c00130"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00130">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c00130&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c00130&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c00130&amp;href=/doi/10.1021/acs.jmedchem.0c00130" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2020</span><span class="cit-fg-volume">, 63</span><span class="cit-fg-issue">, 15</span><span class="cit-fg-pageRange">, 8276-8295</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/63/15" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c00494" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c00529" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Thomas Knoepfel</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas Knoepfel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><span class="conrtib-corresp"><strong>*</strong>Email: <a href="/cdn-cgi/l/email-protection#d5a1bdbab8b4a6fbbebbbab0a5b3b0b995bbbaa3b4a7a1bca6fbb6bab8"><span class="__cf_email__" data-cfemail="7b0f1314161a08551015141e0b1d1e173b15140d1a090f120855181416">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Knoepfel">Thomas Knoepfel</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1675-6297" title="Orcid link">http://orcid.org/0000-0002-1675-6297</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pierre Nimsgern</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pierre Nimsgern</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pierre++Nimsgern">Pierre Nimsgern</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sébastien Jacquier</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sébastien Jacquier</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=S%C3%A9bastien++Jacquier">Sébastien Jacquier</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Marjorie Bourrel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Marjorie Bourrel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Marjorie++Bourrel">Marjorie Bourrel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Eric Vangrevelinghe</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Eric Vangrevelinghe</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Vangrevelinghe">Eric Vangrevelinghe</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ralf Glatthar</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ralf Glatthar</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ralf++Glatthar">Ralf Glatthar</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dirk Behnke</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dirk Behnke</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dirk++Behnke">Dirk Behnke</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Phil B. Alper</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Phil B. Alper</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genomics Institute of the Novartis Research Foundation, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Phil+B.++Alper">Phil B. Alper</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4115-0633" title="Orcid link">http://orcid.org/0000-0002-4115-0633</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pierre-Yves Michellys</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pierre-Yves Michellys</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genomics Institute of the Novartis Research Foundation, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pierre-Yves++Michellys">Pierre-Yves Michellys</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jonathan Deane</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jonathan Deane</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Genomics Institute of the Novartis Research Foundation, San Diego, California 92121, United States</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jonathan++Deane">Jonathan Deane</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Tobias Junt</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Tobias Junt</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Tobias++Junt">Tobias Junt</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Géraldine Zipfel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Géraldine Zipfel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=G%C3%A9raldine++Zipfel">Géraldine Zipfel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sarah Limonta</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sarah Limonta</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sarah++Limonta">Sarah Limonta</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stuart Hawtin</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stuart Hawtin</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stuart++Hawtin">Stuart Hawtin</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Cedric Andre</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Cedric Andre</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Cedric++Andre">Cedric Andre</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Thomas Boulay</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Thomas Boulay</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Thomas++Boulay">Thomas Boulay</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pius Loetscher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pius Loetscher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Autoimmunity, Transplantation and Inflammation, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pius++Loetscher">Pius Loetscher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Michael Faller</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Michael Faller</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Michael++Faller">Michael Faller</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jutta Blank</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jutta Blank</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Chemical Biology & Therapeutics, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jutta++Blank">Jutta Blank</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Roland Feifel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Roland Feifel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Pharmacokinetic Sciences, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Roland++Feifel">Roland Feifel</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Claudia Betschart</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Claudia Betschart</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Global Discovery Chemistry, Novartis Institutes for BioMedical Research, CH-4002 Basel, Switzerland</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Claudia++Betschart">Claudia Betschart</a></span></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00130&amp;href=/doi/10.1021%2Facs.jmedchem.0c00130" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2020</span></span><span class="cit-volume">, 63</span><span class="cit-issue">, 15</span><span class="cit-pageRange">, 8276–8295</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">July 30, 2020</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>27 March 2020</li><li><span class="item_label"><b>Published</b> online</span>30 July 2020</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 August 2020</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c00130" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c00130</a></div><div class="article_header-article-copyright"><strong>Copyright © 2020 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D8276%26pageCount%3D20%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DThomas%2BKnoepfel%252C%2BPierre%2BNimsgern%252C%2BS%25C3%25A9bastien%2BJacquier%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D63%26issueNum%3D15%26contentID%3Dacs.jmedchem.0c00130%26title%3DTarget-Based%2BIdentification%2Band%2BOptimization%2Bof%2B5-Indazol-5-yl%2BPyridones%2Bas%2BToll-like%2BReceptor%2B7%2Band%2B8%2BAntagonists%2BUsing%2Ba%2BBiochemical%2BTLR8%2BAntagonist%2BCompetition%2BAssay%26numPages%3D20%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D8295%26publicationDate%3DAugust%2B2020">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c00130"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">1741</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">5</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c00130" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Knoepfel&quot;},{&quot;first_name&quot;:&quot;Pierre&quot;,&quot;last_name&quot;:&quot;Nimsgern&quot;},{&quot;first_name&quot;:&quot;Sébastien&quot;,&quot;last_name&quot;:&quot;Jacquier&quot;},{&quot;first_name&quot;:&quot;Marjorie&quot;,&quot;last_name&quot;:&quot;Bourrel&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Vangrevelinghe&quot;},{&quot;first_name&quot;:&quot;Ralf&quot;,&quot;last_name&quot;:&quot;Glatthar&quot;},{&quot;first_name&quot;:&quot;Dirk&quot;,&quot;last_name&quot;:&quot;Behnke&quot;},{&quot;first_name&quot;:&quot;Phil&quot;,&quot;last_name&quot;:&quot;B. Alper&quot;},{&quot;first_name&quot;:&quot;Pierre-Yves&quot;,&quot;last_name&quot;:&quot;Michellys&quot;},{&quot;first_name&quot;:&quot;Jonathan&quot;,&quot;last_name&quot;:&quot;Deane&quot;},{&quot;first_name&quot;:&quot;Tobias&quot;,&quot;last_name&quot;:&quot;Junt&quot;},{&quot;first_name&quot;:&quot;Géraldine&quot;,&quot;last_name&quot;:&quot;Zipfel&quot;},{&quot;first_name&quot;:&quot;Sarah&quot;,&quot;last_name&quot;:&quot;Limonta&quot;},{&quot;first_name&quot;:&quot;Stuart&quot;,&quot;last_name&quot;:&quot;Hawtin&quot;},{&quot;first_name&quot;:&quot;Cedric&quot;,&quot;last_name&quot;:&quot;Andre&quot;},{&quot;first_name&quot;:&quot;Thomas&quot;,&quot;last_name&quot;:&quot;Boulay&quot;},{&quot;first_name&quot;:&quot;Pius&quot;,&quot;last_name&quot;:&quot;Loetscher&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;Faller&quot;},{&quot;first_name&quot;:&quot;Jutta&quot;,&quot;last_name&quot;:&quot;Blank&quot;},{&quot;first_name&quot;:&quot;Roland&quot;,&quot;last_name&quot;:&quot;Feifel&quot;},{&quot;first_name&quot;:&quot;Claudia&quot;,&quot;last_name&quot;:&quot;Betschart&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2020&quot;,&quot;month&quot;:&quot;07&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;15&quot;,&quot;volume&quot;:&quot;63&quot;,&quot;pages&quot;:&quot;8276-8295&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c00130&quot;},&quot;abstract&quot;:&quot;Inappropriate activation of endosomal TLR7 and TLR8 occurs in several autoimmune diseases, in particular systemic lupus erythematosus (SLE). Herein, the development of a TLR8 antagonist competition assay and its application for hit generation of dual TLR7/8 antagonists are reported. The structure-guided optimization of the pyridone hit 3 using this biochemical assay in combination with cellular and TLR8 cocrystal structural data resulted in the identification of a highly potent and selective TLR7/8 antagonist (27) with in vivo efficacy. The two key steps for optimization were (i) a core morph guided by a TLR7 sequence alignment to achieve a dual TLR7/8 antagonism profile and (ii) introduction of a fluorine in the piperidine ring to reduce its basicity, resulting in attractive oral pharmacokinetic (PK) properties and improved TLR8 binding affinity.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00130&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00130" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00130&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00130" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c00130&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00130" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c00130&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c00130&amp;href=/doi/10.1021/acs.jmedchem.0c00130" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c00130" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c00130" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (7 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c00130&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c00130%26sid%3Dliteratum%253Aachs%26genre%3Darticle%26aulast%3DKnoepfel%26date%3D2020%26atitle%3DTarget-Based%2BIdentification%2Band%2BOptimization%2Bof%2B5-Indazol-5-yl%2BPyridones%2Bas%2BToll-like%2BReceptor%2B7%2Band%2B8%2BAntagonists%2BUsing%2Ba%2BBiochemical%2BTLR8%2BAntagonist%2BCompetition%2BAssay%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D63%26issue%3D15%26spage%3D8276%26epage%3D8295%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (3)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291171" title="Antagonists">Antagonists</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=290831" title="Monomers">Monomers</a>,</li><li><a href="/action/doSearch?ConceptID=291350" title="Assays">Assays</a>,</li><li><a href="/action/doSearch?ConceptID=291352" title="Screening assays">Screening assays</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/63/15" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/jmcmar.2020.63.issue-15/20200813/jmcmar.2020.63.issue-15.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Inappropriate activation of endosomal TLR7 and TLR8 occurs in several autoimmune diseases, in particular systemic lupus erythematosus (SLE). Herein, the development of a TLR8 antagonist competition assay and its application for hit generation of dual TLR7/8 antagonists are reported. The structure-guided optimization of the pyridone hit <b>3</b> using this biochemical assay in combination with cellular and TLR8 cocrystal structural data resulted in the identification of a highly potent and selective TLR7/8 antagonist (<b>27</b>) with <i>in vivo</i> efficacy. The two key steps for optimization were (i) a core morph guided by a TLR7 sequence alignment to achieve a dual TLR7/8 antagonism profile and (ii) introduction of a fluorine in the piperidine ring to reduce its basicity, resulting in attractive oral pharmacokinetic (PK) properties and improved TLR8 binding affinity.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18834" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18834" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Toll-like receptors (TLRs) are a class of molecular pattern recognition receptors that are a part of the innate immune system. They recognize a variety of specific molecular motifs indicative of infections and initiate effective immune responses. Both TLR7 and TLR8 are located at the endosomal membrane and recognize guanidine-/uridine-rich single-stranded RNA (ssRNA) inside the endosomal lumen. Inappropriate activation of these endosomal TLRs occurs in several autoimmune diseases, in particular systemic lupus erythematosus (SLE), as the body’s own RNA gains access to endosomes, e.g., upon complexation with autoantibodies.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> TLR7 is predominantly expressed in plasmacytoid dendritic cells (pDCs) and B cells, whereas TLR8 is expressed in monocytes/macrophages and neutrophils. In autoimmune diseases such as SLE or Sjögren’s syndrome, there is involvement of a broad range of immune cells.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Therefore, as an approach toward treatment of such diseases, we aimed at identifying potent dual TLR7/8 antagonists.</div><div class="NLM_p">Identification and optimization of TLR7 and TLR8 antagonists have previously relied on phenotypic cellular assays.<a onclick="showRef(event, 'ref2 ref3 ref4 ref5 ref6 ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref2 ref3 ref4 ref5 ref6 ref7 ref8">(2−8)</a> While this hit generation approach has been successfully applied, some limitations exist. For example, validation and optimization of hits from cellular screening campaigns can be time and resource intensive. To demonstrate target- or pathway-specificity, effective counterassays are required, and rational optimization can be complicated by the complexity of various assays and cell types used. With the ligand binding domain (or ectodomain, ECD) of both TLR7 and 8 being localized inside the endosomal lumen, these assays favor identification of compounds that are locally enriched in the endolysosomal compartment. Consequently, the mode of action of some antagonists of endosomal TLRs has been attributed to rely on a combination of high local concentration within the endosome and binding to TLR ligand oligonucleotides, rather than direct interaction with the receptors.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Although such compounds show cellular efficacy, the presence of several basic moieties needed for such a behavior<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> negatively influences physicochemical properties, off-target effects, and risk of accumulation upon repeated dosing.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></div><div class="NLM_p">Our strategy was to develop a robust biochemical assay that would allow identification and subsequent optimization of small molecules acting directly on the ECD of these receptors. In 2013, the expression and X-ray structure of human TLR8 ECD were reported by the Shimizu group in the apo form and bound to a small-molecule agonist.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> Since TLR7 and TLR8 show high sequence homology (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf" class="ext-link">Supporting Information</a> for a sequence alignment), we assumed that their structure and function would also be closely related. No TLR7 crystal structure was available at the time this work was initiated. In the meantime, the structures of monkey TLR7 in the apo and agonist bound forms have been reported.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> As such, we decided to use the recombinant human TLR8 ECD as a surrogate system for hit generation of dual TLR7/8 antagonists.</div><div class="NLM_p last">Herein, we report the development and use of a TLR8 antagonist competition assay for high-throughput screening of TLR8 antagonists. Furthermore, we describe the optimization of a pyridone biaryl scaffold identified in this screen. Using a combination of structural, binding, and cellular approaches, we have identified a highly potent, selective, and orally active dual TLR7/8 antagonist.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25155" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25155" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> TLR8 Antagonist Competition Assay</h3><div class="NLM_p">To devise an assay system that would be amenable for high-throughput screening, we established a ligand competition assay using a fluorescently labeled antagonist. At that time, no TLR8 antagonist had been reported, which showed direct receptor binding. In an alternative approach aimed at identifying TLR7/8 pathway antagonists based on cellular screening and phenotypic optimization, we had identified compound <b>1</b> (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>). The discovery of compound <b>1</b> and related structures is described in a separate publication.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> Based on structure–activity relationship (SAR) data, modifications of the primary amine were well tolerated, making it an attractive attachment point for a fluorescent tracer. Coupling of a fluorescent Cy5 dye to the primary amine in <b>1</b> resulted in probe <b>2</b>. Binding experiments using fluorescence polarization (FP) as a readout with 2 nM compound <b>2</b> and varying concentrations of TLR8 ECD protein yielded an apparent <i>K</i><sub>d</sub> of 65 nM. Binding of <b>2</b> to TLR8 could be competed with excess of unlabeled compounds such as <b>1</b> and its analogues.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0001.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. TLR8 binder <b>1</b> and fluorescent probe <b>2</b> used in the time-resolved fluorescence resonance energy transfer (TR-FRET) assay. IC<sub>50</sub> reported as geometric mean ± standard deviation (SD).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> TR-FRET Assay and High-Throughput Screen</h3><div class="NLM_p last">Fluorescence polarization does not require any labeling of the target protein. However, these assays are run with low nM concentrations of the labeled ligand and target concentrations above the apparent <i>K</i><sub>d</sub>. In this case, the amounts required (>80 nM TLR8), would limit the utility of the assay for a large screen. Consequently, we converted this assay to a TR-FRET format (time-resolved fluorescence resonance energy transfer),<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> using biotinylated TLR8 protein and Eu-labeled streptavidin. Binding of <b>2</b> to TLR8 brings the Cy5 acceptor dye on the ligand in close proximity to the Eu fluorophore. The TR-FRET assay was miniaturized to 1536-well plates. A set of about 50 000 compounds from the Novartis compound collection was selected based on chemical diversity; TLR8 structural information was not considered for the selection. The compounds were evaluated for their ability to compete with the fluorescent probe <b>2</b> in the TR-FRET assay at 20 μM. In total, approximately 1500 compounds were identified with potency determined in dose-response experiments. Representatives of the most interesting hit classes were assessed in relevant human cell-based assay systems based on peripheral blood mononuclear cells (PBMCs), which express both TLR7 and TLR8.</div></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Hit-to-Lead Optimization</h3><div class="NLM_p">Pyridone <b>3</b> was identified as a hit compound with moderate binding affinity and attractive TLR8 cellular potency as assessed by inhibition of TNFα release from stimulated human PBMCs (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The presence of a moderately basic piperazine (p<i>K</i><sub>a</sub>: 6.1) was assumed to lead to some degree of enrichment of the compound in the acidic endosome, possibly contributing to the improved cellular inhibition relative to its binding affinity. Compound <b>3</b> was docked into the antagonist binding site of TLR8 ECD of a previously internally obtained TLR8 antagonist structure by applying a combination of manual and automated docking with Glide<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> (PDB file of the model in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf" class="ext-link">Supporting Information</a>). According to this model, two antagonist molecules bind to two symmetrical pockets at the interface of two TLR8 ECDs that form a homodimer (see <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a> for the detailed description of a TLR8 antagonist cocrystal structure). As shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>, the pyridone carbonyl of compound <b>3</b> was predicted to make a key hydrogen bond with the backbone NH of Gly351 and the piperazine NH+ a salt bridge with the carboxylate of Glu427. The quinazoline core is located in a hydrophobic part of the pocket making face-to-edge contact with Phe495* and Phe494* side chains. The model revealed a small hydrophobic cavity, defined by the side chains of residues Phe346, Tyr348, and Val378, which could be reached from the 8-position of the quinazoline.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0002.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding model of compound <b>3</b> with TLR8. Amino acids belonging to one TLR8 monomer in green and the second monomer amino acid in light gray. Amino acids belonging to the green monomer were labeled with an asterisk. The PDB file of the model in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. Evolution of Hit Compound <b>3</b> to Lead Compound <b>8</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0012.gif" alt="" id="fx1" /></img><div class="scrollable-table-wrap"><table class="table "><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">IC<sub>50</sub> [μM]<a class="ref internalNav" href="#t1fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center"><b>3</b></th><th class="colsep0 rowsep0" align="center"><b>4</b></th><th class="colsep0 rowsep0" align="center"><b>5</b></th><th class="colsep0 rowsep0" align="center"><b>6</b></th><th class="colsep0 rowsep0" align="center"><b>7</b></th><th class="colsep0 rowsep0" align="center"><b>8</b></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR8 FRET</td><td class="colsep0 rowsep0" align="left">2.4 ± 2.0</td><td class="colsep0 rowsep0" align="left">0.22 ± 0.22</td><td class="colsep0 rowsep0" align="left">7.6 ± 1.8</td><td class="colsep0 rowsep0" align="left">1.7 ± 0.7</td><td class="colsep0 rowsep0" align="left">19 ± 5.4</td><td class="colsep0 rowsep0" align="left">3.7 ± 1.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR4 PBMCs</td><td class="colsep0 rowsep0" align="left">1.4 ± 0.48</td><td class="colsep0 rowsep0" align="left">5.9 ± 2.2</td><td class="colsep0 rowsep0" align="left">1.6 ± 1.5</td><td class="colsep0 rowsep0" align="left">0.25 ± 0.079</td><td class="colsep0 rowsep0" align="left">>4.2</td><td class="colsep0 rowsep0" align="left">>10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR7 PBMCs</td><td class="colsep0 rowsep0" align="left">1.5 ± 1.8</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">0.14 ± 0.013</td><td class="colsep0 rowsep0" align="left">0.034 ± 0.0021</td><td class="colsep0 rowsep0" align="left">0.014 ± 0.0078</td><td class="colsep0 rowsep0" align="left">0.028 ± 0.00071</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR8 PBMCs</td><td class="colsep0 rowsep0" align="left">0.091 ± 0.036</td><td class="colsep0 rowsep0" align="left">0.045 ± 0.012</td><td class="colsep0 rowsep0" align="left">0.32 ± 0.021</td><td class="colsep0 rowsep0" align="left">0.033 ± 0.0042</td><td class="colsep0 rowsep0" align="left">0.076 ± 0.021</td><td class="colsep0 rowsep0" align="left">0.039 ± 0.013</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TLR9 PBMCs</td><td class="colsep0 rowsep0" align="left">2.2 ± 0.96</td><td class="colsep0 rowsep0" align="left">>10</td><td class="colsep0 rowsep0" align="left">2.0 ± 0.55</td><td class="colsep0 rowsep0" align="left">0.20 ± 0.035</td><td class="colsep0 rowsep0" align="left">7.2 ± 1.8</td><td class="colsep0 rowsep0" align="left">>10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> determined as geometric mean (<i>n</i> ≥ 2) ± SD. Cytokine readouts for TLR7 and TLR9 (IFNα) and TLR8 and TLR4 (TNF) are shown.</p></div></div></div><div class="NLM_p">The 8-methylquinazoline <b>4</b> indeed showed an improved binding affinity and cellular potency, in agreement with the TLR8 model. However, when <b>4</b> was profiled against TLR7/8/9/4 in PBMCs, the compound lacked antagonism of TLR7 (<a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>), which was in contrast with our initial hypothesis that TLR7 and TLR8 are structurally and functionally equivalent. To rationalize this finding, we aligned the sequences of TLR7 and TLR8 (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf" class="ext-link">Supporting Information</a>) looking for nonconserved amino acids in TLR7 vs TLR8, which are in direct contact with the ligand.</div><div class="NLM_p">As highlighted in purple in <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>, we identified two amino acids that are different in TLR7. In TLR8, alanine 518* is a serine (530*) and glutamic acid 427 is a valine (430) in TLR7. Based on this analysis, we decided to morph the quinazoline core of <b>4</b> to an indazole as is the case in compound <b>5</b>. Our hypothesis was to avoid a steric clash of the hetero-bicyclic ring of the ligand with Ser530* in TLR7 and at the same time change the exit vector to the piperazine avoiding direct interaction with Glu427 in TLR8.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0003.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding model of compound <b>4</b> with TLR8; amino acid differences in TLR7 are shown in purple. Amino acids belonging to one TLR8 monomer are in green, and the second monomer amino acids are in light gray. Amino acids belonging to the green monomer are labeled with an asterisk. PDB file of the model is provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While compound <b>5</b> lost significant binding affinity to TLR8, the cellular TLR7 activity did increase to a similar potency level as TLR8, in line with our desired inhibition profile. The loss in binding affinity was attributed to the inability of <b>5</b> to directly interact with Glu427, but to get to a balanced TLR7/8 antagonist profile, we considered this necessary. The observed low micromolar antagonistic activity of <b>5</b> on TLR4 and TLR9 in PBMCs was not believed to be a result of receptor binding. Based on the structural dissimilarity of TLR4 and TLR9 to TLR8, we considered it highly unlikely that an equivalent antagonist binding pocket exists in these receptors (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf" class="ext-link">Supporting Information</a> for sequence alignment of human TLR7/8/9 ECD; the similarity to TLR4 was too low for an alignment with sufficient confidence). Hence, the cellular response on TLR4 and 9 is likely caused by an off-target effect. A methyl scan on the pyridone revealed the possibility of separating TLR7/8 from TLR4/9 antagonism (compounds <b>6</b>–<b>8</b> in <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a></a>). The 6-methyl derivative <b>8</b> displayed the desired cellular profile, with equipotent TLR7/8 antagonism, while eliminating measurable TLR4/9 effects. Based on this promising cellular TLR antagonism profile, the favorable physicochemical and <i>in vitro</i> absorption, distribution, metabolism, and excretion (ADME) profile (albeit with a moderate permeability) of compound <b>8</b>, it was selected as a lead structure (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>).</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0004.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Lead profile of compound <b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Lead Optimization</h3><div class="NLM_p">TLR8 receptor binding and permeation were key parameters for further optimization. Systematic modification of the indazole substituents (R, R′, and R″) was aimed at identifying the substituent with the strongest contribution to TLR8 binding (<a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a></a>), which ultimately could be combined in a single molecule with an overall acceptable profile. For this phase of the project, TLR8 binding and cellular data were used for decision-making in terms of compound potency. TLR7 and TLR4 cellular data were generated for selected compounds as tertiary assays to confirm that the desired dual antagonism profile was maintained.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Structure–Activity Relationship of 5-Indazol-5-yl Pyridones<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0013.gif" alt="" id="fx2" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0014.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0015.gif" alt="" id="fx4" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> determined as the geometric mean (<i>n</i> ≥ 2) ± SD.</p></div><div class="footnote" id="t2fn2"><sup><sup>bS</sup></sup><p class="last">ingle measurement.</p></div><div class="footnote" id="t2fn3"><sup><sup>c</sup></sup><p class="last">Measured p<i>K</i><sub>a</sub> of the corresponding <i>R</i>-enantiomer. n.d., not determined.</p></div></div><div></div></div><div class="NLM_p">For the pyridone (R) position, the binding model suggested only limited space for further growth from the 6-position. Consequently, we focused on substituents maintaining or slightly decreasing the size. The 6-fluoro-substituted pyridone <b>9</b> displayed a slightly improved binding affinity, whereas the 6-chloro derivative <b>10</b> was similar to the methyl pyridone. We hypothesized that annulation to a 6,5-bicylic system would have a similar effect of slight size reduction at the 6-position due to the ring constraint and that such a compound could nicely fit into the binding pocket. Indeed, incorporation of the annulated 5-membered rings in <b>11</b> and <b>12</b> led to improved affinities in TLR8 binding and improved the cellular TLR8 antagonism.</div><div class="NLM_p">The important contribution to binding of the indazole substituent (R′) at the 7-position was confirmed by the loss in affinity for the unsubstituted compound <b>13</b>. A slightly larger R′ residue compared to a methyl group was expected to optimally fill the hydrophobic subpocket. In line with this, chloro-substituted <b>14</b> was equipotent, but trifluoromethyl <b>15</b> and cyclopropyl <b>16</b> both led to a small but consistent positive effect on TLR8 binding and cellular antagonism.</div><div class="NLM_p last">According to the binding model, the piperidine portion of the molecule (R″) is located at the exit of the binding pocket facing the solvent. As a consequence, we did not expect a significant gain in binding affinity by modifications in this area. The basic piperidine nitrogen could be <i>N</i>-methylated (<b>17</b>), acylated with dimethylamino acetamide (<b>18</b>), or moved to the 3-position (<b>19</b>) without loss of potency, in line with the above hypothesis. For the 3-piperidine, the impact of basicity on the ratio of binding affinity and cellular potency was studied by modulation of p<i>K</i><sub>a</sub> either through introduction of fluorines or by aromatization. While the TLR8 binding affinity remained comparable for the fluorinated piperidines <b>20</b>, <b>21</b>, and trifluoroethyl-substituted <b>23</b>, it was increased for pyridine <b>22</b>. Basic compounds with a p<i>K</i><sub>a</sub> of 6.2 or higher consistently gained in cellular potency relative to the binding affinity, whereas compounds with a p<i>K</i><sub>a</sub> of 4.7 and below had comparable binding affinities and cellular potencies. These data are consistent with a p<i>K</i><sub>a</sub>-dependent permeability leading to the colocalization of basic compounds with the receptor in acidic endosomes.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> Based on the SAR generated in the piperidine (R″) position, we kept the 4-piperidine substituent for further optimization; the pyridine was deprioritized based on the lack of sp<sup>3</sup> carbons.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a></div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10"> Cocrystal Structure of <b>11</b> with TLR8 ECD</h3><div class="NLM_p">Cocrystals of compound <b>11</b> with the TLR8 ECD suitable for X-ray diffraction analysis were obtained. The structure was solved with a resolution of 2.79 Å, and it confirmed the expected binding mode of the antagonist at the interface of the dimeric TLR8 units in two symmetrical pockets (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>a,b). The protein adopts a conformation very similar to the apo form, which is in line with stabilization of the inactive state, leading to antagonism as the mode of action of these compounds. The structural basis of inhibition is believed to be the same as has been published and well described in detail in the literature.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0005.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cocrystal structure of compound <b>11</b> with TLR8 ECD: (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TY5">6TY5</a>) (a) full view, one TLR8 monomer in green, the second monomer in light gray, compound <b>11</b> in light blue; (b) top view, turned by 90°; (c) close-up view on one binding site showing amino acids within 5 Å of <b>11</b>, except for Phe261, which is not shown for clarity. Amino acids belonging to the green monomer were labeled with an asterisk. (d) Side view of the binding site only showing one monomer with surface representation and the 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> map contoured at 1.0 σ for the bound inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The binding mode in the two individual sites is very similar and can be superimposed. In the binding sites, there are only minor changes in the orientation of residues compared to the apo structure of TLR8. The postulated key interaction of the pyridone carbonyl with the backbone NH of Gly351was nicely confirmed. In addition, two water-mediated hydrogen bonds from the pyridone carbonyl to Gln529* and from the indazole nitrogen to Tyr576* were observed (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>c). The 7-methyl indazole substituent fills the hydrophobic subpocket described above, and the piperidine points into the solvent without directly contacting Glu427 (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>d). Taken together, this experimental data was in good agreement with our model that had been used to drive the optimization and the SAR generated. This indicates that even though the binding pocket is at the interface of two large proteins and made up of flexible loops, it is well suited for structure-based compound optimization.</div><div class="NLM_p">Based on the SAR information generated in all three parts (R, R′, and R″) of the molecule, we then explored the synergy of single effects by preparing two combinations with substituents we considered optimal (<a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a></a>). Both compounds <b>24</b> and <b>25</b> showed additive effects for enhanced TLR8 affinity and were considered as candidates for testing <i>in vivo</i>. For the 6-fluoro pyridone <b>24</b>, we had concerns about potential chemical reactivity with nucleophiles, even though during the synthesis (<i>vide infra</i>) we had not observed any byproducts resulting from fluoride substitution even under basic conditions and heating. To assess the potential reactivity of the 6-fluoro pyridone in a physiologically more relevant system, we exposed <b>24</b> to 5 mM glutathione (GSH)<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> in aqueous phosphate buffer (pH 7) at room temperature (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf" class="ext-link">Supporting Information</a>). We observed the formation of a new product by liquid chromatography–mass spectrometry (LC–MS), which by mass was consistent with fluoride substitution with GSH (32% conversion after 15.5 h assuming the same absorption of <b>24</b> and adduct at 254 nm). This qualitative observation of reactivity led to the decision not to pursue the 6-fluoro pyridone structural motif any further due to the risk of unspecific covalent adduct formation in cells and later <i>in vivo</i>.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Combination of R Groups</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0016.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> determined as geometric mean (<i>n</i> ≥ 2) ± SD.</p></div></div><div></div></div><div class="NLM_p">The combination of the bicyclic pyridone with the CF<sub>3</sub>-indazole in <b>25</b> resulted in the lowest cellular IC<sub>50</sub> of 2.7 nM we had observed so far. However, to our disappointment, the <i>in vitro</i> passive permeability measured in the low efflux (LE)-MDCK assay was significantly lower than for <b>24</b> (P<sub>app</sub><b>24</b>: 4.8 cm/s*10<sup>–6</sup> → <b>25</b>: 1.8 cm/s*10<sup>–6</sup>). This was in line with a reduction in log <i>D</i> (<b>24</b>: 0.63 → <b>25</b>: 0.3), indicating that the annulation at the pyridone resulted in increased polarity, which was limiting the permeation.</div><div class="NLM_p">Our strategy to improve the permeation properties of compound <b>25</b> was to slightly lower the p<i>K</i><sub>a</sub> to reduce the fraction ionized at neutral pH, but only to a degree at which the cellular potency was not negatively impacted as previously observed. Both cis and trans isomers of the 3-fluoropiperidine derivatives shown in <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a></a> were prepared, the trans isomer in both enantiopure forms. This desired effect on lowering the p<i>K</i><sub>a</sub> translated into a significantly higher permeability for all stereoisomers. Interestingly, we observed an improvement in the TLR8 binding affinity for the trans isomers <b>26</b> and <b>27</b> relative to the nonfluorinated <b>25</b> and the racemic cis isomer <b>28</b>.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. Fluorinated Analogs of <b>25</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0017.gif" alt="" id="fx6" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> determined as geometric mean (<i>n</i> ≥ 2) ± SD.</p></div></div><div></div></div><div class="NLM_p">In an attempt to rationalize the effect of the relative stereochemistry in the 3-F-piperidines on the binding affinities, the lowest energy solution conformations of compounds <b>27</b> and <b>28</b> were calculated with a high-accuracy quantum-chemistry-based calculation method.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> As shown in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>, the lowest energy conformations of the cis and trans isomers have a different preference for the dihedral angle about the bond connecting the indazole and piperidine rings (63° for <b>27</b>; 94° for <b>28</b>). The conformation of the piperidine is nearly inverted between the two isomers. The lowest energy conformation of the trans isomer is characterized by a fluorine atom in an equatorial position and the basic nitrogen pointing toward the same direction as the nitrogen acceptor of the indazole ring. In the case of the cis isomer, the fluorine atom is in an axial position and the basic nitrogen is pointing toward the opposite direction. The orientation of the fluorine could explain the observed difference in p<i>K</i><sub>a</sub> for both isomers,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> thereby further increasing our confidence in the relevance of the calculated conformations. The calculated lowest energy conformation is in agreement with a conformation observed in a crystal structure of <b>27</b> where the measured dihedral angle is similar (53°, <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>). The unit cell in the crystal structure of compound <b>27</b> contains two molecules. One of this is displayed in <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>; the other molecule is disordered and has a 60:40 ratio of two rotamers about the piperidine indazole bond (see the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf" class="ext-link">Supporting Information</a>). This structure also unambiguously proved the chemical structure and absolute stereochemistry of <b>27</b>.</div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0006.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Calculated lowest energy conformations of <b>28</b> and <b>27</b> in water at neutral pH and small-molecule crystal structure of <b>27</b> (CCDC 1979262). Orange lines indicate dihedral angles about the indazole–piperdine C–C bond.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">While the moderate resolution of the TLR8 cocrystal structure obtained with compound <b>11</b> does not allow one to experimentally determine the exact binding conformation in the region of the piperidine, we propose that the introduction of the fluorine in the trans isomer is responsible for the stabilization of the bioactive conformation, leading to the increased binding affinity.</div><div class="NLM_p">Compound <b>27</b> combined high TLR8 binding affinity and TLR8 cellular potency in human PBMCs with good permeation and was therefore selected for broader characterization <i>in vitro</i> and <i>in vivo</i>. As summarized in <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>, compound <b>27</b> is a highly potent, dual TLR7/8 antagonist in human PBMCs and blood. Furthermore, <b>27</b> was very selective against a panel of other human TLR isoforms and IL1R-driven cytokine pathways with an overall selectivity profile >1000-fold. It displayed cross-species activity albeit slightly weaker, with selective inhibition of TLR7-driven cytokine responses in mouse blood. Compound <b>27</b> has a favorable physicochemical and <i>in vitro</i> ADME profile with good solubility, passive permeability, and low clearance in liver microsomes of mouse, rat, and human. This translated into a good pharmacokinetic profile of <b>27</b> in mice and rats (see <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). In both species, the compound had a low to moderate clearance and a good to excellent oral bioavailability. Overall, the profile was attractive to assess oral efficacy in an acute TLR-driven mechanistic <i>in vivo</i> mouse model.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. TLR Pathway and Selectivity, Physicochemical, ADME, and Pharmacokinetic (PK) Profile of <b>27</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0018.gif" alt="" id="fx7" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup><sup>a</sup></sup><p class="last">IC<sub>50</sub> determined as geometric mean (<i>n</i> ≥ 2) ± SD. Cytokine readouts for TLR7, TLR9 (IFNα), and TLR8 (TNF) are shown. Similar TLR8 IC<sub>50</sub> value of 0.0021 ± 0.0034 μM using LMW agonist R848 (1 μg/mL) to induce TNF in PBMCs.</p></div><div class="footnote" id="t5fn2"><sup><sup>b</sup></sup><p class="last">mean (<i>n</i> = 3) ± SD. n.a., not applicable; dn, dose normalized to 1 mg/kg.</p></div></div><div></div></div></div><div id="sec2_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i14" class="anchor-spacer"></div><h3 class="article-section__title" id="_i14"> <i>In Vivo</i> Evaluation</h3><div class="NLM_p">The <i>in vivo</i> efficacy of <b>27</b> was assessed in a short-term mechanistic model in mice. It is controversial whether murine TLR8 is functional or not;<a onclick="showRef(event, 'ref23 ref24'); return false;" href="javascript:void(0);" class="ref ref23 ref24">(23,24)</a> however, cells that express TLR8 in humans express TLR7 in mice and respond to ssRNA40. Therefore, TLR7-dependent responses were used as surrogate readouts. Groups of animals were dosed orally with different doses of compound <b>27</b>, one hour prior to intravenous injection of ssRNA to elicit a TLR7 response. Two hours later, IFNα protein and compound levels were determined from circulation, and dose-dependent inhibition of IFNα release was demonstrated (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). These data are consistent with the <i>in vitro</i> efficacy of compound <b>27</b> in mouse blood, where TLR7-driven IFNα inhibition was observed at IC<sub>50</sub> = 180 nM. Collectively, these results demonstrate that compound <b>27</b> is an efficacious TLR7 pathway inhibitor <i>in vivo</i> and has potential for further development toward use in TLR7/8-driven autoimmune diseases.</div><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0007.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>27</b> inhibits TLR7-dependent IFNα secretion in mice <i>in vivo</i>. Exposure (blue squares) in blood and concentration of IFNα in serum (gray bars) at the indicated doses are shown. Data points for compound-treated groups represent means of <i>n</i> = 5 mice and for the vehicle-treated group means of <i>n</i> = 10 mice ± SD. Pooled data from two experiments. Horizontal dotted blue line represents <i>in vitro</i> TLR7 IC<sub>50</sub> of compound <b>27</b> in mouse whole blood (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001 for IFNα, analysis of variance (ANOVA) with Dunnett’s post test, compared to the vehicle group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i15" class="anchor-spacer"></div><h3 class="article-section__title" id="_i15"> Compound Synthesis</h3><div class="NLM_p">The initial compounds containing a quinazoline core (<b>3</b> and <b>4</b>) were prepared by S<sub>N</sub>Ar of 6-bromo-2-chloro quinazolines <b>31</b> and <b>32</b> with <i>N</i>-alkyl piperazines followed by Suzuki coupling with pyridone-3-pinacol boronic ester <b>35</b> as shown in <a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>. 6-Bromo-2-chloro-8-methyl-quinazoline (<b>32</b>) was prepared in four steps from anthranilic acid <b>29</b>.</div><figure id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0008.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Quinazoline Core Containing Compounds 3 and 4<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) LiAlH<sub>4</sub>, tetrahydrofuran (THF), 0 °C; 79%; (b) MnO<sub>2</sub>, dichloromethane (DCM), room temperature (RT); 91%; (c) urea, 180 °C; quant.; (d) POCl<sub>3</sub>, 110 °C; 50%; (e) <i>N</i>-methyl-2-pyrrolidinone (NMP), 150 °C; (f) PdCl<sub>2</sub>(dppf), aq. Na<sub>2</sub>CO<sub>3</sub>, 1,2-dimethoxyethane (DME), 80 °C.</p></p></figure><div class="NLM_p">The first synthetic route to the indazol-5-pyridones is shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>. Indazoles lacking an 8-substituent could be conveniently prepared starting with a reductive Cadogan cyclization of 5-bromo-2-nitrobenzaldehyde (<b>36</b>) with primary amines.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> The resulting 5-bromo indazoles were coupled with 5-halo pyridinones in a one-pot borylation/Suzuki coupling sequence.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> We found that, generally, borylation of the indazole followed by coupling with a 5-halo pyridone was preferred over borylation of the pyridone followed by coupling. Due to the lack of efficient synthetic access to the corresponding nitro benzaldehydes, the 8-substituted indazoles were accessed by <i>N</i>-alkylation of the indazoles at the 2-position. However, this reaction resulted in mixtures of regioisomers of 1- and 2-alkylated products that needed to be separated by chromatography. To avoid this, we developed an alternative synthesis that is shown in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>.</div><figure id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0009.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. First-Generation Syntheses of Indazole-Core-Containing Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Ag<sub>2</sub>SO<sub>4</sub>, I<sub>2</sub>, EtOH, RT; 67%; (b) NaNO<sub>2</sub>, AcOH, RT; 83%; (c) Cs<sub>2</sub>CO<sub>3</sub>, <i>N</i>,<i>N-</i>dimethylacetamide (DMA), 150 °C; (d) NaH, DMF, 100 °C; (e) 2-PrOH, 80 °C; then, PBu<sub>3</sub>, 80 °C; (f) CuI, phenanthroline, TMSCF<sub>3</sub>, KF, B(OMe)<sub>3</sub>, dimethyl sulfoxide (DMSO), 60 °C; (g) XPhos Pd G3, XPhos, B<sub>2</sub>(OH)<sub>4</sub>, KOAc, EtOH, 80 °C; (h) K<sub>2</sub>CO<sub>3</sub>, 80 °C; (i) trifluoroacetic acid (TFA) or HCl, DCM, RT; (j) formaldehyde, AcOH, NaBH(OAc)<sub>3</sub>, DCM; (k) 2-(dimethylamino)acetic acid, <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate (HATU), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), DMF, RT.</p></p></figure><figure id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0010.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Second-Generation Synthesis of Indazole-Core-Containing Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NBS, DCM, RT; 91%; (b) LiAlH<sub>4</sub>, THF, 0 °C; 72%; (c) MnO<sub>2</sub>, DCM, RT; 96%; (d) HCl, NaNO<sub>2</sub>, H<sub>2</sub>O, 0 °C to RT; then, NaN<sub>3</sub>, 0°C to RT; quant.; (e) RNH<sub>2</sub>, Cu<sub>2</sub>O, DCE, 80 °C; (f) XPhos Pd G3, XPhos, B<sub>2</sub>(OH)<sub>4</sub>, KOAc, EtOH, 80 °C; then, K<sub>2</sub>CO<sub>3</sub>, 80 °C; (g) TFA, DCM, RT; (h) <i>n</i>-BuLi, THF, −78°C; 47%; (i) 48% HBr, reflux, then NaOH; 98%; (j) NBS, DMF, RT; 42%.</p></p></figure><div class="NLM_p">The second-generation synthesis relied on a reductive cyclization of azido benzaldehydes with primary amines to build the 2-alkyl indazole core. We found that this reaction proceeded smoothly when preformed in 1,2-dichloroethane at 80 °C in the presence of catalytic copper(I) oxide.<a onclick="showRef(event, 'ref27 ref28'); return false;" href="javascript:void(0);" class="ref ref27 ref28">(27,28)</a> The appropriately substituted azido benzaldehyde <b>45</b> could be conveniently accessed in four robust steps from readily available anthranilic acid <b>44</b>. The synthesis of the bicyclic bromo-pyridone <b>51</b> started with bromo-lithium exchange on 2-bromo-6-methoxypyridine (<b>49</b>) followed by alkylation with THP-protected 3-bromo propanol to give <b>50</b>. The following two steps have been reported previously<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> and gave rise to <b>51</b>. Two-step one-pot borylation/Suzuki coupling as described above followed by Boc cleavage furnished compounds <b>26</b>–<b>28</b>.</div><div class="NLM_p">To be able to introduce the basic amine in the molecule at the very end of the synthesis, we developed an alternative route relying on the steps described in <a class="ref internalNav" href="#sch3" aria-label="Scheme 3">Scheme 3</a>, but in a different order. As shown in <a class="ref internalNav" href="#sch4" aria-label="Scheme 4,">Scheme 4,</a> pyridone-coupled azido benzaldehyde <b>55</b> was prepared in three steps from <b>52</b>. The copper-catalyzed cyclization proceeded smoothly to furnish the indazoles <b>20</b>–<b>23</b>.</div><figure id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0011.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Alternative Route with Late-Stage Introduction of Amine<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) XPhos Pd G3, XPhos, B<sub>2</sub>(OH)<sub>4</sub>, KOAc, EtOH, 80 °C; then, K<sub>2</sub>CO<sub>3</sub>, 80 °C; 80%; (b) MnO<sub>2</sub>, DCM, RT; 91%; (c) HCl, NaNO<sub>2</sub>, H<sub>2</sub>O, 0 °C to RT; then, NaN<sub>3</sub>, 0 °C to RT; 87%; (d) Cu<sub>2</sub>O, DCE, 80 °C; (e) HCl, DCM, RT.</p></p></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i20">Conclusions</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05367" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05367" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Herein, we have reported a novel biochemical TLR8 antagonist binding assay that is amenable to high-throughput screening. Together with structural data on TLR8, this assay proved to be highly effective in optimizing pyridone screening hit <b>3</b> into the highly potent and selective dual TLR7/8 antagonist <b>27</b>, which demonstrated <i>in vivo</i> efficacy after oral dosing in mice.</div><div class="NLM_p">It is noteworthy that others have reported TLR8 selective antagonists that bind in the same pocket,<a onclick="showRef(event, 'ref19 ref31'); return false;" href="javascript:void(0);" class="ref ref19 ref31">(19,31)</a> similar to our early compound <b>4</b>. An ECD sequence alignment with TLR7 allowed us to morph this hit into a dually active TLR7/8 antagonist. We assumed that for TLR7 an equivalent pocket for antagonist binding exists. However, this ultimately would need to be proven by a TLR7 structure in complex with an antagonist.</div><div class="NLM_p last">To the best of our knowledge, this is the first report of a ligand binding assay for an endosomal TLR and the use of such an assay as a screening tool enabling optimization of TLR8 antagonists biochemically. This target-based approach is an attractive alternative to cellular phenotypic-based screens in which optimization of hits proved to be more complex.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i21">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_81880" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_81880" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> Chemistry: General information</h3><div class="NLM_p">Unless otherwise stated, all commercial reagents were used as supplied without further purification and all reactions were performed under a nitrogen atmosphere using dry solvents under anhydrous conditions. Compounds were purified by flash column chromatography using Redisep Rf flash columns with a Teledyne Isco CombiFlash Rf companion using gradient elution with the solid phase and eluents given in parentheses or by preparative high-performance liquid chromatography (HPLC) on a Gilson HPLC prep-system using C-18 OBD, 100 mm × 30 mm, a 5 μm SunFire Prep column using decreasingly polar mixtures of acetonitrile in water with a TFA modifier or Agilent 1260 Infinity systems equipped with DAD and mass detectors using a Waters X-bridge column, 100 Å, 5 μm, 19 mm × 100 mm with a SunFire C18 Prep Guard Cartridge, 100 Å, 10 μm, 19 mm × 10 mm, using a MeOH/water optimized gradient elution or a supercritical fluid chromatography (SFC) system using Waters SFC 100 prep-system Reprospher C18 WCX, 5 μm, 100 Å, 250 mm × 30 mm with a Waters 2998 photodiode array (PDA) detector and a Waters 3100 mass detector using supercritical CO<sub>2</sub>/MeOH optimized gradient elution. <sup>1</sup>H and <sup>13</sup>C NMR spectra were obtained on a Bruker UltrashieldTM 600 (600 MHz) or a 400 MHz DRX Bruker CryoProbe (400 MHz) spectrometer. Chemical shifts (δ-values) are reported in ppm downfield from tetramethylsilane; spectra splitting patterns are designated as singlet (s), doublet (d), triplet (t), quartet (q), pentet (p) multiplet, unresolved or more overlapping signals (m), and broad signal (br). <sup>19</sup>F data were recorded at 300 K using a Bruker 500 MHz AVANCE III spectrometer equipped with a 5 mm BBO probe with a <i>z</i>-gradient system; shifts were referenced to CCl3F = 0.0 ppm. All tested compounds have purity ≥95% as determined by the Waters ACQUITY ultraperformance liquid chromatograph (UPLC) using the reverse phase column (Acquity HSS T3 1.8 μm, 2.1 mm × 50 mm) and a solvent gradient of A (H<sub>2</sub>O with 0.05% formic acid and 3.75 mM ammonium acetate) and solvent B (CH<sub>3</sub>CN with 0.04% formic acid) coupled to electrospray ionization (ESI) with positive/negative ion switching on a single-stage quadrupole detector acquiring mass spectra over a mass range from 100 to 1200 <i>m</i>/<i>z</i> or by the Agilent 1100 Series LC/MSD system with DAD/ELSD. Analytical chiral HPLC was performed on a Shimadzu LC-10 analytical system with a UV detector, Chiralpak IC column, 5 μm, 4.6 mm × 250 mm, detection wavelength of 240 nm, using heptane/DCM/isopropanol 50:20:30 with 0.05% diethylamine.</div><div id="sec4_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 5-(2-(4-Cyclobutylpiperazin-1-yl)quinazolin-6-yl)-1-methylpyridin-2(1<i>H</i>)-one (<b>3</b>)</h4><div class="NLM_p last">Compound <b>3</b> was prepared according to the procedure described for compound <b>4</b> replacing <b>32</b> by 6-bromo-2-chloroquinazoline (<b>31</b>) and 1-isopropylpiperazine by 1-cyclobutylpiperazine. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.19 (s, 1H), 8.24 (d, <i>J</i> = 2.7 Hz, 1H), 8.03 (d, <i>J</i> = 2.2 Hz, 1H), 8.00 (dd, <i>J</i> = 8.9, 2.3 Hz, 1H), 7.93 (dd, <i>J</i> = 9.5, 2.8 Hz, 1H), 7.55 (d, <i>J</i> = 8.7 Hz, 1H), 6.52 (d, <i>J</i> = 9.4 Hz, 1H), 3.86 (t, <i>J</i> = 5.0 Hz, 4H), 3.53 (s, 3H), 2.73 (p, <i>J</i> = 7.8 Hz, 1H), 2.34 (t, <i>J</i> = 5.1 Hz, 4H), 2.04–1.96 (m, 2H), 1.88–1.80 (m, 2H), 1.65 (tt, <i>J</i> = 10.3, 7.3 Hz, 2H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.88, 161.11, 158.61, 150.60, 138.58, 137.30, 132.14, 130.07, 125.67, 123.26, 119.37, 119.35, 116.86, 59.66, 48.80, 43.48, 37.06, 26.57, 14.05. HRMS-ESI [M + H]<sup>+</sup><i>m</i>/<i>z</i> calcd for C<sub>22</sub>H<sub>25</sub>N<sub>5</sub>O 376.2132; found 376.2144.</div></div><div id="sec4_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 5-(2-(4-Isopropylpiperazin-1-yl)-8-methylquinazolin-6-yl)-1-methylpyridin-2(1<i>H</i>)-one (<b>4</b>)</h4><div class="NLM_p last">Step a: (2-Amino-5-bromo-3-methylphenyl)methanol (<b>52</b>). A solution of 2-amino-5-bromo-3-methylbenzoic acid (<b>29</b>, 500 mg, 2.17 mmol) in THF (9.00 mL) at 0 °C was treated dropwise with LiAlH<sub>4</sub> in THF (2.3 M, 1.89 mL, 4.35 mmol). The reaction mixture was allowed to warm to RT for 1 h; then, more LiAlH<sub>4</sub> in THF (2.3 M, 1.89 mL, 4.35 mmol) was added and the reaction mixture was stirred at RT for 1.5 h. The reaction mixture was quenched by slow addition of water (0.352 mL, 19.6 mmol) (warning: gas evolution) followed by addition of 1 M aq. NaOH (1.52 mL, 1.52 mmol). The resulting suspension was filtered, and the solid was rinsed with EtOAc. The filtrate was concentrated, and the residue was purified by flash chromatography (silica gel, DCM/MeOH) to give <b>52</b> as a light-brown powder (371 mg, 79%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.07 (d, <i>J</i> = 2.1 Hz, 1H), 7.02 (d, <i>J</i> = 2.1 Hz, 1H), 5.12 (t, <i>J</i> = 5.5 Hz, 1H), 4.77 (s, 2H), 4.35 (d, <i>J</i> = 5.5 Hz, 2H), 2.05 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 216.1 [M + H]<sup>+</sup>. Step b: 2-Amino-5-bromo-3-methylbenzaldehyde (<b>30</b>). To a solution of <b>52</b> (370 mg, 1.71 mmol) in DCM (8.00 mL) was added MnO<sub>2</sub> (1.16 g, 12.00 mmol), and the suspension was stirred at RT for 5 h. Subsequently, more MnO<sub>2</sub> (447 mg, 5.14 mmol) was added and the reaction mixture was stirred at RT for 16 h. The suspension was filtered over a pad of hyflo, and the solid was rinsed with DCM. The filtrate was concentrated to give <b>30</b> as an orange powder (334 mg, 91%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.78 (s, 1H), 7.62 (d, <i>J</i> = 2.3 Hz, 1H), 7.38 (d, <i>J</i> = 1.9 Hz, 1H), 7.08 (s, 2H), 2.10 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 214.1 [M + H]<sup>+</sup>. Step c: 6-Bromo-8-methylquinazolin-2(1<i>H</i>)-one. A mixture of <b>30</b> (333 mg, 1.56 mmol) and urea (1.40 g, 23.3 mmol) was stirred at 180 °C for 1 h. The obtained yellow solid was cooled to RT, triturated in water, filtered, rinsed with water, and dried under high vacuum to give the title compound (444 mg, 100%). ESI-MS <i>m</i>/<i>z</i> 239.1 [M + H]<sup>+</sup>. Step d: 6-Bromo-2-chloro-8-methylquinazoline (<b>32</b>). A suspension of 6-bromo-8-methylquinazolin-2(1<i>H</i>)-one (443 mg, 1.56 mmol) and POCl<sub>3</sub> (2.03 mL, 21.8 mmol) was stirred at 110 °C for 30 min. The reaction mixture was cooled to RT and poured into ice water. It was then neutralized with saturated aq. NaHCO<sub>3</sub> and extracted with DCM (3 times). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash chromatography (silica gel, heptanes/EtOAc) to give <b>32</b> as a light-yellow powder (215 mg, 50%). <sup>1</sup>H NMR: δ 9.52 (s, 1H), 8.33 (d, <i>J</i> = 2.1 Hz, 1H), 8.11 (s, 1H), 2.62 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 257.1 [M + H]<sup>+</sup>. Step e: 6-Bromo-2-(4-isopropylpiperazin-1-yl)-8-methylquinazoline (<b>34</b>). In a sealed tube, a mixture of <b>32</b> (100 mg, 0.388 mmol) and 1-isopropylpiperazine (149 mg, 1.16 mmol) in NMP (1.00 mL) was stirred at 150 °C for 1 h. The reaction mixture was cooled to RT and poured into water; the product was then extracted twice with EtOAc. The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash chromatography (silica gel, DCM/MeOH) to give <b>34</b> as an orange oil (107 mg, 79%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.11 (s, 1H), 7.89 (d, <i>J</i> = 2.1 Hz, 1H), 7.72–7.68 (m, 1H), 3.88–3.79 (m, 4H), 2.72–2.63 (m, 4H), 2.53–2.50 (m, 4H), 0.98 (d, <i>J</i> = 6.5 Hz, 6H). ESI-MS <i>m</i>/<i>z</i> 349.2 [M + H]<sup>+</sup>. Step f: 5-(2-(4-Isopropylpiperazin-1-yl)-8-methylquinazolin-6-yl)-1-methylpyridin-2(1<i>H</i>)-one (<b>4</b>). A mixture of <b>34</b> (30 mg, 0.086 mmol), 1-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)pyridin-2(1<i>H</i>)-one (40.4 mg, 0.172 mmol), PdCl<sub>2</sub>(dppf) (3.14 mg, 4.29 μmol), and aq. Na<sub>2</sub>CO<sub>3</sub> (2 M, 0.129 mL, 0.258 mmol) in DME (500 μL) was stirred at 80 °C for 2 h. The reaction mixture was cooled to RT, diluted with EtOAc, and washed with water. The organic phase was dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash chromatography (C18, (H<sub>2</sub>O + 0.1% TFA)/MeCN), and then a basic workup was performed to remove the TFA salt (aq. Na<sub>2</sub>CO<sub>3</sub> and extraction with DCM) to give <b>4</b> (10.4 mg, 32%) as a yellow powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.13 (s, 1H), 8.20 (d, <i>J</i> = 2.6 Hz, 1H), 7.90 (dd, <i>J</i> = 9.5, 2.6 Hz, 1H), 7.85 (d, <i>J</i> = 13.7 Hz, 2H), 6.49 (d, <i>J</i> = 9.5 Hz, 1H), 3.90–3.81 (m, 4H), 3.51 (s, 3H), 2.73–2.67 (m, 1H), 2.55–2.51 (m, 7 H), 0.99 (d, <i>J</i> = 6.5 Hz, 6H). ESI-MS <i>m</i>/<i>z</i> 378.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> 5-Bromo-7-iodo-1<i>H</i>-indazole (<b>37d</b>)</h4><div class="NLM_p last">4-Bromo-2-methylaniline (2.0 g, 10.8 mmol) was dissolved in EtOH (40.0 mL). Silver sulfate (3.35 g, 10.8 mmol) and iodine (2.75 g, 10.8 mmol) were added, and the mixture was stirred at RT for 4 h. The solvent was evaporated, and the residue was dissolved in DCM (50.0 mL), washed with 1 M aq. NaOH (3 times 40.0 mL) and water (30.0 mL), dried with sodium sulfate, and evaporated to dryness to give 4-bromo-2-iodo-6-methylaniline (2.30 g, 67%) as a solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.55 (d, <i>J</i> = 2.3 Hz, 1H), 7.16 (d, <i>J</i> = 2.3 Hz, 1H), 5.03 (s, 2H), 2.14 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 311.9, 313.9 [M + H]<sup>+</sup>. A solution of 4-bromo-2-iodo-6-methylaniline (2.3 g, 7.37 mmol) in acetic acid (30.0 mL) was treated with sodium nitrite (0.560 g, 8.11 mmol) in water (2.00 mL) and stirred at RT for 0.5 h. The solvent was evaporated to dryness. The residue was triturated with water (20.0 mL) for 15 min. The suspension was filtered and dried in vacuo to give <b>37d</b> (2.20 g, 83%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.55–13.32 (m, 1H), 8.23 (s, 1H), 8.03 (d, <i>J</i> = 1.6 Hz, 1H), 7.87 (d, <i>J</i> = 1.9 Hz, 1H). ESI-MS <i>m</i>/<i>z</i> 322.8, 324.8 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>tert</i>-Butyl 4-(5-Bromo-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate (<b>38</b>)</h4><div class="NLM_p last">A mixture of 5-bromo-2-nitrobenzaldehyde <b>36</b> (100 mg, 0.435 mmol) and <i>tert</i>-butyl 4-aminopiperidine-1-carboxylate (96.0 mg, 0.478 mmol) in 2-PrOH (1.50 mL) was stirred at 80 °C for 2 h, cooled to RT, and treated with PBu<sub>3</sub> (0.322 mL, 1.30 mmol). The reaction mixture was then stirred at 80 °C overnight. The reaction mixture was cooled to RT, diluted with EtOAc, and washed with saturated aq. NH<sub>4</sub>Cl and brine. The organic phase was then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude material was purified by flash chromatography (silica gel, heptanes/EtOAc) to give <b>38</b> (121 mg, 69%) as a yellow powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.43 (s, 1H), 7.93 (d, <i>J</i> = 1.3 Hz, 1H), 7.58 (d, <i>J</i> = 9.1 Hz, 1H), 7.29 (dd, <i>J</i> = 9.1, 1.9 Hz, 1H), 4.76–4.65 (m, 1H), 4.07 (d, <i>J</i> = 12.6 Hz, 2H), 3.02–2.82 (m, 2H), 2.09 (d, <i>J</i> = 10.1 Hz, 2H), 1.99–1.85 (m, 2H), 1.41 (s, 9H). ESI-MS <i>m</i>/<i>z</i> 380.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>tert</i>-Butyl 4-(5-Bromo-7-methyl-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate (<b>39</b>)</h4><div class="NLM_p last">In a sealed tube, a mixture of 5-bromo-7-methyl-1<i>H</i>-indazole (<b>37a</b>) (500 mg, 2.37 mmol), <i>tert</i>-butyl 4-((methylsulfonyl)oxy)piperidine-1-carboxylate (794 mg, 2.84 mmol), and Cs<sub>2</sub>CO<sub>3</sub> (1.54 g, 4.74 mmol) in DMA (7.00 mL) was stirred at 150 °C overnight. The reaction mixture was cooled to room temperature, diluted with EtOAc, and washed with water. The organic phase was then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude material was purified twice by flash chromatography ((silica gel, heptanes/EtOAc) and (C18, (H<sub>2</sub>O + 0.1%TFA)/MeCN)). The obtained material was treated with saturated aq. Na<sub>2</sub>CO<sub>3</sub> and extracted with DCM. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give <b>39</b> (243 mg, 26%) as an oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.39 (s, 1H), 7.67–7.78 (m, 1H), 7.15–7.03 (m, 1H), 4.80–4.60 (m, 1H), 4.08 (d, <i>J</i> = 12.4 Hz, 2H), 3.03–2.82 (m, 2H), 2.48 (s, 3H), 2.13–2.06 (m, 2H), 1.98–1.85 (m, 2H), 1.41 (s, 9H). ESI-MS <i>m</i>/<i>z</i> 394.2 [M + H]<sup>+</sup> and its regioisomer <i>tert</i>-butyl 4-(5-bromo-7-methyl-1<i>H</i>-indazol-1-yl)piperidine-1-carboxylate (214 mg, 23%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.03 (s, 1H), 7.80 (d, <i>J</i> = 1.3 Hz, 1H), 7.32–7.22 (m, 1H), 5.04–4.89 (m, 1H), 4.10–4.01 (m, 2H), 3.06–2.87 (m, 2H), 2.72 (s, 3H), 1.97–1.88 (m, 4H), 1.41 (s, 9H). ESI-MS <i>m</i>/<i>z</i> 394.2, 396.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> <i>tert</i>-Butyl 3-(5-Bromo-7-methyl-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate (<b>40</b>)</h4><div class="NLM_p last">A solution of 5-bromo-7-methyl-1<i>H</i>-indazole <b>37a</b> (200 mg, 0.948 mmol) in DMF (4.00 mL, ratio: 2.00) was treated with NaH (60% dispersion in mineral oil) (45.5 mg, 1.14 mmol) and stirred for 10 min. Subsequently, <i>tert</i>-butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate (318 mg, 1.14 mmol) was added, and the reaction mixture was heated to 100 °C and stirred for 18 h. The reaction mixture was cooled to room temperature and treated with more NaH (60% dispersion in mineral oil) (45.5 mg, 1.14 mmol) and <i>tert</i>-butyl 3-((methylsulfonyl)oxy)piperidine-1-carboxylate (318 mg, 1.14 mmol), heated to 100 °C, and stirred for 4 h. The reaction mixture was cooled to RT, treated with water, and extracted with EtOAc. The organic layer was washed with water and brine, dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. To facilitate the separation of the product from the remaining indazole starting material, the crude mixture was dissolved in DCM (2.00 mL, ratio: 1.00), treated with Ac<sub>2</sub>O (0.089 mL, 0.948 mmol) and NEt<sub>3</sub> (0.132 mL, 0.948 mmol), and stirred for 14 h. More Ac<sub>2</sub>O (0.089 mL, 0.948 mmol) and NEt<sub>3</sub> (0.132 mL, 0.948 mmol) were added, and the reaction was stirred at RT for 1 h. The reaction mixture was treated with water and extracted with EtOAc. The organic layer was dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material was purified by flash chromatography (silica gel, heptanes/EtOAc) to give <b>40</b> (72.8 mg, 0.185 mmol, 19.5 % yield) as an orange oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.42 (s, 1H), 7.79–7.73 (m, 1H), 7.13 (s, 1H), 4.62–4.49 (m, 1H), 4.30–4.07 (m, 1H), 3.82 (s, 1H), 3.05–2.87 (m, 1H), 2.50–2.49 (m, 3H), 2.26–2.09 (m, 2H), 1.88–1.75 (m, 1H), 1.68–1.51 (m, 2H), 1.42–1.35 (m, 9H). ESI-MS <i>m</i>/<i>z</i> 394.1, 396.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> <i>tert</i>-Butyl 4-(5-Bromo-7-chloro-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate (<b>41</b>)</h4><div class="NLM_p last">To a solution of <b>37c</b> (300 mg, 1.30 mmol) in DMF (6.00 mL) was added tBuOK (175 mg, 1.55 mmol) followed by <i>tert</i>-butyl 4-((methylsulfonyl)oxy)piperidine-1-carboxylate (434 mg, 1.55 mmol). The reaction mixture was stirred at 60 °C for 24 h. Then, the reaction mixture was cooled to RT and Ac<sub>2</sub>O (0.122 mL, 1.30 mmol) was added, and the reaction mixture was stirred at RT for 15 min. The reaction mixture was poured into water, and the product was extracted with EtOAc. The organic phase was then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude material was purified by flash chromatography (silica gel, Heptane/EtOAc) to give <b>41</b> (162.5 mg, 30%) as a brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.58 (s, 1H), 7.95 (d, <i>J</i> = 1.6 Hz, 1H), 7.50 (d, <i>J</i> = 1.6 Hz, 1H), 4.82–4.68 (m, 1H), 4.15–4.02 (m, 2H), 3.07–2.82 (m, 2H), 2.15–2.06 (m, 2H), 2.00–1.85 (m, 2H), 1.42 (s, 9H). ESI-MS <i>m</i>/<i>z</i> 414.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> <i>tert</i>-Butyl 4-(5-Bromo-7-iodo-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate (<b>42</b>)</h4><div class="NLM_p last">Compound <b>42</b> was prepared starting from <b>37d</b> according to the procedure used to make compound <b>41</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.64 (s, 1H), 7.97 (d, <i>J</i> = 1.6 Hz, 1H), 7.79 (d, <i>J</i> = 1.6 Hz, 1H), 4.65–4.83 (m, 1H), 3.99–4.18 (m, 2H), 2.95 (s, 2H), 2.04–2.17 (m, 2H), 1.82–2.00 (m, 2H), 1.42 (s, 9H). ESI-MS <i>m</i>/<i>z</i> 506.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> <i>tert</i>-Butyl 4-(5-Bromo-7-(trifluoromethyl)-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate (<b>43</b>)</h4><div class="NLM_p last">Compound <b>43</b> was prepared by three different methods. Method 1 included starting from <b>37b</b> according to the procedure used to make compound <b>40</b>; method 2 included starting from <b>45</b> according to the procedure used to make compound <b>47</b>; and in method 3 (step f, shown in <a class="ref internalNav" href="#sch2" aria-label="Scheme 2">Scheme 2</a>), KF (20.0 mg, 0.344 mmol), CuI (4.36 mg, 0.023 mmol), and 1,10-phenanthroline (4.13 mg, 0.023 mmol) were combined in a vial and dried under high vacuum at 40 °C for 1 h. Under argon, a solution of <b>42</b> (58.0 mg, 0.115 mmol) (previously dried under high vacuum) in DMSO (1.00 mL), B(OMe)<sub>3</sub> (0.038 mL, 0.344 mmol), and TMSCF<sub>3</sub> in THF (2 M, 0.172 mL, 0.344 mmol) was added via a syringe, and the reaction mixture was stirred at 60 °C for 16 h. The reaction mixture was diluted with EtOAc and washed with saturated aq. NaHCO<sub>3</sub>. The organic phase was then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude material was purified by flash chromatography (silica gel, heptanes/EtOAc) to give <b>43</b> (35.5 mg, 69%) as a brown resin. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.69 (s, 1H), 8.31 (s, 1H), 7.72 (s, 1H), 4.81 (tt, <i>J</i> = 11.4, 3.9 Hz, 1H), 4.09 (d, <i>J</i> = 12.4 Hz, 2H), 2.95 (s, 2H), 2.12 (d, <i>J</i> = 10.1 Hz, 2H), 1.94 (qd, <i>J</i> = 12.3, 4.3 Hz, 2H), 1.42 (s, 9H): ESI-MS <i>m</i>/<i>z</i> 448.2, 450.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i32" class="anchor-spacer"></div><h4 class="article-section__title" id="_i32"> 1-Methyl-5-(7-methyl-2-(piperidin-4-yl)-2<i>H</i>-indazol-5-yl)pyridin-2(1<i>H</i>)-one Hydrochloride (<b>5</b>)</h4><div class="NLM_p last">A glass microwave vial was charged with <i>tert</i>-butyl 4-(5-bromo-7-methyl-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate <b>39</b> (44.0 mg, 0.112 mmol), tetrahydroxydiboron (28.6 mg, 0.319 mmol), XPhos Pd G3 (9.00 mg, 10.6 μmol), XPhos (10.1 mg, 0.021 mmol), and potassium acetate (31.3 mg, 0.319 mmol) and flushed with argon; then, degassed EtOH (500 μL) was added, and the reaction mixture was stirred at 80 °C for 30 min; then, aq. K<sub>2</sub>CO<sub>3</sub> (2 M, 0.160 mL, 0.319 mmol) (degassed) was added followed by a solution of 5-bromo-1-methylpyridin-2(1<i>H</i>)-one (20 mg, 0.106 mmol) in degassed EtOH (200 μL). The reaction mixture was stirred at 80 °C for 1 h. The reaction mixture was poured into water and extracted twice with DCM. The organic phase was then dried over MgSO<sub>4</sub>, filtered, and evaporated. The residue was purified by flash chromatography (C18, (H<sub>2</sub>O + 0.1% TFA)/MeCN) to give <i>tert</i>-butyl 4-(7-methyl-5-(1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate as a colorless solid (28.9 mg, 64%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.40 (s, 1H), 8.07 (d, <i>J</i> = 2.6 Hz, 1H), 7.82 (dd, <i>J</i> = 9.4, 2.7 Hz, 1H), 7.25 (s, 1H), 7.62 (s, 1H), 6.46 (d, <i>J</i> = 9.4 Hz, 1H), 4.75–4.62 (m, 1H), 4.10 (d, <i>J</i> = 11.4 Hz, 2H), 3.50 (s, 3H), 3.08–2.84 (m, 2H), 2.52 (s, 3H), 2.06–2.14 (m, 2H), 2.01–1.89 (m, 2H), 1.42 (s, 9H). ESI-MS <i>m</i>/<i>z</i> 423.4 [M + H]<sup>+</sup>. To a solution of <i>tert</i>-butyl 4-(7-methyl-5-(1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate (28.0 mg, 0.066 mmol) in DCM (500 μL) was added HCl in Et<sub>2</sub>O (2 M, 0.663 mL, 1.33 mmol); then, the suspension was stirred at RT for 30 min. The reaction mixture was concentrated. The residue was dissolved in water and lyophilized to give <b>5</b> (21.5 mg, 90%) as a colorless powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.92–9.03 (m, 1H), 8.55–8.71 (m, 1H), 8.38 (s, 1H), 8.07 (d, <i>J</i> = 2.6 Hz, 1H), 7.82 (dd, <i>J</i> = 9.4, 2.7 Hz, 1H), 7.65 (s, 1H), 7.28 (s, 1H), 6.47 (d, <i>J</i> = 9.4 Hz, 1H), 4.76–4.90 (m, 1H), 3.50 (s, 3H), 3.41–3.48 (m, 2H), 3.03–3.17 (m, 2H), 2.53 (s, 3H), 2.25–2.34 (m, 4H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.10, 147.41, 139.16, 136.74, 129.32, 127.27, 123.48, 122.88, 121.20, 119.15, 118.62, 113.78, 56.65, 42.25, 37.01, 29.02, 17.02. HRMS-ESI [M + H]<sup>+</sup><i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>23</sub>ON<sub>4</sub> 323.18664; found 323.18683.</div></div><div id="sec4_1_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 1,3-Dimethyl-5-(7-methyl-2-(piperidin-4-yl)-2<i>H</i>-indazol-5-yl)pyridin-2(1<i>H</i>)-one Hydrochloride (<b>6</b>)</h4><div class="NLM_p last">Compound <b>6</b> was prepared starting from <b>39</b> and 5-bromo-1,3-dimethylpyridin-2(1<i>H</i>)-one according to the procedure used to make compound <b>5</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.12–8.88 (m, 1H), 8.82–8.52 (m, 1H), 8.36 (s, 1H), 7.93 (d, <i>J</i> = 2.6 Hz, 1H), 7.76–7.72 (m, 1H), 7.65 (s, 1H), 7.28 (s, 1H), 4.89–4.78 (m, 1H), 3.51 (s, 3H), 3.48–3.41 (m, 2H), 3.18–3.02 (m, 2H), 2.53 (s, 3H), 2.35–2.25 (m, 4H), 2.08 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 337.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> 1,4-Dimethyl-5-(7-methyl-2-(piperidin-4-yl)-2<i>H</i>-indazol-5-yl)pyridin-2(1<i>H</i>)-one Hydrochloride (<b>7</b>)</h4><div class="NLM_p last">Compound <b>7</b> was prepared starting from <b>39</b> and 5-bromo-1,4-dimethylpyridin-2(1<i>H</i>)-one according to the procedure used to make compound <b>5</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.23–9.05 (m, 1H), 8.90–8.71 (m, 1H), 8.38 (s, 1H), 7.56 (s, 1H), 7.41 (s, 1H), 6.97 (s, 1H), 6.33 (s, 1H), 4.91–4.78 (m, 1H), 3.49–3.39 (m, 5H), 3.18–3.04 (m, 2H), 2.51 (s, 3H), 2.37–2.26 (m, 4H), 2.05 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 337.3 [M + H]<sup>+</sup>. <i>5-bromo-1,4-dimethylpyridin-2(1H)-one</i>. Step 1: A mixture of 5-bromo-2-fluoro-4-methylpyridine (523 mg, 2.75 mmol) and NaOH (385 mg, 9.63 mmol) in water (2.50 mL) was stirred at 100 °C for 16 h and then at 150 °C under microwave irradiation for 30 min. The reaction mixture was cooled to 0 °C, and conc. HCl (0.904 mL, 11.0 mmol) was slowly added dropwise. The solid was collected by filtration, rinsed with water, and dried under high vacuum to give 5-bromo-4-methylpyridin-2(1<i>H</i>)-one (539 mg, 100%) as a colorless powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 11.56 (s, 1H), 7.66 (s, 1H), 6.38 (s, 1H), 2.16 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 188.0 [M + H]<sup>+</sup>. Step 2: To a suspension of 5-bromo-4-methylpyridin-2(1<i>H</i>)-one (539 mg, 2.75 mmol) and K<sub>2</sub>CO<sub>3</sub> (761 mg, 5.50 mmol) in DMF (6.00 mL) was added MeI (0.258 mL, 4.13 mmol), and the reaction mixture was stirred at RT for 2 h. The reaction mixture was diluted with water and acidified with conc. HCl (0.376 mL, 12.4 mmol). The product was then extracted with DCM (3 times). The organic phase was then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and evaporated. The crude material was purified by flash chromatography (silica gel, heptanes/EtOAc) to give 5-bromo-1,4-dimethylpyridin-2(1<i>H</i>)-one (359 mg, 64%) as a colorless powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.01 (s, 1H), 6.39 (s, 1H), 3.36 (s, 3H), 2.14 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 202.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i35" class="anchor-spacer"></div><h4 class="article-section__title" id="_i35"> 5-Bromo-1,6-dimethylpyridin-2(1<i>H</i>)-one (<b>53</b>)</h4><div class="NLM_p last">A suspension of 5-bromo-6-methylpyridin-2(1<i>H</i>)-one (10.0 g, 53.2 mmol) and K<sub>2</sub>CO<sub>3</sub> (14.7 g, 106 mmol) in DMF (100 mL) was treated with iodomethane (5.00 mL, 80.0 mmol) and stirred at RT for 2 h. The reaction mixture was diluted with water and extracted with DCM (3 times) and EtOAc (twice). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (silica gel, heptanes/EtOAc) to give 5-bromo-1,6-dimethylpyridin-2(1<i>H</i>)-one (<b>53</b>) (6.92 g, 61%) as a light-yellow powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.51 (d, <i>J</i> = 9.7 Hz, 1H), 6.25 (d, <i>J</i> = 9.7 Hz, 1H), 3.48 (s, 3H), 2.49 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 202.0, 204.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i36" class="anchor-spacer"></div><h4 class="article-section__title" id="_i36"> 1,6-Dimethyl-5-(7-methyl-2-(piperidin-4-yl)-2<i>H</i>-indazol-5-yl)pyridin-2(1<i>H</i>)-one (<b>8</b>)</h4><div class="NLM_p last">Compound <b>8</b> was prepared starting from <b>39</b> and 5-bromo-1,6-dimethylpyridin-2(1<i>H</i>)-one (<b>53</b>) according to the procedure used to make compound <b>5</b>. The HCl salt of <b>8</b> was converted into the free base by basic extraction using saturated aq. Na<sub>2</sub>CO<sub>3</sub> and EtOAc. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.38 (s, 1H), 7.34 (d, <i>J</i> = 1.6 Hz, 1H), 7.32 (d, <i>J</i> = 9.2 Hz, 1H), 6.88 (t, <i>J</i> = 1.4 Hz, 1H), 6.34 (d, <i>J</i> = 9.2 Hz, 1H), 4.54 (tt, <i>J</i> = 11.7, 4.2 Hz, 1H), 3.51 (s, 3H), 3.08 (dt, <i>J</i> = 12.8, 3.3 Hz, 2H), 2.64 (t, <i>J</i> = 11.7 Hz, 2H), 2.51 (s, 3H), 2.30 (s, 3H), 2.03 (dd, <i>J</i> = 12.6, 3.6 Hz, 2H), 1.96 (qd, <i>J</i> = 12.0, 4.1 Hz, 2H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.85, 146.90, 144.65, 141.42, 131.82, 126.73, 126.69, 122.00, 120.90, 119.57, 118.30, 115.52, 60.81, 45.20, 33.96, 31.15, 18.24, 16.98. HRMS-ESI [M + H]<sup>+</sup><i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>25</sub>ON<sub>4</sub> 337.20229; found 337.20218.</div></div><div id="sec4_1_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i37" class="anchor-spacer"></div><h4 class="article-section__title" id="_i37"> 6-Fluoro-1-methyl-5-(7-methyl-2-(piperidin-4-yl)-2<i>H</i>-indazol-5-yl)pyridin-2(1<i>H</i>)-one Hydrochloride (<b>9</b>)</h4><div class="NLM_p last">Compound <b>9</b> was prepared starting from <b>39</b> and 5-bromo-6-fluoro-1-methylpyridin-2(1<i>H</i>)-one according to the procedure used to make compound <b>5</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.89–8.78 (m, 1H), 8.61–8.45 (m, 1H), 8.42 (s, 1H), 7.71 (dd, <i>J</i> = 11.3, 9.4 Hz, 1H), 7.58 (s, 1H), 7.11 (d, <i>J</i> = 1.5 Hz, 1H), 6.40 (d, <i>J</i> = 9.4 Hz, 1H), 4.90–4.78 (m, 1H), 3.51–3.41 (m, 5H), 3.18–3.05 (m, 2H), 2.52 (s, 3H), 2.36–2.26 (m, 4H). ESI-MS <i>m</i>/<i>z</i> 341.2 [M + H]<sup>+</sup>. <i>5-bromo-6-fluoro-1-methylpyridin-2(1H)-one</i>. A solution of 5-bromo-6-fluoropyridin-2(1<i>H</i>)-one (7.64 g, 39.8 mmol) in DMF (100 mL) was treated with Li<sub>2</sub>CO<sub>3</sub> (5.90 g, 80.0 mmol) and then cooled to 0 °C. The resulting suspension was treated with iodomethane (3.70 mL, 60.0 mmol), allowed to warm to room temperature, and stirred for 3 h. The reaction mixture was heated to 50 °C and stirred for 1 h and then treated with iodomethane (2.0 mL, 32 mmol) and stirred at 50 °C for 16 h. The reaction mixture was cooled to room temperature, diluted with water, and extracted with DCM (3 times). The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material containing 3-bromo-2-fluoro-6-methoxypyridine as the major component and the title compound as the minor component was purified by flash chromatography (silica gel, heptanes/EtOAc) to give 5-bromo-6-fluoro-1-methylpyridin-2(1<i>H</i>)-one (1.33 g, 15%) as a brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.67 (t, <i>J</i> = 10.0 Hz, 1H), 6.29 (d, <i>J</i> = 9.8 Hz, 1H), 3.41 (d, <i>J</i> = 3.6 Hz, 3H). ESI-MS <i>m</i>/<i>z</i> 206.1, 208.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> 6-Chloro-1-methyl-5-(7-methyl-2-(piperidin-4-yl)-2<i>H</i>-indazol-5-yl)pyridin-2(1<i>H</i>)-one Hydrochloride (<b>10</b>)</h4><div class="NLM_p last">Compound <b>10</b> was prepared starting from <b>39</b> and 5-bromo-6-chloro-1-methylpyridin-2(1<i>H</i>)-one according to the procedure used to make compound <b>5</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.86–8.75 (m, 1H), 8.55–8.45 (m, 1H), 8.43 (s, 1H), 7.50 (s, 1H), 7.47 (d, <i>J</i> = 9.3 Hz, 1H), 7.01–6.97 (m, 1H), 6.50 (d, <i>J</i> = 9.3 Hz, 1H), 4.91–4.79 (m, 1H), 3.64 (s, 3H), 3.51–3.41 (m, 2H), 3.19–3.04 (m, 2H), 2.51 (s, 3H), 2.34–2.27 (m, 4H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.38, 147.33, 141.64, 135.75, 130.16, 126.70, 126.36, 123.20, 120.67, 119.26, 118.73, 117.20, 56.76, 42.18, 33.41, 29.02, 16.89. HRMS-ESI [M + H]<sup>+</sup><i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>22</sub>ON<sub>4</sub>Cl 357.14767; found 357.14767. <i>5-bromo-6-chloro-1-methylpyridin-2(1H)-one</i>. Step 1: <i>6-chloro-1-methylpyridin-2(1H)-one</i>. A solution of 6-chloropyridin-2(1<i>H</i>)-one (10.0 g, 77.0 mmol) in DMF (100 mL) was treated with Li<sub>2</sub>CO<sub>3</sub> (11.4 g, 154 mmol) and then cooled to 0 °C. The resulting suspension was treated with methyl iodide (7.24 mL, 116 mmol), stirred for 1 h at 0 °C, allowed to warm to room temperature, and then stirred for 24 h. The reaction was treated with water and extracted with DCM (3 times). The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The crude material was purified by flash chromatography (silica gel, DCM/MeOH) to give 6-chloro-1-methylpyridin-2(1<i>H</i>)-one (9.98 g, 90%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.38 (dd, <i>J</i> = 9.2, 7.3 Hz, 1H), 6.47 (dd, <i>J</i> = 7.3, 1.2 Hz, 1H), 6.39 (dd, <i>J</i> = 9.2, 1.1 Hz, 1H), 3.54 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 144.0 [M + H]<sup>+</sup>. Step 2: <i>5-bromo-6-chloro-1-methylpyridin-2(1H)-one</i>. A solution of 6-chloro-1-methylpyridin-2(1<i>H</i>)-one (9.69 g, 67.5 mmol) in acetic acid (50.0 mL) at 0 °C was treated with <i>N</i>-bromosuccinimide (10.0 g, 56.2 mmol), allowed to warm to room temperature, and stirred for 1.5 h. The reaction mixture was concentrated; the residue was treated with saturated aq. NaHCO<sub>3</sub> and extracted twice with DCM. The combined organic layers were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (silica gel, heptanes/EtOAc) to give 5-bromo-6-chloro-1-methylpyridin-2(1<i>H</i>)-one (4.97 g, 32%) as a brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.67 (d, <i>J</i> = 9.7 Hz, 1H), 6.42 (d, <i>J</i> = 9.7 Hz, 1H), 3.61 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 222.0, 224.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 5-Methyl-7-(7-methyl-2-(piperidin-4-yl)-2<i>H</i>-indazol-5-yl)furo[3,2-<i>c</i>]pyridin-4(5<i>H</i>)-one Hydrochloride (<b>11</b>)</h4><div class="NLM_p last">Compound <b>11</b> was prepared starting from <b>39</b> and 7-bromo-5-methylfuro[3,2-<i>c</i>]pyridin-4(5<i>H</i>)-one according to the procedure used to make compound <b>5</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.17–8.97 (m, 1H), 8.83–8.62 (m, 1H), 8.46 (s, 1H), 7.99 (d, <i>J</i> = 2.1 Hz, 1H), 7.96 (s, 1H), 7.93 (s, 1H), 7.39 (s, 1H), 7.05 (d, <i>J</i> = 2.1 Hz, 1H), 4.91–4.80 (m, 1H), 3.60 (s, 3H), 3.51–3.39 (m, 2H), 3.20–3.05 (m, 2H), 2.56 (s, 3H), 2.36–2.29 (m, 4H). ESI-MS <i>m</i>/<i>z</i> 363.2 [M + H]<sup>+</sup>. <i>7-Bromo-5-methylfuro[3,2-<i>c</i>]pyridin-4(5H)-one</i>. A suspension of 7-bromofuro[3,2-<i>c</i>]pyridin-4(5<i>H</i>)-one (0.20 g, 0.94 mmol) and K<sub>2</sub>CO<sub>3</sub> (0.26 g, 1.90 mmol) in DMF (2.00 mL) was treated with iodomethane (0.088 mL, 1.40 mmol) and stirred at room temperature for 1.5 h. The reaction mixture was diluted with water, and the precipitate was collected by centrifugation and dried to give 7-bromo-5-methylfuro[3,2-<i>c</i>]pyridin-4(5<i>H</i>)-one (173 mg, 80%) as a yellow powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.03 (s, 1H), 7.99 (d, <i>J</i> = 2.0 Hz, 1H), 7.07 (d, <i>J</i> = 2.1 Hz, 1H), 3.49 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 228.0, 230.0 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 8-(7-Methyl-2-(piperidin-4-yl)-2<i>H</i>-indazol-5-yl)-2,3-dihydroindolizin-5(1<i>H</i>)-one (<b>12</b>)</h4><div class="NLM_p last">Compound <b>12</b> was prepared starting from <b>39</b> and <i>8-bromo-2,3-dihydroindolizin-5(1H)-one</i> (<b>51</b>) according to the procedure used to make compound <b>5</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.35 (s, 1H), 7.51 (d, <i>J</i> = 9.2 Hz, 1H), 7.44 (s, 1H), 7.02 (s, 1H), 6.30 (d, <i>J</i> = 9.2 Hz, 1H), 4.59–4.48 (m, 1H), 4.06–3.98 (m, 2H), 3.16 (t, <i>J</i> = 7.6 Hz, 2H), 3.12–3.04 (m, 2H), 2.68–2.59 (m, 2H), 2.51 (s, 3H), 2.11–1.89 (m, 6H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.19, 148.20, 146.88, 141.77, 130.24, 126.79, 125.31, 121.90, 120.98, 116.67, 116.45, 115.34, 60.66, 48.77, 45.12, 33.82, 31.71, 21.10, 16.94. HRMS-ESI [M + H]<sup>+</sup><i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>25</sub>ON<sub>4</sub> 349.20229; found 349.20224.</div></div><div id="sec4_1_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 1-Methyl-5-(2-(piperidin-4-yl)-2<i>H</i>-indazol-5-yl)pyridin-2(1<i>H</i>)-one Hydrochloride (<b>13</b>)</h4><div class="NLM_p last">Compound <b>13</b> was prepared starting from <b>38</b> according to the procedure used to make compound <b>5</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.96–8.83 (m, 1H), 8.73–8.59 (m, 1H), 8.42 (s, 1H), 8.09 (d, <i>J</i> = 2.3 Hz, 1H), 7.89–7.79 (m, 2H), 7.66 (d, <i>J</i> = 9.0 Hz, 1H), 7.49 (d, <i>J</i> = 9.1 Hz, 1H), 6.48 (d, <i>J</i> = 9.4 Hz, 1H), 4.87–4.78 (m, 1H), 3.50–3.34 (m, 5H), 3.20–3.04 (m, 2H), 2.34–2.24 (m, 4H). ESI-MS <i>m</i>/<i>z</i> 309.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> 5-(7-Chloro-2-(piperidin-4-yl)-2<i>H</i>-indazol-5-yl)-1,6-dimethylpyridin-2(1<i>H</i>)-one Hydrochloride (<b>14</b>)</h4><div class="NLM_p last">Compound <b>14</b> was prepared starting from <b>42</b> and 5-bromo-1,6-dimethylpyridin-2(1<i>H</i>)-one (<b>53</b>) according to the procedure used to make compound <b>5</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.94–8.77 (m, 1H), 8.62 (s, 1H), 8.60–8.47 (m, 1H), 7.60 (d, <i>J</i> = 1.3 Hz, 1H), 7.37 (d, <i>J</i> = 9.3 Hz, 1H), 7.31 (d, <i>J</i> = 1.3 Hz, 1H), 6.38 (d, <i>J</i> = 9.3 Hz, 1H), 5.01–4.83 (m, 1H), 3.54 (s, 3H), 3.53–3.47 (m, 2H), 3.22–3.09 (m, 2H), 2.38–2.30 (m, 7 H). ESI-MS <i>m</i>/<i>z</i> 357.2, 359.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 1,6-Dimethyl-5-(2-(piperidin-4-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-5-yl)pyridin-2(1<i>H</i>)-one Hydrochloride (<b>15</b>)</h4><div class="NLM_p last">Compound <b>15</b> was prepared starting from <b>41</b> and 5-bromo-1,6-dimethylpyridin-2(1<i>H</i>)-one (<b>53</b>) according to the procedure used to make compound <b>5</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.01–8.83 (m, 1H), 8.69 (s, 1H), 8.64–8.48 (m, 1H), 7.93 (s, 1H), 7.55 (s, 1H), 7.39 (d, <i>J</i> = 9.3 Hz, 1H), 6.38 (d, <i>J</i> = 9.3 Hz, 1H), 5.04–4.89 (m, 1H), 3.54–3.47 (m, 5H), 3.22–3.06 (m, 2H), 2.37–2.29 (m, 7 H). ESI-MS <i>m</i>/<i>z</i> 391.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 5-(7-Cyclopropyl-2-(piperidin-4-yl)-2<i>H</i>-indazol-5-yl)-1,6-dimethylpyridin-2(1<i>H</i>)-one (<b>16</b>)</h4><div class="NLM_p last">Compound <b>16</b> was prepared starting from <i>tert</i>-butyl 4-(5-chloro-7-cyclopropyl-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate and 5-bromo-1,6-dimethylpyridin-2(1<i>H</i>)-one (<b>53</b>) according to the procedure used to make compound <b>5</b>. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.37 (s, 1H), 7.31 (d, <i>J</i> = 9.2 Hz, 1H), 7.28 (s, 1H), 6.64 (s, 1H), 6.33 (d, <i>J</i> = 9.2 Hz, 1H), 4.57–4.50 (m, 1H), 3.51 (s, 3H), 3.08 (br d, <i>J</i> = 12.7 Hz, 2H), 2.64 (br t, <i>J</i> = 11.6 Hz, 2H), 2.42–2.36 (m, 1H), 2.29 (s, 3H), 2.08–2.00 (m, 2H), 1.95 (dq, <i>J</i> = 3.9, 11.8 Hz, 2H), 1.06–0.96 (m, 4H). ESI-MS <i>m</i>/<i>z</i> 363.4 [M + H]<sup>+</sup>. <i>tert</i>-Butyl 4-(5-chloro-7-cyclopropyl-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate. Step 1: (2-Amino-5-chloro-3-iodophenyl)methanol. A solution of methyl-2-amino-5-chloro-3-iodobenzoate (10.0 g, 31.1 mmol) in THF (160 mL) was treated portionwise with LiBH<sub>4</sub> (2.00 g, 93.0 mmol). The reaction mixture was stirred at RT for 1.75 h, cautiously quenched with saturated aq. NH<sub>4</sub>Cl, and extracted twice with EtOAc. The combined organic phases were washed with brine, dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was recrystallized from hot EtOAc. The mother liquor was concentrated, and the residue was triturated with hot MeOH. Both solids were combined and dried to give the title compound as a light-pink solid (7.07 g, 79%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.52 (d, <i>J</i> = 2.5 Hz, 1H), 7.17 (d, <i>J</i> = 2.5 Hz, 1H), 5.32 (t, <i>J</i> = 5.5 Hz, 1H), 5.07 (s, br, 2H), 4.38 (d, <i>J</i> = 5.5 Hz, 2H). ESI-MS <i>m</i>/<i>z</i> 284.0, 286.0 [M + H]<sup>+</sup>. Step 2: 2-Amino-5-chloro-3-iodobenzaldehyde. 2-Amino-5-chloro-3-iodobenzaldehyde was prepared starting from (2-amino-5-chloro-3-iodophenyl)methanol according to the procedure used to make compound <b>30</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.70 (s, 1H), 7.94 (d, <i>J</i> = 2.4 Hz, 1H), 7.78 (d, <i>J</i> = 2.4 Hz, 1H), 7.12 (s, br, 2H). Step 3: 2-Azido-5-chloro-3-iodobenzaldehyde. 2-Azido-5-chloro-3-iodobenzaldehyde was prepared starting from 2-amino-5-chloro-3-iodobenzaldehyde according to the procedure used to make compound <b>45</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.02 (s, 1H), 8.28 (d, <i>J</i> = 2.5 Hz, 1H), 8.00 (d, <i>J</i> = 2.5 Hz, 1H). Step 4: <i>tert</i>-Butyl 4-(5-chloro-7-iodo-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate. <i>tert</i>-Butyl 4-(5-chloro-7-iodo-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate was prepared starting from 2-azido-5-chloro-3-iodobenzaldehyde according to the procedure used to make compound <b>46</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.65 (s, 1H), 7.82 (s, 1H), 7.70 (s, 1H), 4.86–4.62 (m, 1H), 4.17–4.00 (m, 2H), 3.04–2.81 (m, 2H), 2.17–2.04 (m, 2H), 2.01–1.83 (m, 2H), 1.42 (s, 9H). ESI-MS <i>m</i>/<i>z</i> 462.1, 464.1 [M + H]<sup>+</sup>. Step 5: <i>tert</i>-Butyl 4-(5-chloro-7-cyclopropyl-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate. A suspension of <i>tert</i>-butyl 4-(5-chloro-7-iodo-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate (810 mg, 1.75 mmol), cyclopropylboronic acid (301 mg, 3.51 mmol), and potassium phosphate (1.30 g, 6.14 mmol) in toluene (16 mL) and water (1.6 mL) was degassed with nitrogen for 5 min. Then, Pd(OAc)<sub>2</sub> (19.69 mg, 0.088 mmol) and tricyclohexylphosphonium tetrafluoroborate (64.6 mg, 0.175 mmol) were added and the reaction mixture was stirred at 100 °C for 18 h. The reaction mixture was cooled to RT, quenched with water, and extracted with DCM (3 times). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (silica gel, heptanes/EtOAc) to give the title compound (673 mg, 92%) as a light-yellow oil. <sup>1</sup>H NMR (600 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 8.40 (s, 1H), 7.51 (s, 1H), 6.75 (s, 1H), 4.75–4.66 (m, 1H), 4.09 (br s, 2H), 2.98 (br s, 2H), 2.41–2.32 (m, 1H), 2.10 (br d, <i>J</i> = 11.9 Hz, 2H), 1.93 (dq, <i>J</i> = 4.2, 12.1 Hz, 2H), 1.43 (s, 9H), 1.07–0.99 (m, 4H). ESI-MS <i>m</i>/<i>z</i> 376.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 1,6-Dimethyl-5-(7-methyl-2-(1-methylpiperidin-4-yl)-2<i>H</i>-indazol-5-yl)pyridin-2(1<i>H</i>)-one (<b>17</b>)</h4><div class="NLM_p last">A mixture of <b>8</b> (30 mg, 89 μmol), acetic acid (6.10 μL, 0.110 mmol), formaldehyde in water (37%, 9.96 μL, 0.134 mmol), and DCM (500 μL) was treated with sodium triacetoxyborohydride (28.3 mg, 0.134 mmol) and stirred at room temperature for 1.5 h. The reaction mixture was slowly poured into saturated aq. Na<sub>2</sub>CO<sub>3</sub> and extracted with DCM (4 times). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (silica gel, DCM/(7 M NH<sub>3</sub>·in MeOH)) to give the title compound <b>17</b> (26.7 mg, 85%) as a colorless powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.41 (s, 1H), 7.37–7.26 (m, 2H), 6.88 (s, 1H), 6.34 (d, <i>J</i> = 9.3 Hz, 1H), 4.52–4.40 (m, 1H), 3.52 (s, 3H), 2.96–2.85 (m, 2H), 2.53–2.51 (m, 3H), 2.31 (s, 3H), 2.23 (s, 3H), 2.16–2.05 (m, 6H). ESI-MS <i>m</i>/<i>z</i> 351.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i46" class="anchor-spacer"></div><h4 class="article-section__title" id="_i46"> 5-(2-(1-(2-(Dimethylamino)acetyl)piperidin-4-yl)-7-methyl-2<i>H</i>-indazol-5-yl)-1,6-dimethylpyridin-2(1<i>H</i>)-one (<b>18</b>)</h4><div class="NLM_p last">A mixture of <b>8</b>, 2-(dimethylamino)acetic acid (12.7 mg, 0.120 mmol), HATU (46.7 mg, 0.120 mmol), and <i>N</i>-ethyl-<i>N</i>-isopropylpropan-2-amine (0.030 mL, 0.170 mmol) was stirred at room temperature for 1 h. The reaction mixture was diluted with DCM and washed with saturated aq. Na<sub>2</sub>CO<sub>3</sub>. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (silica gel, DCM/(7 M NH<sub>3</sub>·in MeOH)) to give <b>18</b> (39.0 mg, 82%) as a colorless powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 (s, 1H), 7.36–7.29 (m, 2H), 6.89 (s, 1H), 6.34 (d, <i>J</i> = 9.2 Hz, 1H), 4.86–4.73 (m, 1H), 4.52 (d, <i>J</i> = 12.9 Hz, 1H), 4.23 (d, <i>J</i> = 13.0 Hz, 1H), 3.52 (s, 3H), 3.27–3.10 (m, 3H), 2.87–2.75 (m, 1H), 2.51–2.51 (m, 3H), 2.31 (s, 3H), 2.25–2.12 (m, 8 H), 2.10–2.01 (m, 1H), 1.98–1.86 (m, 1H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 167.85, 161.78, 146.93, 144.61, 141.32, 131.93, 126.79, 126.70, 122.32, 120.91, 119.43, 118.24, 115.48, 62.08, 59.71, 45.18, 45.17, 44.02, 33.08, 32.30, 31.10, 18.19, 16.89. HRMS-ESI [M + H]<sup>+</sup><i>m</i>/<i>z</i> calcd for C<sub>24</sub>H<sub>32</sub>O<sub>2</sub>N<sub>5</sub> 422.25505; found 422.25500.</div></div><div id="sec4_1_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i47" class="anchor-spacer"></div><h4 class="article-section__title" id="_i47"> 1,6-Dimethyl-5-(7-methyl-2-(piperidin-3-yl)-2<i>H</i>-indazol-5-yl)pyridin-2(1<i>H</i>)-one (<b>19</b>)</h4><div class="NLM_p last">Compound <b>19</b> was prepared starting from <b>40</b> and 5-bromo-1,6-dimethylpyridin-2(1<i>H</i>)-one (<b>53</b>) according to the procedure used to make compound <b>5</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.42 (s, 1H), 7.37–7.28 (m, 2H), 6.89 (s, 1H), 6.34 (d, <i>J</i> = 9.2 Hz, 1H), 4.59–4.46 (m, 1H), 3.51 (d, <i>J</i> = 4.1 Hz, 4H), 3.29–3.29 (m, 1H), 3.04–2.92 (m, 2H), 2.64–2.56 (m, 1H), 2.31 (s, 3H), 2.24–2.16 (m, 1H), 2.14–2.02 (m, 1H), 1.83–1.75 (m, 1H), 1.65–1.55 (m, 1H). ESI- MS <i>m</i>/<i>z</i> 337.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 5-(4-Amino-3-(hydroxymethyl)-5-methylphenyl)-1,6-dimethylpyridin-2(1<i>H</i>)-one (<b>54</b>)</h4><div class="NLM_p last">A mixture of <b>52</b> (5.43 g, 25.1 mmol), tetrahydroxydiboron (6.76 g, 75.0 mmol), XPhos Pd G3 (0.850 g, 1.01 mmol), XPhos (0.960 g, 2.01 mmol), and potassium acetate (7.40 g, 75.0 mmol) in ethanol (100 mL) was stirred under reflux for 20 min (reaction mixture color turned from yellow to orange). The reaction mixture was treated with 2 M aq. K<sub>2</sub>CO<sub>3</sub> (37.7 mL, 75.0 mmol) followed by a solution of <b>53</b> (5.08 g, 25.1 mmol) in ethanol (20.0 mL), stirred at reflux for 1 h, and concentrated, and the residue was diluted with water. The mixture was extracted with EtOAc (5 times) and DCM (twice); the combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (silica gel, DCM/MeOH) to give the title compound <b>54</b> (5.19 g, 80%) as a brown powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 7.21 (d, <i>J</i> = 9.2 Hz, 1H), 6.83–6.75 (m, 2H), 6.28 (d, <i>J</i> = 9.2 Hz, 1H), 5.04 (t, <i>J</i> = 5.4 Hz, 1H), 4.76 (s, 2H), 4.42 (d, <i>J</i> = 5.4 Hz, 2H), 3.48 (s, 3H), 2.28 (s, 3H), 2.10 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 259.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-Azido-5-(1,2-dimethyl-6-oxo-1,6-dihydropyridin-3-yl)-3-methylbenzaldehyde (<b>55</b>)</h4><div class="NLM_p last">Step b: 2-Amino-5-(1,2-dimethyl-6-oxo-1,6-dihydropyridin-3-yl)-3-methylbenzaldehyde was prepared starting from <b>54</b> according to the procedure used to make compound <b>30</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.84 (s, 1H), 7.32 (d, <i>J</i> = 1.9 Hz, 1H), 7.29 (d, <i>J</i> = 9.3 Hz, 1H), 7.15 (s, 1H), 7.04 (s, 2H), 6.32 (d, <i>J</i> = 9.2 Hz, 1H), 3.49 (s, 3H), 2.29 (s, 3H), 2.14 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 257.2 [M + H]<sup>+</sup>. Step c: To a suspension of amino-5-(1,2-dimethyl-6-oxo-1,6-dihydropyridin-3-yl)-3-methylbenzaldehyde (4.68 g, 18.3 mmol) in water (45 mL) and conc. HCl (15.0 mL, 183 mmol) at 0 °C was added NaNO<sub>2</sub> (1.58 g, 22.8 mmol) in 2.5 mL of water. The reaction mixture was stirred at 0 °C for 30 min and allowed to warm to RT for 30 min. The reaction mixture was then cooled to 0 °C, and a solution of NaN<sub>3</sub> (1.19 g, 18.3 mmol) in 2.5 mL of water was added slowly (warning: gas evolution). The reaction mixture was stirred at RT for 1 h and diluted with 100 mL of water. Because the reaction was not complete, NaN<sub>3</sub> (0.594 g, 9.13 mmol) was added, and the resulting red suspension was stirred at RT for 1 h; then, NaN<sub>3</sub> (0.594 g, 9.13 mmol) was added and the reaction mixture was stirred at RT for 3 h. The precipitate was collected by filtration and rinsed with water. The solid was then dried under high vacuum to give <b>55</b> (4.48 g, 87%) as a light-brown powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 10.19 (s, 1H), 7.64 (d, <i>J</i> = 2.2 Hz, 1H), 7.51 (d, <i>J</i> = 1.6 Hz, 1H), 7.33 (d, <i>J</i> = 9.3 Hz, 1H), 6.37 (d, <i>J</i> = 9.3 Hz, 1H), 3.51 (s, 3H), 2.41 (s, 3H), 2.30 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 283.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 5-(2-(4,4-Difluoropiperidin-3-yl)-7-methyl-2<i>H</i>-indazol-5-yl)-1,6-dimethylpyridin-2(1<i>H</i>)-one (<b>20</b>)</h4><div class="NLM_p last">In a capped vial, a suspension of <b>55</b> (0.125 mmol), <i>tert</i>-butyl 3-amino-4,4-difluoropiperidine-1-carboxylate (0.138 mmol), and Cu<sub>2</sub>O (12.6 μmol) in DCE (500 μL) was stirred at 80 °C for 2 h. The reaction mixture was filtered. HCl in dioxane (10%) was added to the filtrate, and the mixture was left stirring overnight. The solvent was evaporated under reduced pressure, and the residue was purified by flash chromatography (C18, (H<sub>2</sub>O + 0.3% NH<sub>3</sub>)/MeOH + 0.3%NH<sub>3</sub>) to give the title compound <b>20</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.35 (s, 1H), 8.59 (s, 1H), 7.43 (s, 1H), 7.33 (d, <i>J</i> = 9.3 Hz, 1H), 6.99 (s, 1H), 6.36 (d, <i>J</i> = 9.2 Hz, 1H), 5.65–5.37 (m, 1H), 4.10–3.84 (m, 2H), 3.64–3.46 (m, 5H), 2.68–2.58 (m, 1H), 2.55 (s, 3H), 2.47–2.36 (m, 1H), 2.31 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 373.4 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 5-(2-(5,5-Difluoropiperidin-3-yl)-7-methyl-2<i>H</i>-indazol-5-yl)-1,6-dimethylpyridin-2(1<i>H</i>)-one Hydrochloride (<b>21</b>)</h4><div class="NLM_p last">In a sealed tube, a suspension of <b>56</b> (30 mg, 0.106 mmol), <i>tert</i>-butyl 5-amino-3,3-difluoropiperidine-1-carboxylate (27.6 mg, 0.117 mmol), and Cu<sub>2</sub>O (1.52 mg, 10.6 μmol) in DCE (500 μL) was stirred at 80 °C for 5 h. The reaction mixture was filtered. The crude material was purified by SFC to give <i>tert</i>-butyl 5-(5-(1,2-dimethyl-6-oxo-1,6-dihydropyridin-3-yl)-7-methyl-2<i>H</i>-indazol-2-yl)-3,3-difluoropiperidine-1-carboxylate (15.6 mg, 31%) as a colorless resin. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.57 (s, 1H), 7.41 (s, 1H), 7.35 (d, <i>J</i> = 9.3 Hz, 1H), 6.96 (s, 1H), 6.37 (d, <i>J</i> = 9.3 Hz, 1H), 4.97–4.79 (m, 1H), 4.40–4.17 (m, 2H), 3.71–3.46 (m, 5H), 2.99–2.72 (m, 2H), 2.55 (s, 3H), 2.33 (s, 3H), 1.45 (s, 9H). ESI-MS <i>m</i>/<i>z</i> 473.3 [M + H]<sup>+</sup>. To a solution of <i>tert</i>-butyl 5-(5-(1,2-dimethyl-6-oxo-1,6-dihydropyridin-3-yl)-7-methyl-2<i>H</i>-indazol-2-yl)-3,3-difluoropiperidine-1-carboxylate (15.6 mg, 0.033 mmol) in DCM (400 μL) was added HCl in Et<sub>2</sub>O (2 M, 0.330 mL, 0.660 mmol), and the suspension was stirred at room temperature for 1 h. Then, HCl in diethylether (2 M, 0.330 mL, 0.660 mmol) was added and the reaction mixture was stirred at RT for 2 h. The reaction mixture was evaporated. The product was then dissolved in water, frozen, and lyophilized to give the title compound <b>21</b> (14.2 mg, quant.) as a light-brown powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.57 (s, 1H), 7.40 (s, 1H), 7.32 (d, <i>J</i> = 9.3 Hz, 1H), 6.95 (s, 1H), 6.35 (d, <i>J</i> = 9.2 Hz, 1H), 5.19–5.06 (m, 1H), 3.89–3.72 (m, 2H), 3.71–3.64 (m, 2H), 3.51 (s, 3H), 3.00–2.83 (m, 2H), 2.53 (s, 3H), 2.30 (s, 3H). ESI-MS <i>m</i>/<i>z</i> 373.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i52" class="anchor-spacer"></div><h4 class="article-section__title" id="_i52"> 1,6-Dimethyl-5-(7-methyl-2-(pyridin-3-yl)-2<i>H</i>-indazol-5-yl)pyridin-2(1<i>H</i>)-one (<b>22</b>)</h4><div class="NLM_p last">The title compound <b>22</b> was prepared according to the procedure used to make <b>20</b> starting from <b>55</b> and 3-aminopyridine. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 9.33 (d, <i>J</i> = 2.5 Hz, 1H), 9.17 (s, 1H), 8.65 (dd, <i>J</i> = 4.7, 1.3 Hz, 1H), 8.54–8.45 (m, 1H), 7.65 (dd, <i>J</i> = 8.3, 4.7 Hz, 1H), 7.44 (s, 1H), 7.37 (d, <i>J</i> = 9.3 Hz, 1H), 7.01 (s, 1H), 6.36 (d, <i>J</i> = 9.2 Hz, 1H), 3.52 (s, 3H), 2.59 (s, 3H), 2.34 (s, 3H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 161.80, 148.86, 148.74, 144.84, 141.52, 141.16, 136.48, 133.42, 128.59, 127.86, 127.32, 124.46, 122.74, 122.40, 119.01, 118.42, 115.58, 31.13, 18.26, 16.81. HRMS-ESI [M + H]<sup>+</sup><i>m</i>/<i>z</i> calcd for C<sub>20</sub>H<sub>19</sub>ON<sub>4</sub> 331.15534; found 331.15527.</div></div><div id="sec4_1_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i53" class="anchor-spacer"></div><h4 class="article-section__title" id="_i53"> 1,6-Dimethyl-5-(7-methyl-2-(1-(2,2,2-trifluoroethyl)piperidin-3-yl)-2<i>H</i>-indazol-5-yl)pyridin-2(1<i>H</i>)-one (<b>23</b>)</h4><div class="NLM_p last">The title compound <b>23</b> was prepared according to the procedure used to make <b>20</b> starting from <b>55</b> and 1-(2,2,2-trifluoroethyl)piperidin-3-amine. <sup>1</sup>H NMR (400 MHz, chloroform-<i>d</i>) δ 8.14 (s, 1H), 7.35–7.27 (m, 2H), 6.88 (s, 1H), 6.53 (d, <i>J</i> = 9.2 Hz, 1H), 4.78–4.66 (m, 1H), 3.63 (s, 3H), 3.33 (dd, <i>J</i> = 11.2, 3.9 Hz, 1H), 3.17–2.99 (m, 3H), 2.98–2.85 (m, 1H), 2.73–2.65 (m, 1H), 2.63 (s, 3H), 2.32 (s, 3H), 2.26–2.15 (m, 1H), 2.12–2.00 (m, 1H), 1.91–1.71 (m, 2H). ESI-MS 419.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_32" class="NLM_sec NLM_sec_level_3"><div id="ac_i54" class="anchor-spacer"></div><h4 class="article-section__title" id="_i54"> 6-Fluoro-1-methyl-5-(2-(piperidin-4-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-5-yl)pyridin-2(1<i>H</i>)-one (<b>24</b>)</h4><div class="NLM_p last">Compound <b>24</b> was prepared starting from <b>43</b> and 5-bromo-6-fluoro-1-methylpyridin-2(1<i>H</i>)-one according to the procedure used to make compound <b>5</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.69 (s, 1H), 8.08 (s, 1H), 7.79 (dd, <i>J</i> = 11.3, 9.4 Hz, 1H), 7.71 (s, 1H), 6.42 (d, <i>J</i> = 9.4 Hz, 1H), 4.69–4.60 (m, 1H), 3.47 (d, <i>J</i> = 3.7 Hz, 3H), 3.13–3.05 (m, 2H), 2.71–2.61 (m, 2H), 2.11–2.03 (m, 2H), 2.02–1.90 (m, 2H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.00 (d, <i>J</i> = 5.6 Hz), 152.91 (d, <i>J</i> = 269.0 Hz), 141.48 (d, <i>J</i> = 8.0 Hz), 141.47, 124.82 (d, <i>J</i> = 7.5 Hz), 124.68–124.40 (m), 124.28 (d, <i>J</i> = 2.7 Hz), 123.59 (q, <i>J</i> = 272.7 Hz), 123.58, 122.70, 117.12 (q, <i>J</i> = 32.2 Hz), 114.48 (d, <i>J</i> = 4.4 Hz), 100.54 (d, <i>J</i> = 14.0 Hz), 61.23, 45.01, 33.77, 28.02 (d, <i>J</i> = 7.2 Hz). HRMS-ESI [M + H]<sup>+</sup><i>m</i>/<i>z</i> calcd for C<sub>19</sub>H<sub>19</sub>ON<sub>4</sub>F<sub>4</sub> 395.14895; found 395.14883.</div></div><div id="sec4_1_33" class="NLM_sec NLM_sec_level_3"><div id="ac_i55" class="anchor-spacer"></div><h4 class="article-section__title" id="_i55"> 2-Azido-5-bromo-3-(trifluoromethyl)benzaldehyde (<b>45</b>)</h4><div class="NLM_p last">Step a: <i>2-Amino-5-bromo-3-(trifluoromethyl)benzoic acid</i>. A suspension of 2-amino-3-(trifluoromethyl)benzoic acid (<b>44</b>) (5.00 g, 24.4 mmol) in DCM (150 mL) at room temperature was treated with <i>N</i>-bromosuccinimide (4.60 g, 25.6 mmol) and stirred at room temperature for 1 h. The resulting suspension was filtered; the solid was washed with heptanes, leading to precipitation in the filtrate. The mother liquor was filtered through the same filter funnel. The solid was washed with heptanes and dried to give 2-amino-5-bromo-3-(trifluoromethyl)benzoic acid (6.30 g, 91%) as a colorless solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 13.53 (s, br, 1H), 8.07 (d, <i>J</i> = 2.4 Hz, 1H), 7.75 (d, <i>J</i> = 2.4 Hz, 1H), 7.16 (s, br, 2H). ESI-MS <i>m</i>/<i>z</i> 282.0, 284.0 [M – H]<sup>−</sup>. Step b: <i>(2-amino-5-bromo-3-(trifluoromethyl)phenyl)methanol</i>. A solution of 2-amino-5-bromo-3-(trifluoromethyl)benzoic acid (9.50 g, 33.4 mmol) in THF (120 mL) at 0 °C was treated dropwise with LiAlH<sub>4</sub> in THF (2 M, 33.4 mL, 66.9 mmol) and stirred at room temperature for 1 h. The reaction mixture was cooled to 0 °C and quenched dropwise with water (3.60 mL, 200 mmol). The resulting mixture was treated with aq. NaOH (2 M, 8.40 mL, 16.8 mmol) and stirred until a well-stirrable suspension was obtained and then filtered through celite (rinse with EtOAc); the filtrates were then concentrated. The crude material was purified by flash chromatography (silica gel, DCM/MeOH) to give (2-amino-5-bromo-3-(trifluoromethyl)phenyl)methanol (6.53 g, 72%) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.51 (d, <i>J</i> = 2.3 Hz, 1H), 7.41 (d, <i>J</i> = 2.4 Hz, 1H), 5.46 (s, 2H), 5.40 (t, <i>J</i> = 5.5 Hz, 1H), 4.43 (d, <i>J</i> = 5.4 Hz, 2H). ESI-MS <i>m</i>/<i>z</i> 270.0, 272.0 [M + H]<sup>+</sup>. Step c: <i>2-Amino-5-bromo-3-(trifluoromethyl)benzaldehyde</i>. A solution of (2-amino-5-bromo-3-(trifluoromethyl)phenyl)methanol (6.53 g, 24.2 mmol) in DCM (150 mL) was treated with manganese(IV) oxide (23.4 g, 242 mmol), and the resulting suspension was stirred at room temperature for 1 h. The reaction mixture was filtered through celite (rinse with DCM), and the filtrates were concentrated to give 2-amino-5-bromo-3-(trifluoromethyl)benzaldehyde (6.20 g, 96%) as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 9.88 (s, 1H), 8.14 (d, <i>J</i> = 2.3 Hz, 1H), 7.82 (d, <i>J</i> = 2.3 Hz, 1H), 7.49 (s, br, 2H). Step d: <i>2-Azido-5-bromo-3-(trifluoromethyl)benzaldehyde</i> (<b>45</b>). A solution of 2-amino-5-bromo-3-(trifluoromethyl)benzaldehyde (5.87 g, 21.9 mmol) in TFA (30.0 mL) at 0 °C was treated with sodium nitrite (2.27 g, 32.9 mmol), stirred for 1 h at 0 °C, and then treated portionwise with sodium azide (2.14 g, 32.9 mmol). The reaction mixture was stirred for 0.5 h at 0 °C; the resulting suspension was diluted with DCM and cautiously quenched at 0 °C with 30% solution of NaOH until the pH was above 7. The resulting mixture was diluted with saturated aq. NaHCO<sub>3</sub> and extracted with DCM (3 times). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give <b>45</b> (6.66 g, quant.) as an orange solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 10.11 (s, 1H), 8.49 (d, <i>J</i> = 2.3 Hz, 1H), 8.24 (d, <i>J</i> = 2.3 Hz, 1H). ESI-MS <i>m</i>/<i>z</i> mass not observed.</div></div><div id="sec4_1_34" class="NLM_sec NLM_sec_level_3"><div id="ac_i56" class="anchor-spacer"></div><h4 class="article-section__title" id="_i56"> (3<i>R</i>,4<i>R</i>)-<i>tert</i>-Butyl-4-(5-bromo-7-(trifluoromethyl)-2<i>H</i>-indazol-2-yl)-3-fluoropiperidine-1-carboxylate (<b>46</b>)</h4><div class="NLM_p last">Compound <b>46</b> was prepared starting from <b>45</b> and (3<i>R</i>,4<i>R</i>)-<i>tert</i>-butyl 4-amino-3-fluoropiperidine-1-carboxylate according to the procedure used to make compound <b>47</b>. ESI-MS <i>m</i>/<i>z</i> 466.3, 468.3 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_35" class="NLM_sec NLM_sec_level_3"><div id="ac_i57" class="anchor-spacer"></div><h4 class="article-section__title" id="_i57"> (3<i>S</i>,4<i>S</i>)-<i>tert</i>-Butyl-4-(5-bromo-7-(trifluoromethyl)-2<i>H</i>-indazol-2-yl)-3-fluoropiperidine-1-carboxylate (<b>47</b>)</h4><div class="NLM_p last">A suspension of 2-azido-5-bromo-3-(trifluoromethyl)benzaldehyde (<b>45</b>) (400 mg, 1.36 mmol), (3<i>S</i>,4<i>S</i>)-<i>tert</i>-butyl 4-amino-3-fluoropiperidine-1-carboxylate (312 mg, 1.43 mmol), and Cu<sub>2</sub>O (19.5 mg, 0.14 mmol) in DCE (7.0 mL) was stirred at 80 °C for 15 h. The reaction mixture was cooled to RT, directly absorbed on isolute, and dried under vacuum. The absorbed crude material was purified by flash chromatography (silica gel, heptanes/EtOAc) to give the title compound <b>47</b> (561 mg, 88%) as a light-yellow foam. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.79 (s, 1H), 8.36 (s, 1H), 7.76 (s, 1H), 5.11–4.87 (m, 2H), 4.44–4.28 (m, 1H), 4.07–3.96 (m, 1H), 3.15–2.87 (m, 2H), 2.21–2.03 (m, 2H), 1.44 (s, 9H). ESI-MS <i>m</i>/<i>z</i> 466.2, 468.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_36" class="NLM_sec NLM_sec_level_3"><div id="ac_i58" class="anchor-spacer"></div><h4 class="article-section__title" id="_i58"> Racemic-(3<i>S</i>*,4<i>R</i>*)-<i>tert</i>-butyl-4-(5-bromo-7-(trifluoromethyl)-2<i>H</i>-indazol-2-yl)-3-fluoropiperidine-1-carboxylate (<b>48</b>)</h4><div class="NLM_p last">Compound <b>48</b> was prepared starting from <b>45</b> and racemic (3<i>S</i>*,4<i>R</i>*)-<i>tert</i>-butyl 4-amino-3-fluoropiperidine-1-carboxylate according to the procedure used to make compound <b>47</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.67 (s, 1H), 8.32 (s, 1H), 7.76 (s, 1H), 5.26–4.98 (m, 2H), 4.44–4.09 (m, 2H), 3.00 (s, 2H), 2.42–2.29 (m, 1H), 2.12 (d, <i>J</i> = 10.6 Hz, 1H), 1.41 (s, 9H). ESI-MS <i>m</i>/<i>z</i> 466.2, 468.2 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_37" class="NLM_sec NLM_sec_level_3"><div id="ac_i59" class="anchor-spacer"></div><h4 class="article-section__title" id="_i59"> 8-Bromo-2,3-dihydroindolizin-5(1<i>H</i>)-one (<b>51</b>)</h4><div class="NLM_p last">Step h: <i>2-Methoxy-6-(3-((tetrahydro-2H-pyran-2-yl)oxy)propyl)pyridine</i> (<b>50</b>). A solution of 2-bromo-6-methoxypyridine (<b>49</b>, 5.52 mL, 43.6 mmol) in THF (75.0 mL) at −78 °C was treated dropwise with <i>n</i>-butyllithium in hexanes (2.5 M, 17.4 mL, 43.6 mmol). The reaction mixture was stirred at −78 °C for 30 min, treated dropwise with 2-(3-bromopropoxy)tetrahydro-2<i>H</i>-pyran (4.91 mL, 29.0 mmol), stirred at −78 °C for 1 h, and allowed to warm to room temperature over 1 h. The reaction mixture was poured into ice water and extracted twice with EtOAc. The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (silica gel, heptanes/EtOAc) to give <b>50</b> (3.46 g, 47%) as a yellow oil. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.57 (dd, <i>J</i> = 8.1, 7.4 Hz, 1H), 6.81 (d, <i>J</i> = 7.2 Hz, 1H), 6.59 (d, <i>J</i> = 8.2 Hz, 1H), 4.55–4.49 (m, 1H), 3.81 (s, 3H), 3.76–3.68 (m, 1H), 3.68–3.62 (m, 1H), 3.43–3.33 (m, 2H), 2.73–2.65 (m, 2H), 1.95–1.87 (m, 2H), 1.76–1.65 (m, 1H), 1.65–1.55 (m, 1H), 1.51–1.39 (m, 4H). ESI-MS <i>m</i>/<i>z</i> 252.3 [M + H]<sup>+</sup>. Step i: 2,3-dihydroindolizin-5(1<i>H</i>)-one. A solution of <b>50</b> (3.46 g, 13.8 mmol) in 48% aq. HBr (78.0 mL, 0.690 mol) was stirred under reflux for 4 h. The reaction mixture was cooled to RT, filtered, and slowly basified with sodium hydroxide (27.5 g, 0.690 mol). The crude mixture was then diluted with water and extracted twice with DCM. The organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated to give 2,3-dihydroindolizin-5(1<i>H</i>)-one (1.83 g, 98%) as a brown solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.35 (dd, <i>J</i> = 8.8, 7.0 Hz, 1H), 6.18–6.10 (m, 2H), 3.97–3.90 (m, 2H), 3.04 (t, <i>J</i> = 7.7 Hz, 2H), 2.06 (p, <i>J</i> = 7.6 Hz, 2H). ESI-MS <i>m</i>/<i>z</i> 136.1 [M + H]<sup>+</sup>. Step j: <i>8-Bromo-2,3-dihydroindolizin-5(1H)-one</i> (<b>51</b>). A solution of 2,3-dihydroindolizin-5(1<i>H</i>)-one (1.82 g, 13.5 mmol) in DMF (35.0 mL) at 0 °C was treated with <i>N</i>-bromosuccinimide (2.40 g, 13.5 mmol). The reaction mixture was stirred at room temperature for 30 min, poured into water, and extracted twice with DCM. The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was dissolved in a mixture of DCM and heptanes. The solution was then concentrated until precipitation occurred. The suspension was filtered, and the filtrates were concentrated. The residue was purified by flash chromatography (silica gel, DCM/MeOH) to give <b>51</b> (1.43 g, 42%) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 7.49 (d, <i>J</i> = 9.5 Hz, 1H), 6.18 (d, <i>J</i> = 9.5 Hz, 1H), 4.04 (t, <i>J</i> = 7.5 Hz, 2H), 3.05 (t, <i>J</i> = 7.8 Hz, 2H), 2.12 (p, <i>J</i> = 7.7 Hz, 2H). ESI-MS <i>m</i>/<i>z</i> 214.1, 216.1 [M + H]<sup>+</sup>.</div></div><div id="sec4_1_38" class="NLM_sec NLM_sec_level_3"><div id="ac_i60" class="anchor-spacer"></div><h4 class="article-section__title" id="_i60"> 8-(2-(Piperidin-4-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-5-yl)-2,3-dihydroindolizin-5(1<i>H</i>)-one (<b>25</b>)</h4><div class="NLM_p last">Step 1: <i>tert</i>-Butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate. A mixture of bis(pinacolato)diboron (1.21 g, 4.68 mmol), XPhos Pd G3 (0.20 g, 0.23 mmol), XPhos (0.15 g, 0.31 mmol), and potassium acetate (0.92 g, 9.37 mmol) was treated with a solution of <b>43</b> (1.40 g, 3.12 mmol) in dioxane (20.0 mL). The reaction mixture was purged with nitrogen, sealed, and stirred at 80 °C for 18 h. The reaction mixture was diluted with water and extracted with DCM (3 times). The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified by flash chromatography (silica gel, heptanes/EtOAc) to give <i>tert</i>-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate (1.38 g, 80%) as a colorless foam. <sup>1</sup>H NMR (400 MHz, methanol-<i>d</i><sub>4</sub>) δ 8.53 (s, 1H), 8.41 (s, 1H), 7.86 (s, 1H), 4.79–4.69 (m, 1H), 4.33–4.20 (m, 2H), 3.11–2.95 (m, 2H), 2.28–2.18 (m, 2H), 2.16–2.03 (m, 2H), 1.49 (s, 9H), 1.37 (s, 12H). ESI-MS <i>m</i>/<i>z</i> 496.4 [M + H]<sup>+</sup>. Step 2: <i>tert</i>-Butyl 4-(5-(5-oxo-1,2,3,5-tetrahydroindolizin-8-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate. A mixture of <i>tert</i>-butyl 4-(5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate (80 mg, 0.162 mmol), <b>51</b> (34.6 mg, 0.162 mmol), aq. Na<sub>2</sub>CO<sub>3</sub> (2 M, 0.162 mL, 0.323 mmol), and DME (1.50 mL) was purged with argon; then, PdCl<sub>2</sub>(dppf) (5.91 mg, 8.08 μmol) was added, and the reaction mixture was stirred at 80 °C for 3 days. The reaction mixture was poured into water and extracted twice with EtOAc. The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was purified by flash chromatography (silica gel, DCM/MeOH) to give <i>tert</i>-butyl 4-(5-(5-oxo-1,2,3,5-tetrahydroindolizin-8-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate (44.0 mg, 54%) as a colorless resin. ESI-MS <i>m</i>/<i>z</i> 504.3 [M + H]<sup>+</sup>. Step 3: 8-(2-(Piperidin-4-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-5-yl)-2,3-dihydroindolizin-5(1<i>H</i>)-one (<b>25</b>). A solution of <i>tert</i>-butyl 4-(5-(5-oxo-1,2,3,5-tetrahydroindolizin-8-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate (44.0 mg, 0.088 mmol) in DCM (1 mL) was treated with TFA (500 μL) and allowed to stand for 1 h. The reaction mixture was diluted with DCM, quenched with saturated aq. NaHCO<sub>3</sub> (caution: gas evolution), and extracted with DCM (3 times). The combined organic layers were dried over anhydrous Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under reduced pressure. The residue was lyophilized from MeCN/water to give <b>25</b> (24.0 mg, 64%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.64 (s, 1H), 7.99 (s, 1H), 7.63 (s, 1H), 7.59 (d, <i>J</i> = 9.2 Hz, 1H), 6.34 (d, <i>J</i> = 9.2 Hz, 1H), 4.71–4.57 (m, 1H), 4.05 (t, <i>J</i> = 7.2 Hz, 2H), 3.18 (t, <i>J</i> = 7.5 Hz, 2H), 3.13–3.04 (m, 2H), 2.70–2.61 (m, 2H), 2.14–1.89 (m, 6H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.23, 148.99, 141.58, 141.46, 129.00, 124.73 (q, <i>J</i> = 5.2 Hz), 124.44, 123.34, 123.98 (q, <i>J</i> = 272.4 Hz), 122.73, 117.05 (q, <i>J</i> = 32.2 Hz), 116.64, 113.80, 61.20, 48.86, 45.04, 33.79, 31.59, 21.04. HRMS-ESI [M + H]<sup>+</sup><i>m</i>/<i>z</i> calcd for C<sub>21</sub>H<sub>22</sub>ON<sub>4</sub>F<sub>3</sub> 403.17402; found 403.17410.</div></div><div id="sec4_1_39" class="NLM_sec NLM_sec_level_3"><div id="ac_i61" class="anchor-spacer"></div><h4 class="article-section__title" id="_i61"> 8-(2-((3<i>R</i>,4<i>R</i>)-3-Fluoropiperidin-4-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-5-yl)-2,3-dihydroindolizin-5(1<i>H</i>)-one (<b>26</b>)</h4><div class="NLM_p last">Compound <b>26</b> was prepared according to the method of <b>27</b> by replacing <b>47</b> with <b>46</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.71 (s, 1H), 8.02 (s, 1H), 7.65 (s, 1H), 7.59 (d, <i>J</i> = 9.2 Hz, 1H), 6.33 (d, <i>J</i> = 9.2 Hz, 1H), 5.08–4.78 (m, 2H), 4.04 (t, <i>J</i> = 7.2 Hz, 2H), 3.38–3.32 (m, 1H), 3.18 (t, <i>J</i> = 7.5 Hz, 2H), 3.03–2.93 (m, 1H), 2.64–2.53 (m, 2H), 2.18–2.02 (m, 4H). ESI-MS <i>m</i>/<i>z</i> 421.3 [M + H]<sup>+</sup>. Chiral HPLC Rt = 28.25 min, >99% ee.</div></div><div id="sec4_1_40" class="NLM_sec NLM_sec_level_3"><div id="ac_i62" class="anchor-spacer"></div><h4 class="article-section__title" id="_i62"> 8-(2-((3<i>S</i>,4<i>S</i>)-3-Fluoropiperidin-4-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-5-yl)-2,3-dihydroindolizin-5(1<i>H</i>)-one (<b>27</b>)</h4><div class="NLM_p last">Step f: (3<i>S</i>,4<i>S</i>)-<i>tert</i>-Butyl-3-fluoro-4-(5-(5-oxo-1,2,3,5-tetrahydroindolizin-8-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate. A vial was charged with <b>47</b> (1.36 g, 2.92 mmol), tetrahydroxydiboron (748 mg, 8.34 mmol), XPhos Pd G3 (235 mg, 0.278 mmol), XPhos (265 mg, 0.556 mmol), and potassium acetate (818 mg, 8.34 mmol) and flushed with argon and capped. Then, degassed EtOH (10.0 mL) was added and the reaction mixture was stirred at 80 °C for 30 min. The reaction mixture was cooled to room temperature, and aq. K<sub>2</sub>CO<sub>3</sub> (2 M, 4.20 mL, 8.40 mmol) was added dropwise followed by a solution of <b>51</b> (700 mg, 2.78 mmol) in degassed EtOH (2.00 mL). The reaction mixture was stirred at 80 °C for 1 h, poured into water, and extracted twice with EtOAc. The combined organic phases were dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The crude material was purified twice by flash chromatography ((silica gel, DCM/MeOH) and (C18, (H<sub>2</sub>O + 0.1%TFA)/MeCN)). The obtained material was treated with a saturated solution of Na<sub>2</sub>CO<sub>3</sub> and extracted with DCM. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was dissolved in DCM (15.0 mL), and metal scavenger resin (MP-TMT) (2.67 g, 1.39 mmol) was added. The resulting suspension was shaken overnight and filtered (one rinse with DCM), and the filtrate was concentrated to afford (3<i>S</i>,4<i>S</i>)-<i>tert</i>-butyl-3-fluoro-4-(5-(5-oxo-1,2,3,5-tetrahydroindolizin-8-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate (980 mg, 68%) as a light-yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.79 (s, 1H), 8.04–7.97 (m, 1H), 7.66 (s, 1H), 7.59 (d, <i>J</i> = 9.2 Hz, 1H), 6.33 (d, <i>J</i> = 9.2 Hz, 1H), 5.15–4.91 (m, 2H), 4.44–4.31 (m, 1H), 4.10–3.98 (m, 3H), 3.18 (t, <i>J</i> = 7.5 Hz, 2H), 3.12–2.94 (m, 2H), 2.23–2.02 (m, 4H), 1.44 (s, 9H). ESI-MS <i>m</i>/<i>z</i> 521.4 [M + H]<sup>+</sup>. Step g: <i>8-(2-((3S,4S)-3-Fluoropiperidin-4-yl)-7-(trifluoromethyl)-2H-indazol-5-yl)-2,3-dihydroindolizin-5(1H)-one</i> (<b>27</b>). A solution of (3<i>S</i>,4<i>S</i>)-<i>tert</i>-butyl 3-fluoro-4-(5-(5-oxo-1,2,3,5-tetrahydroindolizin-8-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-2-yl)piperidine-1-carboxylate (980 mg, 1.88 mmol) in DCM (6.00 mL) was treated with TFA (2.90 mL, 37.7 mmol) and stirred at room temperature for 30 min. The reaction mixture was concentrated, and the residue was purified by flash chromatography (C18, (H<sub>2</sub>O + 0.1%TFA)/MeCN). The pure product-containing fractions were concentrated until the bulk of the MeCN had been evaporated, treated with saturated aq. Na<sub>2</sub>CO<sub>3</sub>, and extracted with DCM. The organic phase was dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated. The residue was then dissolved in MeOH and treated with diethylether. The resulting solution was concentrated, and the residue was dried under vacuum to give <b>27</b> (682 mg, 85%) as a colorless powder. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>): δ 8.71 (s, 1H), 8.02 (s, 1H), 7.65 (s, 1H), 7.59 (d, <i>J</i> = 9.2 Hz, 1H), 6.33 (d, <i>J</i> = 9.2 Hz, 1H), 5.09–4.77 (m, 2H), 4.05 (t, <i>J</i> = 7.3 Hz, 2H), 3.39–3.32 (m, 1H), 3.18 (t, <i>J</i> = 7.6 Hz, 2H), 3.03–2.93 (m, 1H), 2.64–2.53 (m, 2H), 2.19–2.02 (m, 4H). <sup>13</sup>C NMR (151 MHz, DMSO-<i>d</i><sub>6</sub>) δ 160.27, 149.03, 141.97, 141.56, 129.28, 125.55, 125.13 (d, <i>J</i> = 5.6 Hz), 124.54, 123.9 (q, <i>J</i> = 272.8 Hz), 122.58, 117.19 (q, <i>J</i> = 32.5 Hz), 116.65, 113.78, 90.49 (d, <i>J</i> = 181.6 Hz), 65.23 (d, <i>J</i> = 16.6 Hz), 49.18 (d, <i>J</i> = 21.8 Hz), 48.87, 44.05, 33.32 (d, <i>J</i> = 4.7 Hz), 31.57, 21.02. <sup>19</sup>F NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>) δ −184.83 (1F), -60.78 (3F). IR (KBr) 3430, 3305, 3090, 2956, 2830, 1654, 1594, 1537, 1463, 1434, 1349, 1293, 1277, 1155, 1122, 1064, 830 cm<sup>–1</sup>. HRMS-ESI [M + H]<sup>+</sup><i>m</i>/<i>z</i> calcd for C21H20F4N4O 421.16460; found 421.16458. Chiral HPLC Rt = 24.29 min, >99% ee.</div></div><div id="sec4_1_41" class="NLM_sec NLM_sec_level_3"><div id="ac_i63" class="anchor-spacer"></div><h4 class="article-section__title" id="_i63"> Racemic-8-(2-((3<i>S</i>*,4<i>R</i>*)-3-fluoropiperidin-4-yl)-7-(trifluoromethyl)-2<i>H</i>-indazol-5-yl)-2,3-dihydroindolizin-5(1<i>H</i>)-one (<b>28</b>)</h4><div class="NLM_p last">Compound <b>28</b> was prepared according to the method of <b>27</b> by replacing <b>47</b> with <b>48</b>. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.60 (d, <i>J</i> = 1.1 Hz, 1H), 8.01 (s, 1H), 7.65 (s, 1H), 7.59 (d, <i>J</i> = 9.2 Hz, 1H), 6.33 (d, <i>J</i> = 9.2 Hz, 1H), 5.07–4.89 (m, 2H), 4.04 (t, <i>J</i> = 7.2 Hz, 2H), 3.25–3.07 (m, 4H), 2.91 (dd, <i>J</i> = 39.8, 14.5 Hz, 1H), 2.76–2.67 (m, 1H), 2.36–2.24 (m, 1H), 2.13–1.99 (m, 3H). ESI-MS <i>m</i>/<i>z</i> 421.3 [M + H]<sup>+</sup>.</div></div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> Biology: TLR8 Protein Production and Purification</h3><div class="NLM_p last">The extracellular domain of TLR8 (residues 27–827) was expressed by Express<sup>2</sup>ion and purified in-house according to the published literature.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> In brief, TLR8 was expressed in a <i>Drosophila</i> S2 expression system. The protein was purified by IgG Sepharose affinity chromatography, subsequent saccharide trimming using EndoHF, and Superdex 200 gel filtration chromatography followed by HiTrap Q anion-exchange chromatography.</div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> TLR8 Binding Assay</h3><div class="NLM_p last">The TR-FRET binding assay was performed in white 1536-well plates (Greiner) in a final volume of 5 μL. An Echo acoustic dispenser was used to transfer 50 nL of 2 mM compound solution in DMSO into the assay plate. Assay components were prepared in 20 mM Tris/HCl pH 7.0, 0.2% Pluronic F127, and 0.1 mM ethylenediamine tetraacetic acid (EDTA). The final concentrations were 10 nM biotinylated TLR8, 50 nM Cy5-ligand 2, and 0.5 nM Eu-Streptavidin (PerkinElmer). Then, 2.5 μL of TLR8 protein was added to the compounds using a Certus dispenser, followed by 30 min of incubation at room temperature. After addition of a 2.5 μL detection mix (Eu-Streptavidin and 2), plates were incubated for 30 min before measuring TR-FRET in an Envision multimode plate reader (PerkinElmer; excitation 340 nm, emission 615 and 665 nm). Control wells without TLR8 protein and with DMSO were used to calculate the % activity. IC<sub>50</sub> values were estimated from a four-parameter logistic fit in a data analysis and visualization package developed at Novartis.</div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> TLR-Driven Cytokine Inhibition in Human PBMCs</h3><div class="NLM_p">Fresh human blood, collected in S-Monovette Heparin tubes (Starstedt), was obtained from healthy individuals with patient informed consent (Santémed Gesundheitszentrum AG Basel Switzerland). PBMCs were prepared by diluting blood 1:1 with phosphate-buffered saline (PBS) and transferred to pre-prepared Leucosep tubes (Greiner Bio-one) containing 15 mL of LSM1077 (EuroBio). The PBMC layer was carefully removed from the plasma/separation medium interface following centrifugation (800<i>g</i>, 20 min at 22 °C without brake). PBMCs were washed with PBS, centrifuged (400<i>g</i>, 10 min at 22 °C), and resuspended in growth media (RPMI1640+GlutaMAX-I supplemented with 0.05 mM 2-mercaptoethanol, 10 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), and 5% v/v FBS, GE Healthcare). PBMCs were seeded in 384-well plates and incubated for 30 min in the presence of increased amounts of compound or vehicle control (0.25% DMSO final per well). Cells were stimulated with fixed amounts of agonists for TLR1/2 (Pam3CSK4, 0.1 μg/mL, Invivogen), TLR4 (LPS, 5 ng/mL, Sigma), TLR5 (flagellin, 1 μg/mL), TLR9 (ODN2216, 0.3 μM), and IL-1β (3 μg/mL, produced internally), TLR7 (ssRNA40, 10 μg/mL, synthesized by Microsynth, Switzerland), or TLR8 (ssRNA40, 1 μg/mL). For both TLR7 and TLR8, ssRNA40 was precomplexed with <i>N</i>-[1-(2,3 dioleoyloxy) propyl]-<i>N</i>,<i>N</i>,<i>N</i> tri-methyl ammonium methylsulfate (DOTAP) (10 or 25 μg/mL, respectively; Roche Life Sciences). For each agonist, EC<sub>90</sub> values were experimentally determined to assess IC<sub>50</sub> compounds across cellular pathways. After 20 h at 37 °C in a humidified incubator, supernatants were transferred to 384-well Optiplates (PerkinElmer) and IFNα levels (TLR7 and TLR9) were quantified by AlphaLisa technology using the human interferon AlphaLISA kit (PerkinElmer) and the EnVision multiplate reader according to the manufacturer’s protocols. TNFα was measured routinely for TLR4 and TLR8, and all other TLRs and IL1R levels in the supernatant were quantified by homogeneous time-resolved fluorescence (HTRF) technology using the human kits (CisBio) and a RUBYstar (BMG Labtech) fluorescent plate reader. Data were analyzed using Excel XL fit 5.0 (Microsoft) with XL<i>fit</i> add-in (IDBS; version 5.2.0). Cytokine concentrations were determined following extrapolation to standard curves using the appropriate reference cytokine. Individual IC<sub>50</sub> (median inhibition concentration) values were determined by nonlinear regression after fitting of curves to the experimental data with each point performed in biological triplicate.</div><div class="NLM_p">Ex vivo TLR stimulated human and murine whole-blood cytokine assays. For blood assays, fresh human blood or blood from 129/SV mice was collected into citrate S-Monovette 9NC tubes (Sarstedt). Blood was diluted 1:1 with RPMI1640 into sterile 96-well U-bottom plates. Blood cells were incubated with increasing concentrations of 27 in RPMI1640 or vehicle control (0.25 % v/v DMSO final per well) for 30 min at 37 °C. Human blood was stimulated with ssRNA40 (1 μg/mL) for TLR7-mediated IFNα and TLR8-mediated TNFα and ODN2216 (0.2 μM) for TLR9-driven IFNα. Both agonists were precomplexed with DOTAP (15 μg/mL) in a final assay volume of 100 μL/well. For murine, blood was stimulated with ssRNA40 (1 μg/mL precomplexed with 15 μg/mL DOTAP) or ODN1585 (0.2 μM precomplexed with 25 μg/mL DOTAP for IFNα) in a final assay volume of 100 μL/well. After 20 h at 37 °C in a humidified incubator, supernatants were collected for quantification of human and murine IFNα (Platinum ELISA kit, Thermo Fisher Scientific) according to the manufacturer’s instructions and a multiplate SpectraMax M5 reader (Molecular Devices, Sunnyvale, CA). Human TNF release was quantified using HTRF technology (CisBio, Bedford, MA) and a RUBYstar (BMG Labtech, Ortenberg, Germany) fluorescence plate reader. The remaining blood cell pellet was washed twice with PBS, and cell viability was assessed using CellTiter Glo (Promega, Madison, WI) or ATPLite assays (PerkinElmer) according to the manufacturer’s protocols. Luminescence was measured using an EnVision multiplate reader (PerkinElmer), SpectraMax M5 reader, or CLIPR (Molecular Devices, Sunnyvale, CA). Individual IC<sub>50</sub> values were determined as indicated above.</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i67" class="anchor-spacer"></div><h4 class="article-section__title" id="_i67"> Animals</h4><div class="NLM_p last">All animal studies described were performed according to Swiss animal welfare guidelines.</div></div><div id="sec4_4_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i68" class="anchor-spacer"></div><h4 class="article-section__title" id="_i68"> <i>In Vivo</i> PK Experiments</h4><div class="NLM_p last">Three male Sprague–Dawley rats or C57BL/6 mice, respectively, were used to assess the principal PK parameters. Compounds were prepared in suitable vehicles for intravenous (i.v.) administration (as solution) and peroral (p.o.) administration (as suspension) at the given doses (mg/kg). For rats, both dosing arms were done as crossover, i.e., with respective washout times in between. Each dosing arm was applied once (single dose), and blood samples were taken from a suitable vein at regular time points thereafter (0.083, 0.25, 0.5, 1, 2, 4, 7, and 24 h after i.v.; 0.25, 0.5, 1, 2, 4, 7, and 24 h after p.o., respectively). Compound blood concentrations were determined by suitable LC/MS/MS methods, using internal standards and calibration curves to integrate the peak areas. From these concentrations, PK parameters were determined by standard methods, i.e., area-under-curve (AUC) via trapezoidal calculation, clearance (CL), and volume of distribution at steady state (<i>V</i><sub>ss</sub>) using AUC and dose information. Finally, oral bioavailability was determined by relating AUCs derived from IV and PO arms including dose correction. For comparison reasons, some of the PK parameters are presented as “dose-normalized, dn”, i.e., related to a standard dose of 1 mg/kg.</div></div><div id="sec4_4_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i69" class="anchor-spacer"></div><h4 class="article-section__title" id="_i69"> <i>In Vivo</i> Efficacy Analysis in Mice</h4><div class="NLM_p last">Compound <b>27</b> in methyl cellulose/Tween-80 (0.5% methyl cellulose (BioConcept, Allschwil, Switzerland)/0.5% Tween-80 (Sigma-Aldrich)) or vehicle alone was administered p.o. to 129Sv mice (<i>n</i> = 5 per dose group). One hour later, mice were injected i.v. with 20 μg of ssRNA R0006, complexed to 140 μg of <i>N</i>-[1-(2,3 dioleoyloxy) propyl]-<i>N</i>,<i>N</i>,<i>N</i> tri-methyl ammonium methylsulfate (DOTAP, Roche) according to the manufacturer’s instructions, and diluted in HEPES-buffered saline. Mice were terminally bled from the vena cava into EDTA microvettes (Sarstedt, Nümbrecht, Germany) 2 h after R0006/DOTAP injection. Serum was isolated by centrifugation (2000<i>g</i>, 10 min, 4 °C), and IFNα levels were determined using the mouse IFNα Platinum ELISA (eBioscience, San Diego, CA). Concentrations of compound <b>27</b> in whole blood were determined by liquid chromatography, coupled to mass spectrometry (LC–MS/MS). Data and statistics were analyzed using GraphPad Prism version 8.</div></div><div id="sec4_4_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i70" class="anchor-spacer"></div><h4 class="article-section__title" id="_i70"> TLR8 Cocrystallization and Structure Determination</h4><div class="NLM_p">Purified TLR8 ECD protein buffered in 50 mM Tris pH 8.0 and 175 mM NaCl at a concentration of 5.9 mg*mL<sup>–1</sup> and containing 2 mM compound <b>11</b> was used to set up a sparse-matrix screen. Then, 0.2 μL of the protein solution was mixed with 0.2 μL of the well solution and equilibrated against 80 μL of the reservoir using SWISSCI MRC 2 well crystallization plates designed in the 96-well plate format and sealed with Hampton Research ClearSeal Film. Crystallization plates were incubated at 20 °C. Crystals were found under several conditions after 2–10 days, while crystals suitable for X-ray diffraction experiments were obtained in condition E4: 20% PEG 3350, 200 mM magnesium chloride, reaching 450 μm length on day 28. Crystals were vitrified by plunging them directly into liquid nitrogen.</div><div class="NLM_p last">Data sets were collected at 1.0 Å wavelength with a PILATUS 6M detector at the Swiss Light Source beamline X10SA (Villigen, Switzerland). Data were collected by Expose GmbH. Diffraction images were processed and scaled using XDS and XSCALE, respectively. Structures were solved by molecular replacement (Phaser) using 3W3G as the starting model. The initial model was subjected to iterative cycles of manual rebuilding and subsequent structure refinement in Coot and autoBuster, respectively. The ligand structure was built into unbiased <i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> difference electron density calculated by autoBuster. Final structure refinement statistics are summarized in <a href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf" class="ext-link">Supporting Table S1</a>. Refined coordinates were deposited to the PDB with entry number <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TY5">6TY5</a>.</div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i71"><a href="/doi/suppl/10.1021/acs.jmedchem.0c00130" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_60444" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_60444" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c00130?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00130</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">X-ray crystal data and structure refinement details, sequence alignment for TLRs, glutathione stability data for compound <b>24</b>, synthesis procedure and spectral data for probe compound <b>2</b> (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings including assay data (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_002.csv" class="ext-link">CSV</a>)</p></li><li><p class="inline">Binding model of compound <b>3</b> to TLR8 (<a href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_003.pdb" class="ext-link">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf">jm0c00130_si_001.pdf (933.85 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_002.csv">jm0c00130_si_002.csv (2.37 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_003.pdb">jm0c00130_si_003.pdb (130.17 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code for the X-ray cocrystal structure of TLR8 ECD in complex with compound <b>11</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TY5">6TY5</a>. CCDC deposition number for the small-molecule crystal structure for compound <b>27</b> is 1979262. The authors will release the atomic coordinates and experimental data upon publication of the article.</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c00130" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70673" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70673" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Knoepfel</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-1675-6297" title="Orcid link">http://orcid.org/0000-0002-1675-6297</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#99edf1f6f4f8eab7f2f7f6fce9fffcf5d9f7f6eff8ebedf0eab7faf6f4"><span class="__cf_email__" data-cfemail="7c081413111d0f52171213190c1a19103c12130a1d0e08150f521f1311">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierre Nimsgern</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sébastien Jacquier</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marjorie Bourrel</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Vangrevelinghe</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ralf Glatthar</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dirk Behnke</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Phil B. Alper</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, San Diego, California 92121, United States</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4115-0633" title="Orcid link">http://orcid.org/0000-0002-4115-0633</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pierre-Yves Michellys</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jonathan Deane</span> - <span class="hlFld-Affiliation affiliation">Genomics
Institute of the Novartis Research Foundation, San Diego, California 92121, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tobias Junt</span> - <span class="hlFld-Affiliation affiliation">Autoimmunity, Transplantation and Inflammation, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Géraldine Zipfel</span> - <span class="hlFld-Affiliation affiliation">Autoimmunity, Transplantation and Inflammation, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sarah Limonta</span> - <span class="hlFld-Affiliation affiliation">Autoimmunity, Transplantation and Inflammation, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stuart Hawtin</span> - <span class="hlFld-Affiliation affiliation">Autoimmunity, Transplantation and Inflammation, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Cedric Andre</span> - <span class="hlFld-Affiliation affiliation">Autoimmunity, Transplantation and Inflammation, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Thomas Boulay</span> - <span class="hlFld-Affiliation affiliation">Autoimmunity, Transplantation and Inflammation, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pius Loetscher</span> - <span class="hlFld-Affiliation affiliation">Autoimmunity, Transplantation and Inflammation, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael Faller</span> - <span class="hlFld-Affiliation affiliation">Chemical Biology
& Therapeutics, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jutta Blank</span> - <span class="hlFld-Affiliation affiliation">Chemical Biology
& Therapeutics, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Roland Feifel</span> - <span class="hlFld-Affiliation affiliation">Pharmacokinetic Sciences, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Claudia Betschart</span> - <span class="hlFld-Affiliation affiliation">Global
Discovery Chemistry, , , , Novartis Institutes
for BioMedical Research, CH-4002 Basel, Switzerland</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="ack" id="ACK-d7e5772-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i74">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_72483" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_72483" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank T. Wager, P. Piéchon, and I. Dix for crystallography support for compound <b>27</b>; R. Denay for analytical support; D. Langenegger for support setting up and running the biochemical assay; Y. Zhang for the preparation of compound <b>1</b>; R. Hemmig and F. Zink for protein purification and crystallization; and G. Ruzzante for support with compound profiling.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations</td></tr><tr><td class="NLM_term">aq.</td><td class="NLM_def"><p class="first last">aqueous solution</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DCE</td><td class="NLM_def"><p class="first last">1,2-dichloroethane</p></td></tr><tr><td class="NLM_term">DMA</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylacetamide</p></td></tr><tr><td class="NLM_term">DME</td><td class="NLM_def"><p class="first last">1,2-dimethoxyethane</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last"><i>N</i>,<i>N</i>-dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">dppf</td><td class="NLM_def"><p class="first last">1,1′-bis(diphenylphosphino)ferrocene</p></td></tr><tr><td class="NLM_term">ECD</td><td class="NLM_def"><p class="first last">ectodomain</p></td></tr><tr><td class="NLM_term">ESI-MS</td><td class="NLM_def"><p class="first last">electrospray ionization mass spectroscopy</p></td></tr><tr><td class="NLM_term">FP</td><td class="NLM_def"><p class="first last">fluorescence polarization</p></td></tr><tr><td class="NLM_term">HATU</td><td class="NLM_def"><p class="first last"><i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HRMS-ESI</td><td class="NLM_def"><p class="first last">high-resolution mass spectroscopy electrospray ionization</p></td></tr><tr><td class="NLM_term">IFN</td><td class="NLM_def"><p class="first last">interferon</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby Canine Kidney cells</p></td></tr><tr><td class="NLM_term">n.a.</td><td class="NLM_def"><p class="first last">not applicable</p></td></tr><tr><td class="NLM_term">n.d.</td><td class="NLM_def"><p class="first last">not determined</p></td></tr><tr><td class="NLM_term">NMP</td><td class="NLM_def"><p class="first last">1-methyl-2-pyrrolidinone</p></td></tr><tr><td class="NLM_term">PBMCs</td><td class="NLM_def"><p class="first last">peripheral blood mononuclear cells</p></td></tr><tr><td class="NLM_term">PEG</td><td class="NLM_def"><p class="first last">poly(ethylene glycol)</p></td></tr><tr><td class="NLM_term">R848</td><td class="NLM_def"><p class="first last">1-[4-amino-2-(ethoxymethyl)-1<i>H</i>-imidazo[4,5-<i>c</i>]chinolin-1-yl]-2-methylpropan-2-ol</p></td></tr><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">room temperature</p></td></tr><tr><td class="NLM_term">SD</td><td class="NLM_def"><p class="first last">standard deviation</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">ssRNA</td><td class="NLM_def"><p class="first last">single-stranded RNA</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">TR-FRET</td><td class="NLM_def"><p class="first last">time-resolved fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">XPhos</td><td class="NLM_def"><p class="first last">2-dicyclohexylphosphino-2′,4′,6′-tri-isopropyl-1,1′-biphenyl</p></td></tr><tr><td class="NLM_term">XPhos</td><td class="NLM_def"><p class="first last">Pd G3 (XPhos)[2-(2′-amino-1,1′-biphenyl)]palladium(II) methanesulfonate</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_02871" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_02871" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 31 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Junt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barchet, W.</span></span> <span> </span><span class="NLM_article-title">Translating Nucleic Acid-Sensing Pathways into Therapies</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1038/nri3875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1038%2Fnri3875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=26292638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOrtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=529-544&author=T.+Juntauthor=W.+Barchet&title=Translating+Nucleic+Acid-Sensing+Pathways+into+Therapies&doi=10.1038%2Fnri3875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Translating nucleic acid-sensing pathways into therapies</span></div><div class="casAuthors">Junt, Tobias; Barchet, Winfried</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">529-544</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nucleic acid sensing by innate receptors initiates immune defences against viruses and other pathogens.  A hallmark of this response is the release of interferons (IFNs), which promote protective immunity by inducing IFN-stimulated genes (ISGs).  A similar ISG signature is found in autoinflammatory and autoimmune conditions, indicating that chronic activation of nucleic acid-sensing pathways may contribute to these diseases.  Here, we review how nucleic acid-sensing pathways are currently being targeted pharmacol. with both agonists and antagonists.  We discuss how an improved understanding of the biol. of these pathways is leading to novel therapies for infections, cancer, and autoimmune and autoinflammatory disorders, and how new therapeutics will, in turn, generate a deeper understanding of these complex diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobYKnDGOTSvbVg90H21EOLACvtfcHk0lhepQuAKBieiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOrtrjM&md5=3afa98f84abcce81338604d3c3c5075c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnri3875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3875%26sid%3Dliteratum%253Aachs%26aulast%3DJunt%26aufirst%3DT.%26aulast%3DBarchet%26aufirst%3DW.%26atitle%3DTranslating%2520Nucleic%2520Acid-Sensing%2520Pathways%2520into%2520Therapies%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2015%26volume%3D15%26spage%3D529%26epage%3D544%26doi%3D10.1038%2Fnri3875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipard, G. B.</span>; <span class="NLM_string-name">Zepp, C. M.</span></span> <span> </span><span class="NLM_article-title">Quinazoline Derivative Useful as Toll-Like Receptor Antagonist</span>. <span class="NLM_patent">WO2008152471</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=G.+B.+Lipard&author=C.+M.+Zepp&title=Quinazoline+Derivative+Useful+as+Toll-Like+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLipard%26aufirst%3DG.%2BB.%26atitle%3DQuinazoline%2520Derivative%2520Useful%2520as%2520Toll-Like%2520Receptor%2520Antagonist%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boivin, R.</span>; <span class="NLM_string-name">Carlson, E.</span>; <span class="NLM_string-name">Endo, A.</span>; <span class="NLM_string-name">Hansen, H.</span>; <span class="NLM_string-name">Hawkins, L. D.</span>; <span class="NLM_string-name">Ishizaka, S.</span>; <span class="NLM_string-name">Mackey, M.</span>; <span class="NLM_string-name">Narayan, S.</span>; <span class="NLM_string-name">Satoh, T.</span>; <span class="NLM_string-name">Schiller, S.</span></span> <span> </span><span class="NLM_article-title">Tetrahydropyrazolopyrimidine compounds</span>. <span class="NLM_patent">US20130324547</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+Boivin&author=E.+Carlson&author=A.+Endo&author=H.+Hansen&author=L.+D.+Hawkins&author=S.+Ishizaka&author=M.+Mackey&author=S.+Narayan&author=T.+Satoh&author=S.+Schiller&title=Tetrahydropyrazolopyrimidine+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoivin%26aufirst%3DR.%26atitle%3DTetrahydropyrazolopyrimidine%2520compounds%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E.</span>; <span class="NLM_string-name">Hansen, H.</span>; <span class="NLM_string-name">Mackey, M.</span>; <span class="NLM_string-name">Schiller, S.</span>; <span class="NLM_string-name">Ogawa, C.</span>; <span class="NLM_string-name">Davis, H.</span></span> <span> </span><span class="NLM_article-title">Selectively Substituted Quinoline Compounds</span>. <span class="NLM_patent">WO2015057659 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=E.+Carlson&author=H.+Hansen&author=M.+Mackey&author=S.+Schiller&author=C.+Ogawa&author=H.+Davis&title=Selectively+Substituted+Quinoline+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCarlson%26aufirst%3DE.%26atitle%3DSelectively%2520Substituted%2520Quinoline%2520Compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boivin, R.</span>; <span class="NLM_string-name">Hansen, H.</span>; <span class="NLM_string-name">Ishizaka, S.</span>; <span class="NLM_string-name">Mackey, M.</span>; <span class="NLM_string-name">Schiller, S.</span>; <span class="NLM_string-name">Ogawa, C.</span>; <span class="NLM_string-name">Narayan, S.</span>; <span class="NLM_string-name">Bertinato, P.</span>; <span class="NLM_string-name">Burger, G.</span></span> <span> </span><span class="NLM_article-title">Selectively Substituted Quinoline Compounds</span>. <span class="NLM_patent">WO2015057655</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=R.+Boivin&author=H.+Hansen&author=S.+Ishizaka&author=M.+Mackey&author=S.+Schiller&author=C.+Ogawa&author=S.+Narayan&author=P.+Bertinato&author=G.+Burger&title=Selectively+Substituted+Quinoline+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoivin%26aufirst%3DR.%26atitle%3DSelectively%2520Substituted%2520Quinoline%2520Compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, L. D.</span></span> <i>E6887: A Novel and Selective Inhibitor of Toll-like Receptors 7 and 8</i>, Presented at the 252nd National Meeting, <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, MEDI 203, August 20–25, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=L.+D.+Hawkins&title=E6887%3A+A+Novel+and+Selective+Inhibitor+of+Toll-like+Receptors+7+and+8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DL.%2BD.%26jtitle%3DE6887%253A%2520A%2520Novel%2520and%2520Selective%2520Inhibitor%2520of%2520Toll-like%2520Receptors%25207%2520and%25208%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Padilla-Salinas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaniwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordeen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel Inhibitors Targeting Toll-like Receptor 7 and 8</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">10221</span>– <span class="NLM_lpage">10244</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01201</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01201" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2hs7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=10221-10244&author=R.+Padilla-Salinasauthor=R.+Andersonauthor=K.+Sakaniwaauthor=S.+Zhangauthor=P.+Nordeenauthor=C.+Luauthor=T.+Shimizuauthor=H.+H.+Yin&title=Discovery+of+Novel+Inhibitors+Targeting+Toll-like+Receptor+7+and+8&doi=10.1021%2Facs.jmedchem.9b01201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Small Molecule Dual Inhibitors Targeting Toll-Like Receptors 7 and 8</span></div><div class="casAuthors">Padilla-Salinas, Rosaura; Anderson, Rachel; Sakaniwa, Kentaro; Zhang, Shuting; Nordeen, Patrick; Lu, Chuanjun; Shimizu, Toshiyuki; Yin, Hang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10221-10244</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Endosomal toll-like receptors (TLRs) 7 and 8 recognize viral single-stranded RNAs, a class of imidazoquinoline compds., 8-oxo-adenosines, 8-aminobenzodiazepines, pyrimidines, and guanosine analogs.  Substantial evidence is present linking chronic inflammation mediated specifically by TLR7 to the progression of autoimmunity.  We identified a new TLR7/8 dual inhibitor (1) and a TLR8-specific inhibitor (2) based on our previous screen targeting TLR8.  Compd. 1, bearing a benzanilide scaffold, was found to inhibit TLR7 and TLR8 at low micromolar concns.  We envisioned making modifications on the benzanilide scaffold of 1 resulting in a class of highly specific TLR7 inhibitors.  Our efforts led to the discovery of a new TLR8 inhibitor (CU-115) and identification of a TLR7/8 dual inhibitor (CU-72), bearing a distinct di-Ph ether skeleton, with potential for TLR7 selectivity optimization.  Given the role of TLR8 in autoimmunity, we also optimized the potency of 2 and developed a new TLR8 inhibitor bearing a 1,3,4-oxadiazole motif.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0h41ew98eKrVg90H21EOLACvtfcHk0lg8fWXRUdb_6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2hs7vF&md5=2c50f570c2837df4220f5c3f3847f518</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01201%26sid%3Dliteratum%253Aachs%26aulast%3DPadilla-Salinas%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DR.%26aulast%3DSakaniwa%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DNordeen%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DH.%2BH.%26atitle%3DDiscovery%2520of%2520Novel%2520Inhibitors%2520Targeting%2520Toll-like%2520Receptor%25207%2520and%25208%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D10221%26epage%3D10244%26doi%3D10.1021%2Facs.jmedchem.9b01201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bou
Karroum, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moarbess, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichou, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patinote, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourharoun-Tayoun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuq, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diab-Assaf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassab, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deleuze-Masquefa, C.</span></span> <span> </span><span class="NLM_article-title">Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]pyrazines, Imidazo[1,5-a]quinoxalines, and Pyrazolo[1,5-a]quinaxoline Series</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7015</span>– <span class="NLM_lpage">7031</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00411</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00411" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlamsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=7015-7031&author=N.+Bou%0AKarroumauthor=G.+Moarbessauthor=J.-F.+Guichouauthor=P.-A.+Bonnetauthor=C.+Patinoteauthor=H.+Bourharoun-Tayounauthor=S.+Chamatauthor=P.+Cuqauthor=M.+Diab-Assafauthor=I.+Kassabauthor=C.+Deleuze-Masquefa&title=Novel+and+Selective+TLR7+Antagonists+among+the+Imidazo%5B1%2C2-a%5Dpyrazines%2C+Imidazo%5B1%2C5-a%5Dquinoxalines%2C+and+Pyrazolo%5B1%2C5-a%5Dquinaxoline+Series&doi=10.1021%2Facs.jmedchem.9b00411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]pyrazines, Imidazo[1,5-a]quinoxalines, and Pyrazolo[1,5-a]quinoxalines Series</span></div><div class="casAuthors">Bou Karroum, Nour; Moarbess, Georges; Guichou, Jean-Francois; Bonnet, Pierre-Antoine; Patinote, Cindy; Bouharoun-Tayoun, Hasnaa; Chamat, Soulaima; Cuq, Pierre; Diab-Assaf, Mona; Kassab, Issam; Deleuze-Masquefa, Carine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7015-7031</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Toll-like receptors (TLRs) 7 and 8 play an important role in the immune system activation, and their agonists may therefore serve as promising candidate vaccine adjuvants.  However, the chronic immune activation by excessive TLR stimulation is a hallmark of several clin. important infectious and autoimmune diseases, which warrants the search for TLR antagonists.  In this study, a variety of compds. belonging to three heterocyclic chem. series: imidazo[1,2-a]pyrazine, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline have been synthesized and characterized.  These compds. have been tested for their TLR7 or TLR8 agonistic and antagonistic activities.  Several of them are shown to be selective TLR7 antagonists without any TLR7 or TLR8 agonistic activity.  The selectivity was confirmed by a comparative ligand-docking study in TLR7 antagonist pocket.  Two compds. of the pyrazolo[1,5-a]quinoxaline series I [R = n-Bu, i-Bu] are potent selective TLR7 antagonists and may be considered as promising starting points for the development of new therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3510Ht_ZHf7Vg90H21EOLACvtfcHk0liqCSXBHYE05g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlamsbnN&md5=b9ffc17dcae442102245eb76face7394</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00411%26sid%3Dliteratum%253Aachs%26aulast%3DBou%2BKarroum%26aufirst%3DN.%26aulast%3DMoarbess%26aufirst%3DG.%26aulast%3DGuichou%26aufirst%3DJ.-F.%26aulast%3DBonnet%26aufirst%3DP.-A.%26aulast%3DPatinote%26aufirst%3DC.%26aulast%3DBourharoun-Tayoun%26aufirst%3DH.%26aulast%3DChamat%26aufirst%3DS.%26aulast%3DCuq%26aufirst%3DP.%26aulast%3DDiab-Assaf%26aufirst%3DM.%26aulast%3DKassab%26aufirst%3DI.%26aulast%3DDeleuze-Masquefa%26aufirst%3DC.%26atitle%3DNovel%2520and%2520Selective%2520TLR7%2520Antagonists%2520among%2520the%2520Imidazo%255B1%252C2-a%255Dpyrazines%252C%2520Imidazo%255B1%252C5-a%255Dquinoxalines%252C%2520and%2520Pyrazolo%255B1%252C5-a%255Dquinaxoline%2520Series%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D7015%26epage%3D7031%26doi%3D10.1021%2Facs.jmedchem.9b00411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kužnik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bencina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svajger, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeras, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerla, R.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>186</i></span>,  <span class="NLM_fpage">4794</span>– <span class="NLM_lpage">4804</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1000702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.4049%2Fjimmunol.1000702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=21398612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1Gqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=4794-4804&author=A.+Ku%C5%BEnikauthor=M.+Bencinaauthor=U.+Svajgerauthor=M.+Jerasauthor=B.+Rozmanauthor=R.+Jerla&title=Mechanism+of+Endosomal+TLR+Inhibition+by+Antimalarial+Drugs+and+Imidazoquinolines&doi=10.4049%2Fjimmunol.1000702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines</span></div><div class="casAuthors">Kuznik, Alenka; Bencina, Mojca; Svajger, Urban; Jeras, Matjaz; Rozman, Blaz; Jerala, Roman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4794-4804</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Endosomal TLRs play an important role in innate immune response as well as in autoimmune processes.  In the therapy of systemic lupus erythematosus, antimalarial drugs chloroquine, hydroxychloroquine, and quinacrine have been used for a long time.  Their suppression of endosomal TLR activation has been attributed to the inhibition of endosomal acidification, which is a prerequisite for the activation of these receptors.  We discovered that chloroquine inhibits only activation of endosomal TLRs by nucleic acids, whereas it augments activation of TLR8 by a small synthetic compd., R848.  We detected direct binding of antimalarials to nucleic acids by spectroscopic expts. and detd. their cellular colocalization.  Further anal. revealed that other nucleic acid-binding compds., such as propidium iodide, also inhibited activation of endosomal TLRs and colocalized with nucleic acids to endosomes.  We found that imidazoquinolines, which are TLR7/8 agonists, inhibit TLR9 and TLR3 even in the absence of TLR7 or TLR8, and their mechanism of inhibition is similar to the antimalarials.  In contrast to bafilomycin, none of the tested antimalarials and imidazoquinolines inhibited endosomal proteolysis or increased the endosomal pH, confirming that inhibition of pH acidification is not the underlying cause of inhibition.  We conclude that the direct binding of inhibitors to nucleic acids mask their TLR-binding epitope and may explain the efficiency of those compds. in the treatment of autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8R0z4GZpekbVg90H21EOLACvtfcHk0liqCSXBHYE05g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1Gqtr0%253D&md5=1d97c9b8ce92ff52546d6d5f0248bb99</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1000702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1000702%26sid%3Dliteratum%253Aachs%26aulast%3DKu%25C5%25BEnik%26aufirst%3DA.%26aulast%3DBencina%26aufirst%3DM.%26aulast%3DSvajger%26aufirst%3DU.%26aulast%3DJeras%26aufirst%3DM.%26aulast%3DRozman%26aufirst%3DB.%26aulast%3DJerla%26aufirst%3DR.%26atitle%3DMechanism%2520of%2520Endosomal%2520TLR%2520Inhibition%2520by%2520Antimalarial%2520Drugs%2520and%2520Imidazoquinolines%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D4794%26epage%3D4804%26doi%3D10.4049%2Fjimmunol.1000702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamphier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spyvee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genest, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mempel, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowbottom, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twine, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gusovsky, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizaka, S.</span></span> <span> </span><span class="NLM_article-title">Novel Small Molecule Inhibitors of TLR7 and TLR9: Mechanism of Action and Efficacy in Vivo</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1124/mol.113.089821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1124%2Fmol.113.089821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=24342772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVylu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=429-440&author=M.+Lamphierauthor=W.+Zhengauthor=E.+Latzauthor=M.+Spyveeauthor=H.+Hansenauthor=J.+Roseauthor=M.+Genestauthor=H.+Yangauthor=C.+Shafferauthor=Y.+Zhaoauthor=Y.+Shenauthor=C.+Liuauthor=D.+Liuauthor=T.+R.+Mempelauthor=C.+Rowbottomauthor=J.+Chowauthor=N.+C.+Twineauthor=M.+Yuauthor=F.+Gusovskyauthor=S.+Ishizaka&title=Novel+Small+Molecule+Inhibitors+of+TLR7+and+TLR9%3A+Mechanism+of+Action+and+Efficacy+in+Vivo&doi=10.1124%2Fmol.113.089821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo</span></div><div class="casAuthors">Lamphier, Marc; Zheng, Wanjun; Latz, Eicke; Spyvee, Mark; Hansen, Hans; Rose, Jeffrey; Genest, Melinda; Yang, Hua; Shaffer, Christina; Zhao, Yan; Shen, Yongchun; Liu, Carrie; Liu, Diana; Mempel, Thorsten R.; Rowbottom, Christopher; Chow, Jesse; Twine, Natalie C.; Yu, Melvin; Gusovsky, Fabian; Ishizaka, Sally T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">429-440, 31 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The discovery that circulating nucleic acid-contg. complexes in the serum of autoimmune lupus patients can stimulate B cells and plasmacytoid dendritic cells via Toll-like receptors 7 and 9 suggested that agents that block these receptors might be useful therapeutics.  We identified two compds., AT791 {3-[4-(6-(3-(dimethylamino)propoxy)benzo[d]oxazol-2-yl)phenoxy]-N,N-dimethylpropan-1-amine} and E6446 {6-[3-(pyrrolidin-1-yl)propoxy)-2-(4-(3-(pyrrolidin-yl)propoxy)phenyl]benzo[d]oxazole}, that inhibit Toll-like receptor (TLR)7 and 9 signaling in a variety of human and mouse cell types and inhibit DNA-TLR9 interaction in vitro.  When administered to mice, these compds. suppress responses to challenge doses of cytidine-phosphate-guanidine (CpG)-contg. DNA, which stimulates TLR9.  When given chronically in spontaneous mouse lupus models, E6446 slowed development of circulating antinuclear antibodies and had a modest effect on anti-double-stranded DNA titers but showed no observable impact on proteinuria or mortality.  We discovered that the ability of AT791 and E6446 to inhibit TLR7 and 9 signaling depends on two properties: weak interaction with nucleic acids and high accumulation in the intracellular acidic compartments where TLR7 a nd 9 reside.  Binding of the compds. to DNA prevents DNA-TLR9 interaction in vitro and modulates signaling in vivo.  Our data also confirm an earlier report that this same mechanism may explain inhibition of TLR7 and 9 signaling by hydroxychloroquine (Plaquenil), a drug commonly prescribed to treat lupus.  Thus, very different structural classes of mols. can inhibit endosomal TLRs by essentially identical mechanisms of action, suggesting a general mechanism for targeting this group of TLRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIxcZmhieLrLVg90H21EOLACvtfcHk0liqCSXBHYE05g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVylu7w%253D&md5=ad98c0ad97065795983540f5caa2b4a5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.089821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.089821%26sid%3Dliteratum%253Aachs%26aulast%3DLamphier%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DSpyvee%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DH.%26aulast%3DRose%26aufirst%3DJ.%26aulast%3DGenest%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DShaffer%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMempel%26aufirst%3DT.%2BR.%26aulast%3DRowbottom%26aufirst%3DC.%26aulast%3DChow%26aufirst%3DJ.%26aulast%3DTwine%26aufirst%3DN.%2BC.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DGusovsky%26aufirst%3DF.%26aulast%3DIshizaka%26aufirst%3DS.%26atitle%3DNovel%2520Small%2520Molecule%2520Inhibitors%2520of%2520TLR7%2520and%2520TLR9%253A%2520Mechanism%2520of%2520Action%2520and%2520Efficacy%2520in%2520Vivo%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D429%26epage%3D440%26doi%3D10.1124%2Fmol.113.089821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krise, J. P.</span></span> <span> </span><span class="NLM_article-title">Lysosomal Sequestration of Amine-Containing Drugs: Analysis and Therapeutic Implications</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">729</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.1002/jps.20792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1002%2Fjps.20792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=17117426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVOjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=729-746&author=A.+M.+Kaufmannauthor=J.+P.+Krise&title=Lysosomal+Sequestration+of+Amine-Containing+Drugs%3A+Analysis+and+Therapeutic+Implications&doi=10.1002%2Fjps.20792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications</span></div><div class="casAuthors">Kaufmann, Allyn M.; Krise, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">729-746</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Amine-contg. drugs represent a very important class of therapeutic agents, with the majority of all drugs contg. at least one basic nitrogen.  For many decades, it has been known that weakly basic compds. can be sequestered into acidic organelles such as lysosomes.  Some amines can achieve very high concns. and induce a dramatic expansion (vacuolization) of the compartment.  In the early 70s, Nobel laureate and discoverer of lysosomes, Christian de Duve et al., wrote an elegant commentary describing the theor. basis for lysosomal sequestration of amines, referring to the process as pH-partitioning and the substrates as lysosomotropics.  Recently, a resurgence of interest in the intracellular distribution of drugs has occurred considering its therapeutic importance.  Specifically, lysosomal sequestration of amines has received considerable attention for reasons including its involvement in drug resistance, inducement of phospholipidosis, and its influence on whole body distribution/pharmacokinetics.  Moreover, the sequestration phenomenon has been recently exploited in the development of a novel drug targeting strategy.  This review will focus on these occurrences/developments and conclude with a commentary on the expected impact that knowledge regarding the intracellular distribution of drugs will likely have on future drug development processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhcSM0IO68KbVg90H21EOLACvtfcHk0lhKbT-Mq3wYVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVOjtbk%253D&md5=2498515d01fa7e220e95a6c1fd623b97</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fjps.20792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20792%26sid%3Dliteratum%253Aachs%26aulast%3DKaufmann%26aufirst%3DA.%2BM.%26aulast%3DKrise%26aufirst%3DJ.%2BP.%26atitle%3DLysosomal%2520Sequestration%2520of%2520Amine-Containing%2520Drugs%253A%2520Analysis%2520and%2520Therapeutic%2520Implications%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D729%26epage%3D746%26doi%3D10.1002%2Fjps.20792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span> <span> </span><span class="NLM_article-title">Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">1426</span>– <span class="NLM_lpage">1429</span>, <span class="refDoi"> DOI: 10.1126/science.1229159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1126%2Fscience.1229159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=23520111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktF2qsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2013&pages=1426-1429&author=H.+Tanjiauthor=U.+Ohtoauthor=T.+Shibataauthor=K.+Miyakeauthor=T.+Shimizu&title=Structural+Reorganization+of+the+Toll-Like+Receptor+8+Dimer+Induced+by+Agonistic+Ligands&doi=10.1126%2Fscience.1229159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands</span></div><div class="casAuthors">Tanji, Hiromi; Ohto, Umeharu; Shibata, Takuma; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6126</span>),
    <span class="NLM_cas:pages">1426-1429</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) and TLR8 recognize single-stranded RNA and initiate innate immune responses.  Several synthetic agonists of TLR7-TLR8 display novel therapeutic potential; however, the mol. basis for ligand recognition and activation of signaling by TLR7 or TLR8 is largely unknown.  In this study, the crystal structures of unliganded and ligand-induced activated human TLR8 dimers were elucidated.  Ligand recognition was mediated by a dimerization interface formed by two protomers.  Upon ligand stimulation, the TLR8 dimer was reorganized such that the two C termini were brought into proximity.  The loop between leucine-rich repeat 14 (LRR14) and LRR15 was cleaved; however, the N- and C-terminal halves remained assocd. and contributed to ligand recognition and dimerization.  Thus, ligand binding induces reorganization of the TLR8 dimer, which enables downstream signaling processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzF-H0sxwN0rVg90H21EOLACvtfcHk0lhKbT-Mq3wYVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktF2qsr4%253D&md5=13b8f32cd70dc59890820d03e88d62ab</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1229159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1229159%26sid%3Dliteratum%253Aachs%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DStructural%2520Reorganization%2520of%2520the%2520Toll-Like%2520Receptor%25208%2520Dimer%2520Induced%2520by%2520Agonistic%2520Ligands%26jtitle%3DScience%26date%3D2013%26volume%3D339%26spage%3D1426%26epage%3D1429%26doi%3D10.1126%2Fscience.1229159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krayukhina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span> <span> </span><span class="NLM_article-title">Structural Analysis Reveals that Toll-like Receptor 7 is a Dual Receptor for Guanosine and Single-Stranded RNA</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2016.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1016%2Fj.immuni.2016.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=27742543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OgtLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=737-748&author=Z.+Zhangauthor=U.+Ohtoauthor=T.+Shibataauthor=E.+Krayukhinaauthor=M.+Taokaauthor=Y.+Yamauchiauthor=H.+Tanjiauthor=T.+Isobeauthor=S.+Uchiyamaauthor=K.+Miyakeauthor=T.+Shimizu&title=Structural+Analysis+Reveals+that+Toll-like+Receptor+7+is+a+Dual+Receptor+for+Guanosine+and+Single-Stranded+RNA&doi=10.1016%2Fj.immuni.2016.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA</span></div><div class="casAuthors">Zhang, Zhikuan; Ohto, Umeharu; Shibata, Takuma; Krayukhina, Elena; Taoka, Masato; Yamauchi, Yoshio; Tanji, Hiromi; Isobe, Toshiaki; Uchiyama, Susumu; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">737-748</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) is a single-stranded RNA (ssRNA) sensor in innate immunity and also responds to guanosine and chem. ligands, such as imidazoquinoline compds.  However, TLR7 activation mechanism by these ligands remain largely unknown.  Here, we generated crystal structures of three TLR7 complexes, and found that all formed an activated m-shaped dimer with two ligand-binding sites.  The first site conserved in TLR7 and TLR8 was used for small ligand-binding essential for its activation.  The second site spatially distinct from that of TLR8 was used for a ssRNA-binding that enhanced the affinity of the first-site ligands.  The first site preferentially recognized guanosine and the second site specifically bound to uridine moieties in ssRNA.  Our structural, biochem., and mutagenesis studies indicated that TLR7 is a dual receptor for guanosine and uridine-contg. ssRNA.  Our findings have important implications for understanding of TLR7 function, as well as for therapeutic manipulation of TLR7 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQskd1L0XeX7Vg90H21EOLACvtfcHk0lhKbT-Mq3wYVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OgtLnI&md5=194f87d5ea0e88009fd682c00e020f38</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2016.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2016.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DKrayukhina%26aufirst%3DE.%26aulast%3DTaoka%26aufirst%3DM.%26aulast%3DYamauchi%26aufirst%3DY.%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DS.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DStructural%2520Analysis%2520Reveals%2520that%2520Toll-like%2520Receptor%25207%2520is%2520a%2520Dual%2520Receptor%2520for%2520Guanosine%2520and%2520Single-Stranded%2520RNA%26jtitle%3DImmunity%26date%3D2016%26volume%3D45%26spage%3D737%26epage%3D748%26doi%3D10.1016%2Fj.immuni.2016.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span> <span> </span><span class="NLM_article-title">Structural Analyses of Toll-like Receptor 7 Reveal Detailed RNA Sequence Specificity and Recognition Mechanism of Agonistic Ligands</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3371</span>– <span class="NLM_lpage">3381.e5</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2018.11.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1016%2Fj.celrep.2018.11.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=30566863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFKhsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=3371-3381.e5&author=Z.+Zhangauthor=U.+Ohtoauthor=T.+Shibataauthor=M.+Taokaauthor=Y.+Yamauchiauthor=R.+Satoauthor=N.+M.+Shuklaauthor=S.+A.+Davidauthor=K.+Isobeauthor=T.+Shimizu&title=Structural+Analyses+of+Toll-like+Receptor+7+Reveal+Detailed+RNA+Sequence+Specificity+and+Recognition+Mechanism+of+Agonistic+Ligands&doi=10.1016%2Fj.celrep.2018.11.081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analyses of Toll-like Receptor 7 Reveal Detailed RNA Sequence Specificity and Recognition Mechanism of Agonistic Ligands</span></div><div class="casAuthors">Zhang, Zhikuan; Ohto, Umeharu; Shibata, Takuma; Taoka, Masato; Yamauchi, Yoshio; Sato, Ryota; Shukla, Nikunj M.; David, Sunil A.; Isobe, Toshiaki; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3371-3381.e5</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) is an innate immune receptor for single-stranded RNA (ssRNA) and has important roles in infectious diseases.  We previously reported that TLR7 shows synergistic activation in response to two ligands, guanosine and ssRNA.  However, the specific ssRNA sequence preference, detailed recognition mode of TLR7 and its ligand, and mol. determinants of TLR7 and TLR8 selectivity remain unknown.  Here, we report on TLR7 from a large-scale crystallog. study combined with a multifaceted approach.  We reveal that successive uridine-contg. ssRNAs fully or moderately bind TLR7, whereas single uridine-contg. ssRNAs have reduced affinities.  We also reveal the detailed relationships between the chem. structures of ligands and their binding to TLR7.  We demonstrate that an engineered TLR8 mutant alters its responsiveness to TLR7-specific ligands.  Finally, we identify guanosine 2',3'-cyclic phosphate (2',3'-cGMP) as a possible endogenous ligand for TLR7 with greater affinity than guanosine.  The abundant structural information will facilitate future development of treatments targeting TLR7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSfIvVPXG7NbVg90H21EOLACvtfcHk0lhKbT-Mq3wYVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFKhsbvK&md5=2b8c37cd45a96e9298540bd87fb77faa</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2018.11.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2018.11.081%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DTaoka%26aufirst%3DM.%26aulast%3DYamauchi%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DR.%26aulast%3DShukla%26aufirst%3DN.%2BM.%26aulast%3DDavid%26aufirst%3DS.%2BA.%26aulast%3DIsobe%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DStructural%2520Analyses%2520of%2520Toll-like%2520Receptor%25207%2520Reveal%2520Detailed%2520RNA%2520Sequence%2520Specificity%2520and%2520Recognition%2520Mechanism%2520of%2520Agonistic%2520Ligands%26jtitle%3DCell%2520Rep.%26date%3D2018%26volume%3D25%26spage%3D3371%26epage%3D3381.e5%26doi%3D10.1016%2Fj.celrep.2018.11.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alper, P. B.</span>; <span class="NLM_string-name">Deane, J.</span>; <span class="NLM_string-name">Betschart, C.</span>; <span class="NLM_string-name">Buffet, D.</span>; <span class="NLM_string-name">Collignon Zipfel, G.</span>; <span class="NLM_string-name">Gordon, P.</span>; <span class="NLM_string-name">Hampton, J.</span>; <span class="NLM_string-name">Hawtin, S.</span>; <span class="NLM_string-name">Ibanez, M.</span>; <span class="NLM_string-name">Jiang, T.</span>; <span class="NLM_string-name">Junt, T.</span>; <span class="NLM_string-name">Knoepfel, T.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">Maginnis, J.</span>; <span class="NLM_string-name">McKeever, U.</span>; <span class="NLM_string-name">Michellys, P.-Y.</span>; <span class="NLM_string-name">Mutnick, D.</span>; <span class="NLM_string-name">Nayak, B.</span>; <span class="NLM_string-name">Niwa, S.</span>; <span class="NLM_string-name">Richmond, W.</span>; <span class="NLM_string-name">Rush, J. S.</span>; <span class="NLM_string-name">Syka, P.</span>; <span class="NLM_string-name">Zhang, Y.</span>; <span class="NLM_string-name">Zhu, X.</span></span> Discovery of Potent, Orally Bioavailable in Vivo Efficacious Antagonists of the TLR7/8 Pathway.  <i>Bioorg. Med. Chem. Lett</i>. [Online early access]. DOI: <span class="refDoi"> DOI: 10.1016/j.bmcl.2020.127366</span> . Published Online: June 24, <span class="NLM_year">2020</span>. <a href="https://www.sciencedirect.com/science/article/pii/S0960894X20304777" class="extLink">https://www.sciencedirect.com/science/article/pii/S0960894X20304777</a> (accessed June 24, <span class="NLM_year">2020</span>).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1016%2Fj.bmcl.2020.127366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=32738975" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=P.+B.+Alper&author=J.+Deane&author=C.+Betschart&author=D.+Buffet&author=G.+Collignon+Zipfel&author=P.+Gordon&author=J.+Hampton&author=S.+Hawtin&author=M.+Ibanez&author=T.+Jiang&author=T.+Junt&author=T.+Knoepfel&author=B.+Liu&author=J.+Maginnis&author=U.+McKeever&author=P.-Y.+Michellys&author=D.+Mutnick&author=B.+Nayak&author=S.+Niwa&author=W.+Richmond&author=J.+S.+Rush&author=P.+Syka&author=Y.+Zhang&author=X.+Zhu&title=Bioorg.+Med.+Chem.+Lett"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2020.127366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1016%252Fj.bmcl.2020.127366%26sid%3Dliteratum%253Aachs%26aulast%3DAlper%26aufirst%3DP.%2BB.%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett%26doi%3D10.1016%2Fj.bmcl.2020.127366%26date%3D2020%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span>; <span class="NLM_string-name">Glicksman, M. A.</span>; <span class="NLM_string-name">Fu, H.</span>; <span class="NLM_string-name">Havel, J. J.</span>; <span class="NLM_string-name">Du, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Protein-Protein Interactions: Non-Cellular Assay Formats</span>. In  <i>Assay Guidance Manual [Online]</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sittampalam, G. S.</span>; <span class="NLM_string-name">Grossman, A.</span>; <span class="NLM_string-name">Brimacombe, K.</span></span>, Eds.; <span class="NLM_publisher-name">Eli Lilly & Company and the National Center for Advancing Translational Sciences</span>: <span class="NLM_publisher-loc">Bethesda (MD)</span>, <span class="NLM_year">2004</span>; <a href="https://www.ncbi.nlm.nih.gov/books/NBK92000/" class="extLink">https://www.ncbi.nlm.nih.gov/books/NBK92000/</a> (accessed June 3, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+R.+Arkin&author=M.+A.+Glicksman&author=H.+Fu&author=J.+J.+Havel&author=Y.+Duauthor=G.+S.+Sittampalam&author=A.+Grossman&author=K.+Brimacombe&title=Assay+Guidance+Manual+%5BOnline%5D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DArkin%26aufirst%3DM.%2BR.%26atitle%3DInhibition%2520of%2520Protein-Protein%2520Interactions%253A%2520Non-Cellular%2520Assay%2520Formats%26btitle%3DAssay%2520Guidance%2520Manual%2520%255BOnline%255D%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26pub%3DEli%2520Lilly%2520%2526%2520Company%2520and%2520the%2520National%2520Center%2520for%2520Advancing%2520Translational%2520Sciences%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span> <i>Glide</i>, version 2015.3; <span class="NLM_publisher-name">Schrödinger,
LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Glide%2C+version+2015.3%3B+Schr%C3%B6dinger%2C%0ALLC%3A+New+York%2C+NY%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%250ALLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span> <span> </span><span class="NLM_article-title">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6752</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+Increasing+Saturation+as+an+Approach+to+Improving+Clinical+Success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0ljcf-ZdyvgIjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520Increasing%2520Saturation%2520as%2520an%2520Approach%2520to%2520Improving%2520Clinical%2520Success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaniwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Inhibition of TLR8 through Stabilization of its Resting State</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1038%2Fnchembio.2518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=29155428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVaksrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=58-64&author=S.+Zhangauthor=Z.+Huauthor=H.+Tanjiauthor=S.+Jiangauthor=N.+Dasauthor=J.+Liauthor=K.+Sakaniwaauthor=J.+Jinauthor=Y.+Bianauthor=U.+Ohtoauthor=T.+Shimizuauthor=H.+Yin&title=Small-Molecule+Inhibition+of+TLR8+through+Stabilization+of+its+Resting+State&doi=10.1038%2Fnchembio.2518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibition of TLR8 through stabilization of its resting state</span></div><div class="casAuthors">Zhang, Shuting; Hu, Zhenyi; Tanji, Hiromi; Jiang, Shuangshuang; Das, Nabanita; Li, Jing; Sakaniwa, Kentaro; Jin, Jin; Bian, Yanyan; Ohto, Umeharu; Shimizu, Toshiyuki; Yin, Hang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-64</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Endosomal Toll-like receptors (TLR3, TLR7, TLR8, and TLR9) are highly analogous sensors for various viral or bacterial RNA and DNA mol. patterns.  Nonetheless, few small mols. can selectively modulate these TLRs.  In this manuscript, we identified the first human TLR8-specific small-mol. antagonists via a novel inhibition mechanism.  Crystal structures of two distinct TLR8-ligand complexes validated a unique binding site on the protein-protein interface of the TLR8 homodimer.  Upon binding to this new site, the small-mol. ligands stabilize the preformed TLR8 dimer in its resting state, preventing activation.  As a proof of concept of their therapeutic potential, we have demonstrated that these drug-like inhibitors are able to suppress TLR8-mediated proinflammatory signaling in various cell lines, human primary cells, and patient specimens.  These results not only suggest a novel strategy for TLR inhibitor design, but also shed crit. mechanistic insight into these clin. important immune receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPrewccnFLv7Vg90H21EOLACvtfcHk0ljcf-ZdyvgIjA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVaksrjN&md5=1b43da16d6670324d77bb5e2c417cfe6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2518%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSakaniwa%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DBian%26aufirst%3DY.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DSmall-Molecule%2520Inhibition%2520of%2520TLR8%2520through%2520Stabilization%2520of%2520its%2520Resting%2520State%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D58%26epage%3D64%26doi%3D10.1038%2Fnchembio.2518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forman, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinna, A.</span></span> <span> </span><span class="NLM_article-title">Glutathione: Overview of its Roles, Measurement, and Biosynthesis</span>. <i>Mol. Aspects Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.mam.2008.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1016%2Fj.mam.2008.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=18796312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFelurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=1-12&author=J.+H.+Formanauthor=H.+Zhangauthor=A.+Rinna&title=Glutathione%3A+Overview+of+its+Roles%2C+Measurement%2C+and+Biosynthesis&doi=10.1016%2Fj.mam.2008.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione: Overview of its protective roles, measurement, and biosynthesis</span></div><div class="casAuthors">Forman, Henry Jay; Zhang, Hongqiao; Rinna, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review is the introduction to a special issue concerning, glutathione (GSH), the most abundant low mol. wt. thiol compd. synthesized in cells.  GSH plays crit. roles in protecting cells from oxidative damage and the toxicity of xenobiotic electrophiles, and maintaining redox homeostasis.  Here, the functions and GSH and the sources of oxidants and electrophiles, the elimination of oxidants by redn. and electrophiles by conjugation with GSH are briefly described.  Methods of assessing GSH status in the cells are also described.  GSH synthesis and its regulation are addressed along with therapeutic approaches for manipulating GSH content that have been proposed.  The purpose here is to provide a brief overview of some of the important aspects of glutathione metab. as part of this special issue that will provide a more comprehensive review of the state of knowledge regarding this essential mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlWapNqV0GqLVg90H21EOLACvtfcHk0lg0MK8vB0H3JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFelurY%253D&md5=c1b1aa2b03389bf1434af0762df78fe1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2008.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2008.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DForman%26aufirst%3DJ.%2BH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRinna%26aufirst%3DA.%26atitle%3DGlutathione%253A%2520Overview%2520of%2520its%2520Roles%252C%2520Measurement%252C%2520and%2520Biosynthesis%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2009%26volume%3D30%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.mam.2008.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pracht, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcken, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udvarhelyi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimme, S.</span></span> <span> </span><span class="NLM_article-title">High Accuracy Quantum-Chemistry-based Calculation and Blind Prediction of Macroscopic p<i>K</i><sub>a</sub> Values in the Context of the SAMPL6 Challenge</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1139</span>– <span class="NLM_lpage">1149</span>, <span class="refDoi"> DOI: 10.1007/s10822-018-0145-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1007%2Fs10822-018-0145-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=30141103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFyktL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=1139-1149&author=P.+Prachtauthor=R.+Wilckenauthor=A.+Udvarhelyiauthor=S.+Roddeauthor=S.+Grimme&title=High+Accuracy+Quantum-Chemistry-based+Calculation+and+Blind+Prediction+of+Macroscopic+pKa+Values+in+the+Context+of+the+SAMPL6+Challenge&doi=10.1007%2Fs10822-018-0145-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">High accuracy quantum-chemistry-based calculation and blind prediction of macroscopic pKa values in the context of the SAMPL6 challenge</span></div><div class="casAuthors">Pracht, Philipp; Wilcken, Rainer; Udvarhelyi, Aniko; Rodde, Stephane; Grimme, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1139-1149</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Recent advances in the development of low-cost quantum chem. methods have made the prediction of conformational preferences and physicochem. properties of medium-sized drug-like mols. routinely feasible, with significant potential to advance drug discovery.  In the context of the SAMPL6 challenge, macroscopic pKa values were blindly predicted for a set of 24 of such mols.  In this paper we present two similar quantum chem. based approaches based on the high accuracy calcn. of std. reaction free energies and the subsequent detn. of those pKa values via a linear free energy relationship.  Both approaches use extensive conformational sampling and apply hybrid and double-hybrid d. functional theory with continuum solvation to calc. free energies.  The blindly calcd. macroscopic pKa values were in excellent agreement with the expt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp114skroUQrLVg90H21EOLACvtfcHk0lg0MK8vB0H3JA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFyktL%252FK&md5=51ee35b57e81d7a15e2874196babd43f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs10822-018-0145-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-018-0145-7%26sid%3Dliteratum%253Aachs%26aulast%3DPracht%26aufirst%3DP.%26aulast%3DWilcken%26aufirst%3DR.%26aulast%3DUdvarhelyi%26aufirst%3DA.%26aulast%3DRodde%26aufirst%3DS.%26aulast%3DGrimme%26aufirst%3DS.%26atitle%3DHigh%2520Accuracy%2520Quantum-Chemistry-based%2520Calculation%2520and%2520Blind%2520Prediction%2520of%2520Macroscopic%2520pKa%2520Values%2520in%2520the%2520Context%2520of%2520the%2520SAMPL6%2520Challenge%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2018%26volume%3D32%26spage%3D1139%26epage%3D1149%26doi%3D10.1007%2Fs10822-018-0145-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann-Röder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, K.</span></span> <span> </span><span class="NLM_article-title">Predicting and Tuning Physicochemical Properties in Lead Optimization: Amine Basicities</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200700059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1002%2Fcmdc.200700059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=17530727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1100-1115&author=M.+Morgenthalerauthor=E.+Schweizerauthor=A.+Hoffmann-R%C3%B6derauthor=F.+Beniniauthor=R.+E.+Martinauthor=G.+Jaeschkeauthor=B.+Wagnerauthor=H.+Fischerauthor=S.+Bendelsauthor=D.+Zimmerliauthor=J.+Schneiderauthor=F.+Diederichauthor=M.+Kansyauthor=K.+M%C3%BCller&title=Predicting+and+Tuning+Physicochemical+Properties+in+Lead+Optimization%3A+Amine+Basicities&doi=10.1002%2Fcmdc.200700059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span></div><div class="casAuthors">Morgenthaler, Martin; Schweizer, Eliane; Hoffmann-Roder, Anja; Benini, Fausta; Martin, Rainer E.; Jaeschke, Georg; Wagner, Bjorn; Fischer, Holger; Bendels, Stefanie; Zimmerli, Daniel; Schneider, Josef; Diederich, Francois; Kansy, Manfred; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1100-1115</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  This review describes simple and useful concepts for predicting and tuning the pKa values of basic amine centers, a crucial step in the optimization of phys. and ADME properties of many lead structures in drug-discovery research.  The article starts with a case study of tricyclic thrombin inhibitors featuring a tertiary amine center with pKa values that can be tuned over a wide range, from the usual value of around 10 to below 2 by (remote) neighboring functionalities commonly encountered in medicinal chem.  Next, the changes in pKa of acyclic and cyclic amines upon substitution by fluorine, oxygen, nitrogen, and sulfur functionalities, as well as carbonyl and carboxyl derivs. are systematically analyzed, leading to the derivation of simple rules for pKa prediction.  Electronic and stereoelectronic effects in cyclic amines are discussed, and the emerging computational methods for pKa predictions are briefly surveyed.  The rules for tuning amine basicities should not only be of interest in drug-discovery research, but also to the development of new crop-protection agents, new amine ligands for organometallic complexes, and in particular, to the growing field of amine-based organocatalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodsWRMtrxWPbVg90H21EOLACvtfcHk0lhE8dfCfsW6lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D&md5=478b70744312c01d3a43cf435d9598de</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700059%26sid%3Dliteratum%253Aachs%26aulast%3DMorgenthaler%26aufirst%3DM.%26aulast%3DSchweizer%26aufirst%3DE.%26aulast%3DHoffmann-R%25C3%25B6der%26aufirst%3DA.%26aulast%3DBenini%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26atitle%3DPredicting%2520and%2520Tuning%2520Physicochemical%2520Properties%2520in%2520Lead%2520Optimization%253A%2520Amine%2520Basicities%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D1100%26epage%3D1115%26doi%3D10.1002%2Fcmdc.200700059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gorden, K. K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binsfeld, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasilakos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alkan, S. S.</span></span> <span> </span><span class="NLM_article-title">Cutting Edge: Activation of Murine TLR8 by a Combination of Imidazoquinoline Immune Response Modifiers and PolyT Oligodeoxynucleotides</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">6584</span>– <span class="NLM_lpage">6587</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.177.10.6584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.4049%2Fjimmunol.177.10.6584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=17082568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFGrsbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2006&pages=6584-6587&author=K.+K.+B.+Gordenauthor=X.+X.+Qiuauthor=C.+C.+Binsfeldauthor=J.+P.+Vasilakosauthor=S.+S.+Alkan&title=Cutting+Edge%3A+Activation+of+Murine+TLR8+by+a+Combination+of+Imidazoquinoline+Immune+Response+Modifiers+and+PolyT+Oligodeoxynucleotides&doi=10.4049%2Fjimmunol.177.10.6584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Cutting Edge: Activation of Murine TLR8 by a Combination of Imidazoquinoline Immune Response Modifiers and PolyT Oligodeoxynucleotides</span></div><div class="casAuthors">Gorden, Keith K. B.; Qiu, Xiaohong X.; Binsfeld, Christine C. A.; Vasilakos, John P.; Alkan, Sefik S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6584-6587</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Synthetic immune response modifiers (IRM) such as imidazoquinolines can selectively activate human TLR7 or TLR8.  Although these endosomal TLRs are close relatives, TLR7-deficient mice are unresponsive to TLR8 agonist IRMs.  Similarly, natural ssRNA cannot activate murine TLR8, leading to the belief that murine TLR8 is nonfunctional.  In this study, the authors transfected HEK293 cells with murine TLR8 and NF-κB reporter constructs and stimulated them with combinations of IRM and oligodeoxynucleotides (ODNs).  When stimulated with TLR7 or TLR8 agonists alone, no NF-κB response was obsd.  However, a combination of polyT ODN plus the TLR8 agonist activated NF-κB, whereas polyT ODN plus the TLR7 agonist did not activate.  Primary mouse cells responded to the IRM/polyT ODN by secreting TNF.  Cells from TLR7-/- and TLR9-/- mice responded to the IRM/polyT ODN combination, whereas MyD88-/- cells did not respond.  In conclusion, this study demonstrates for the first time that mouse TLR8 is functional.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ5dlXy-S_ZrVg90H21EOLACvtfcHk0lhE8dfCfsW6lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFGrsbfF&md5=a8d9515e52adc901902daa716e01c64b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.177.10.6584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.177.10.6584%26sid%3Dliteratum%253Aachs%26aulast%3DGorden%26aufirst%3DK.%2BK.%2BB.%26aulast%3DQiu%26aufirst%3DX.%2BX.%26aulast%3DBinsfeld%26aufirst%3DC.%2BC.%26aulast%3DVasilakos%26aufirst%3DJ.%2BP.%26aulast%3DAlkan%26aufirst%3DS.%2BS.%26atitle%3DCutting%2520Edge%253A%2520Activation%2520of%2520Murine%2520TLR8%2520by%2520a%2520Combination%2520of%2520Imidazoquinoline%2520Immune%2520Response%2520Modifiers%2520and%2520PolyT%2520Oligodeoxynucleotides%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D177%26spage%3D6584%26epage%3D6587%26doi%3D10.4049%2Fjimmunol.177.10.6584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guiducci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cepika, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripodo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crain, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quartier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cush, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrat, F. J.</span></span> <span> </span><span class="NLM_article-title">RNA Recognition by Human TLR8 Can Lead to Autoimmune Inflammation</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>210</i></span>,  <span class="NLM_fpage">2903</span>– <span class="NLM_lpage">2919</span>, <span class="refDoi"> DOI: 10.1084/jem.20131044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1084%2Fjem.20131044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=24277153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFynur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=2903-2919&author=C.+Guiducciauthor=M.+Gongauthor=A.-M.+Cepikaauthor=Z.+Xuauthor=C.+Tripodoauthor=L.+Bennettauthor=C.+Crainauthor=P.+Quartierauthor=J.+J.+Cushauthor=V.+Pascualauthor=R.+L.+Coffmanauthor=F.+J.+Barrat&title=RNA+Recognition+by+Human+TLR8+Can+Lead+to+Autoimmune+Inflammation&doi=10.1084%2Fjem.20131044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">RNA recognition by human TLR8 can lead to autoimmune inflammation</span></div><div class="casAuthors">Guiducci, Cristiana; Gong, Mei; Cepika, Alma-Martina; Xu, Zhaohui; Tripodo, Claudio; Bennett, Lynda; Crain, Chad; Quartier, Pierre; Cush, John J.; Pascual, Virginia; Coffman, Robert L.; Barrat, Franck J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2903-2919</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Studies on the role of the RNA receptor TLR8 in inflammation have been limited by its different function in human vs. rodents.  We have generated multiple lines of transgenic mice expressing different levels of human TLR8.  The high copy no. chimeras were unable to pass germline; developed severe inflammation targeting the pancreas, salivary glands, and joints; and the severity of the specific phenotypes closely correlated with the huTLR8 expression levels.  Mice with relatively low expression levels survived and bred successfully but had increased susceptibility to collagen-induced arthritis, and the levels of huTLR8 correlated with proinflammatory cytokines in the joints of the animals.  At the cellular level, huTLR8 signaling exerted a DC-intrinsic effect leading to up-regulation of co-stimulatory mols. and subsequent T cell activation.  A pathogenic role for TLR8 in human diseases was suggested by its increased expression in patients with systemic arthritis and the correlation of TLR8 expression with the elevation of IL-1β levels and disease status.  We found that the consequence of self-recognition via TLR8 results in a constellation of diseases, strikingly distinct from those related to TLR7 signaling, and points to specific inflammatory diseases that may benefit from inhibition of TLR8 in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrr_1JT3fWY7Vg90H21EOLACvtfcHk0lhE8dfCfsW6lw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFynur3L&md5=133370bf5dd6c76dedd8470091446e45</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1084%2Fjem.20131044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20131044%26sid%3Dliteratum%253Aachs%26aulast%3DGuiducci%26aufirst%3DC.%26aulast%3DGong%26aufirst%3DM.%26aulast%3DCepika%26aufirst%3DA.-M.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DTripodo%26aufirst%3DC.%26aulast%3DBennett%26aufirst%3DL.%26aulast%3DCrain%26aufirst%3DC.%26aulast%3DQuartier%26aufirst%3DP.%26aulast%3DCush%26aufirst%3DJ.%2BJ.%26aulast%3DPascual%26aufirst%3DV.%26aulast%3DCoffman%26aufirst%3DR.%2BL.%26aulast%3DBarrat%26aufirst%3DF.%2BJ.%26atitle%3DRNA%2520Recognition%2520by%2520Human%2520TLR8%2520Can%2520Lead%2520to%2520Autoimmune%2520Inflammation%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D2903%26epage%3D2919%26doi%3D10.1084%2Fjem.20131044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genung, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aspnes, G. E.</span></span> <span> </span><span class="NLM_article-title">Regioselective Synthesis of 2H-Indazoles Using a Mild, One-Pot Condensation–Cadogan Reductive Cyclization</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3114</span>– <span class="NLM_lpage">3117</span>, <span class="refDoi"> DOI: 10.1021/ol5012423</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol5012423" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVOgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=3114-3117&author=N.+E.+Genungauthor=L.+Weiauthor=G.+E.+Aspnes&title=Regioselective+Synthesis+of+2H-Indazoles+Using+a+Mild%2C+One-Pot+Condensation%E2%80%93Cadogan+Reductive+Cyclization&doi=10.1021%2Fol5012423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective Synthesis of 2H-Indazoles Using a Mild, One-Pot Condensation-Cadogan Reductive Cyclization</span></div><div class="casAuthors">Genung, Nathan E.; Wei, Liuqing; Aspnes, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3114-3117</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An operationally simple and efficient one-pot synthesis of 2H-indazoles e. g., I, from com. available reagents is reported.  Ortho-imino-nitrobenzene substrates, generated via condensation, undergo reductive cyclization promoted by tri-n-butylphosophine to afford substituted 2H-indazoles under mild reaction conditions.  A variety of electronically diverse ortho-nitrobenzaldehydes and anilines were examd.  To further extend the scope of the transformation, aliph. amines were also employed to form N2-alkyl indazoles selectively under the optimized reaction conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosMGOKkDGlbrVg90H21EOLACvtfcHk0lhlTu5mn9udFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVOgu7Y%253D&md5=59630646dc650deaf94f10a3aeabdaac</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fol5012423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol5012423%26sid%3Dliteratum%253Aachs%26aulast%3DGenung%26aufirst%3DN.%2BE.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DAspnes%26aufirst%3DG.%2BE.%26atitle%3DRegioselective%2520Synthesis%2520of%25202H-Indazoles%2520Using%2520a%2520Mild%252C%2520One-Pot%2520Condensation%25E2%2580%2593Cadogan%2520Reductive%2520Cyclization%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D3114%26epage%3D3117%26doi%3D10.1021%2Fol5012423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molander, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trice, S. L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, S. M.</span></span> <span> </span><span class="NLM_article-title">Scope of the Two-Step, One-Pot Palladium-Catalyzed Borylation/Suzuki Cross-Coupling Reaction Utilizing Bis-Boronic Acid</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">8678</span>– <span class="NLM_lpage">8688</span>, <span class="refDoi"> DOI: 10.1021/jo301642v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo301642v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlygtLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=8678-8688&author=G.+A.+Molanderauthor=S.+L.+J.+Triceauthor=S.+M.+Kennedy&title=Scope+of+the+Two-Step%2C+One-Pot+Palladium-Catalyzed+Borylation%2FSuzuki+Cross-Coupling+Reaction+Utilizing+Bis-Boronic+Acid&doi=10.1021%2Fjo301642v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Scope of the Two-Step, One-Pot Palladium-Catalyzed Borylation/Suzuki Cross-Coupling Reaction Utilizing Bis-Boronic Acid</span></div><div class="casAuthors">Molander, Gary A.; Trice, Sarah L. J.; Kennedy, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8678-8688</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of bis-boronic acid for the direct synthesis of boronic acids has greatly facilitated the two-step, one-pot borylation/Suzuki cross-coupling reaction between aryl and heteroaryl halides.  With use of Buchwald's second-generation XPhos preformed catalyst, high yields of cross-coupled products were obtained for most substrates.  The method also allows an efficient two-step, one-pot synthesis, providing access to three distinct cross-coupled products after column chromatog.  The method also provides a rapid and convenient route to teraryl compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDMxPPa0A15rVg90H21EOLACvtfcHk0lhlTu5mn9udFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlygtLjO&md5=80b369825dd060e4e3d243d3c85a9354</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo301642v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo301642v%26sid%3Dliteratum%253Aachs%26aulast%3DMolander%26aufirst%3DG.%2BA.%26aulast%3DTrice%26aufirst%3DS.%2BL.%2BJ.%26aulast%3DKennedy%26aufirst%3DS.%2BM.%26atitle%3DScope%2520of%2520the%2520Two-Step%252C%2520One-Pot%2520Palladium-Catalyzed%2520Borylation%252FSuzuki%2520Cross-Coupling%2520Reaction%2520Utilizing%2520Bis-Boronic%2520Acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2012%26volume%3D77%26spage%3D8678%26epage%3D8688%26doi%3D10.1021%2Fjo301642v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Y.</span></span> <span> </span><span class="NLM_article-title">A General and Efficient Approach to 2H-Indazoles and 1H-Pyrazoles through Copper-Catalyzed Intramolecular N–N Bond Formation under Mild Conditions</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">10133</span>– <span class="NLM_lpage">10135</span>, <span class="refDoi"> DOI: 10.1039/c1cc13908h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1039%2Fc1cc13908h" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=21826369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2htrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=10133-10135&author=J.+Huauthor=Y.+Chengauthor=Y.+Yangauthor=Y.+Rao&title=A+General+and+Efficient+Approach+to+2H-Indazoles+and+1H-Pyrazoles+through+Copper-Catalyzed+Intramolecular+N%E2%80%93N+Bond+Formation+under+Mild+Conditions&doi=10.1039%2Fc1cc13908h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A general and efficient approach to 2H-indazoles and 1H-pyrazoles through copper-catalyzed intramolecular N-N bond formation under mild conditions</span></div><div class="casAuthors">Hu, Jiantao; Cheng, Yongfeng; Yang, Yiqing; Rao, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">10133-10135</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A new efficient copper-catalyzed intramol. amination reaction has been developed to readily synthesize a wide variety of multi-substituted 2H-indazole, e.g., I, and 1H-pyrazole, e.g., II,derivs. from easily accessible starting materials under mild conditions.  A highly selective ligand for estrogen receptor β was prepd. in three steps by employing this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhIxwFyyNUcLVg90H21EOLACvtfcHk0lhlTu5mn9udFg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2htrbM&md5=893bc3aa9ea23c4150fbff16cd39ebe9</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2Fc1cc13908h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1cc13908h%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DRao%26aufirst%3DY.%26atitle%3DA%2520General%2520and%2520Efficient%2520Approach%2520to%25202H-Indazoles%2520and%25201H-Pyrazoles%2520through%2520Copper-Catalyzed%2520Intramolecular%2520N%25E2%2580%2593N%2520Bond%2520Formation%2520under%2520Mild%2520Conditions%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D10133%26epage%3D10135%26doi%3D10.1039%2Fc1cc13908h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharghi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberi, M.</span></span> <span> </span><span class="NLM_article-title">Ligand-Free Copper(I) Oxide Nanoparticle Catalyzed Three-Component Synthesis of 2H-Indazole Derivatives from 2-Halobenzaldehydes, Amines and Sodium Azide in Polyethylene Glycol as a Green Solvent</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1111</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi"> DOI: 10.1055/s-0033-1340979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1055%2Fs-0033-1340979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslSrtbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=1111-1115&author=H.+Sharghiauthor=M.+Aberi&title=Ligand-Free+Copper%28I%29+Oxide+Nanoparticle+Catalyzed+Three-Component+Synthesis+of+2H-Indazole+Derivatives+from+2-Halobenzaldehydes%2C+Amines+and+Sodium+Azide+in+Polyethylene+Glycol+as+a+Green+Solvent&doi=10.1055%2Fs-0033-1340979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-free copper(I) oxide nanoparticle catalyzed three-component synthesis of 2H-indazole derivatives from 2-halobenzaldehydes, amines and sodium azide in polyethylene glycol as a green solvent</span></div><div class="casAuthors">Sharghi, Hashem; Aberi, Mahdi</div><div class="citationInfo"><span class="NLM_cas:title">Synlett</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1111-1115, 5 pp.</span>CODEN:
                <span class="NLM_cas:coden">SYNLES</span>;
        ISSN:<span class="NLM_cas:issn">0936-5214</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">An efficient synthesis of 2H-indazole derivs., e.g., I, based on the one-pot three-component reaction of 2-chloro- and 2-bromobenzaldehydes, primary amines and sodium azide is described.  The reaction is catalyzed by copper(I) oxide nanoparticles under ligand-free conditions in polyethylene glycol as a green solvent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzl_ugHCwvg7Vg90H21EOLACvtfcHk0liC43RuBaueCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslSrtbrP&md5=f85b0d19dbbf8ead661706da0b0463f8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1055%2Fs-0033-1340979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0033-1340979%26sid%3Dliteratum%253Aachs%26aulast%3DSharghi%26aufirst%3DH.%26aulast%3DAberi%26aufirst%3DM.%26atitle%3DLigand-Free%2520Copper%2528I%2529%2520Oxide%2520Nanoparticle%2520Catalyzed%2520Three-Component%2520Synthesis%2520of%25202H-Indazole%2520Derivatives%2520from%25202-Halobenzaldehydes%252C%2520Amines%2520and%2520Sodium%2520Azide%2520in%2520Polyethylene%2520Glycol%2520as%2520a%2520Green%2520Solvent%26jtitle%3DSynlett%26date%3D2014%26volume%3D25%26spage%3D1111%26epage%3D1115%26doi%3D10.1055%2Fs-0033-1340979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, E. W.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Indolizinones and a Pyridoazepinone: A New Method for the Annulation of Pyridinones</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2184</span>– <span class="NLM_lpage">2191</span>, <span class="refDoi"> DOI: 10.1021/jo00362a006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00362a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADyaL28XktVKgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1986&pages=2184-2191&author=E.+W.+Thomas&title=Synthesis+of+Indolizinones+and+a+Pyridoazepinone%3A+A+New+Method+for+the+Annulation+of+Pyridinones&doi=10.1021%2Fjo00362a006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of indolizinones and a pyridoazepinone:  a new method for the annulation of pyridinones</span></div><div class="casAuthors">Thomas, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2184-91</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Annulated pyridines I (n = 1-3) were prepd. via regiospecific addn. of LiCH2(CH2)nCH2OTHP (THP = tetrahydro-2H-pyran-2-yl) to C-6 of 2-methoxypyridine.  The resulting lactims were oxidized to 2,6-disubstituted pyridines II.  Under acidic conditions, II (n = 1, 2) afford I (n = 1, 2), resp., but II (n = 3) does not afford I (n = 3), but is converted to the bromide III by HBr, which under basic conditions cyclizes to I (n = 3).  In addn., examples of the synthesis of substituted indolizinones IV (R = H, Et) are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt7iXg6J8GarVg90H21EOLACvtfcHk0liC43RuBaueCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XktVKgu78%253D&md5=831659a3eb98832c89bd0a40a9843ada</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo00362a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00362a006%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DE.%2BW.%26atitle%3DSynthesis%2520of%2520Indolizinones%2520and%2520a%2520Pyridoazepinone%253A%2520A%2520New%2520Method%2520for%2520the%2520Annulation%2520of%2520Pyridinones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1986%26volume%3D51%26spage%3D2184%26epage%3D2191%26doi%3D10.1021%2Fjo00362a006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McComas, C. C.</span>; <span class="NLM_string-name">Kuduk, S. D.</span>; <span class="NLM_string-name">Reger, T. S.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyridone Derivatives as PDE10 Inhibitors</span>. <span class="NLM_patent">WO201481617</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+C.+McComas&author=S.+D.+Kuduk&author=T.+S.+Reger&title=Substituted+Pyridone+Derivatives+as+PDE10+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcComas%26aufirst%3DC.%2BC.%26atitle%3DSubstituted%2520Pyridone%2520Derivatives%2520as%2520PDE10%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaniwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule TLR8 Antagonists via Structure-Based Rational Design</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1286</span>– <span class="NLM_lpage">1291</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2018.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1016%2Fj.chembiol.2018.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=30100350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOksr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=1286-1291&author=Z.+Huauthor=H.+Tanjiauthor=S.+Jiangauthor=S.+Zhangauthor=K.+Kooauthor=J.+Chanauthor=K.+Sakaniwaauthor=U.+Ohtoauthor=A.+Candiaauthor=T.+Shimizuauthor=H.+Yin&title=Small-Molecule+TLR8+Antagonists+via+Structure-Based+Rational+Design&doi=10.1016%2Fj.chembiol.2018.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule TLR8 Antagonists via Structure-Based Rational Design</span></div><div class="casAuthors">Hu, Zhenyi; Tanji, Hiromi; Jiang, Shuangshuang; Zhang, Shuting; Koo, Kyoin; Chan, Jean; Sakaniwa, Kentaro; Ohto, Umeharu; Candia, Albert; Shimizu, Toshiyuki; Yin, Hang</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1286-1291.e3</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Rational design of drug-like small-mol. ligands based on structural information of proteins remains a significant challenge in chem. biol.  In particular, designs targeting protein-protein interfaces have met little success given the dynamic nature of the protein surfaces.  Herein, we utilized the structure of a small-mol. ligand in complex with Toll-like receptor 8 (TLR8) as a model system due to TLR8's clin. relevance.  Overactivation of TLR8 has been suggested to play a prominent role in the pathogenesis of various autoimmune diseases; however, there are still few small-mol. antagonists available, and our rational designs led to the discovery of six exceptionally potent compds. with ∼picomolar IC50 values.  Two X-ray crystallog. structures validated the contacts within the binding pocket.  A variety of biol. evaluations in cultured cell lines, human peripheral blood mononuclear cells, and splenocytes from human TLR8-transgenic mice further demonstrated these TLR8 inhibitors' high efficacy, suggesting strong therapeutic potential against autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr97vmMOWWiELVg90H21EOLACvtfcHk0liC43RuBaueCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOksr3F&md5=29acde5f0074c71209789154399a8119</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2018.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2018.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DKoo%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DSakaniwa%26aufirst%3DK.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DCandia%26aufirst%3DA.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DSmall-Molecule%2520TLR8%2520Antagonists%2520via%2520Structure-Based%2520Rational%2520Design%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2018%26volume%3D25%26spage%3D1286%26epage%3D1291%26doi%3D10.1016%2Fj.chembiol.2018.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 5 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Arindam Talukdar, Dipyaman Ganguly, Swarnali Roy, Nirmal Das, <span class="NLM_string-name hlFld-ContribAuthor">Dipika Sarkar</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Evolution and Translational Potential for Agonists and Antagonists of Endosomal Toll-like Receptors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (12)
                                     , 8010-8041. <a href="https://doi.org/10.1021/acs.jmedchem.1c00300" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00300</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00300&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00300%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStructural%252BEvolution%252Band%252BTranslational%252BPotential%252Bfor%252BAgonists%252Band%252BAntagonists%252Bof%252BEndosomal%252BToll-like%252BReceptors%26aulast%3DTalukdar%26aufirst%3DArindam%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D16022021%26date%3D10062021%26volume%3D64%26issue%3D12%26spage%3D8010%26epage%3D8041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiaoqing  Wang</span>, <span class="hlFld-ContribAuthor ">Yafei  Liu</span>, <span class="hlFld-ContribAuthor ">Xingchun  Han</span>, <span class="hlFld-ContribAuthor ">Ge  Zou</span>, <span class="hlFld-ContribAuthor ">Wei  Zhu</span>, <span class="hlFld-ContribAuthor ">Hong  Shen</span>, <span class="hlFld-ContribAuthor ">Haixia  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule approaches to treat autoimmune and inflammatory diseases (Part II): Nucleic acid sensing antagonists and inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>44 </em>, 128101. <a href="https://doi.org/10.1016/j.bmcl.2021.128101" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.128101</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.128101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.128101%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSmall%252Bmolecule%252Bapproaches%252Bto%252Btreat%252Bautoimmune%252Band%252Binflammatory%252Bdiseases%252B%252528Part%252BII%252529%25253A%252BNucleic%252Bacid%252Bsensing%252Bantagonists%252Band%252Binhibitors%26aulast%3DWang%26aufirst%3DXiaoqing%26date%3D2021%26volume%3D44%26spage%3D128101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fabian H.  Knaup</span>, <span class="hlFld-ContribAuthor ">Christian  Meyners</span>, <span class="hlFld-ContribAuthor ">Anna  Charalampidou</span>, <span class="hlFld-ContribAuthor ">Patryk  Krajczy</span>, <span class="hlFld-ContribAuthor ">Patrick L.  Purder</span>, <span class="hlFld-ContribAuthor ">Tatjana  Ross</span>, <span class="hlFld-ContribAuthor ">Felix  Hausch</span>. </span><span class="cited-content_cbyCitation_article-title">Med Chem Remote: The Frontiers in Medicinal Chemistry 2021. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2021,</strong> <em>157 </em><a href="https://doi.org/10.1002/cmdc.202100355" title="DOI URL">https://doi.org/10.1002/cmdc.202100355</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.202100355&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.202100355%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DMed%252BChem%252BRemote%25253A%252BThe%252BFrontiers%252Bin%252BMedicinal%252BChemistry%252B2021%26aulast%3DKnaup%26aufirst%3DFabian%2BH.%26date%3D2021%26date%3D2021%26volume%3D157" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M. Brittany  Johnson</span>, <span class="hlFld-ContribAuthor ">Morgan  Chandler</span>, <span class="hlFld-ContribAuthor ">Kirill A.  Afonin</span>. </span><span class="cited-content_cbyCitation_article-title">Nucleic acid nanoparticles (NANPs) as molecular tools to direct desirable and avoid undesirable immunological effects. </span><span class="cited-content_cbyCitation_journal-name">Advanced Drug Delivery Reviews</span><span> <strong>2021,</strong> <em>173 </em>, 427-438. <a href="https://doi.org/10.1016/j.addr.2021.04.011" title="DOI URL">https://doi.org/10.1016/j.addr.2021.04.011</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.addr.2021.04.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.addr.2021.04.011%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Drug%2520Delivery%2520Reviews%26atitle%3DNucleic%252Bacid%252Bnanoparticles%252B%252528NANPs%252529%252Bas%252Bmolecular%252Btools%252Bto%252Bdirect%252Bdesirable%252Band%252Bavoid%252Bundesirable%252Bimmunological%252Beffects%26aulast%3DJohnson%26aufirst%3DM.%2BBrittany%26date%3D2021%26volume%3D173%26spage%3D427%26epage%3D438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jinta  Asami</span>, <span class="hlFld-ContribAuthor ">Toshiyuki  Shimizu</span>. </span><span class="cited-content_cbyCitation_article-title">Structural and functional understanding of the toll‐like receptors. </span><span class="cited-content_cbyCitation_journal-name">Protein Science</span><span> <strong>2021,</strong> <em>30 </em>
                                    (4)
                                     , 761-772. <a href="https://doi.org/10.1002/pro.4043" title="DOI URL">https://doi.org/10.1002/pro.4043</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/pro.4043&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fpro.4043%26sid%3Dliteratum%253Aachs%26jtitle%3DProtein%2520Science%26atitle%3DStructural%252Band%252Bfunctional%252Bunderstanding%252Bof%252Bthe%252Btoll%2525E2%252580%252590like%252Breceptors%26aulast%3DAsami%26aufirst%3DJinta%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D4%26spage%3D761%26epage%3D772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0019.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0001.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. TLR8 binder <b>1</b> and fluorescent probe <b>2</b> used in the time-resolved fluorescence resonance energy transfer (TR-FRET) assay. IC<sub>50</sub> reported as geometric mean ± standard deviation (SD).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0002.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Binding model of compound <b>3</b> with TLR8. Amino acids belonging to one TLR8 monomer in green and the second monomer amino acid in light gray. Amino acids belonging to the green monomer were labeled with an asterisk. The PDB file of the model in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0003.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. Binding model of compound <b>4</b> with TLR8; amino acid differences in TLR7 are shown in purple. Amino acids belonging to one TLR8 monomer are in green, and the second monomer amino acids are in light gray. Amino acids belonging to the green monomer are labeled with an asterisk. PDB file of the model is provided in the <a href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf" class="ext-link">Supporting Information</a>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0004.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Lead profile of compound <b>8</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0005.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Cocrystal structure of compound <b>11</b> with TLR8 ECD: (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TY5">6TY5</a>) (a) full view, one TLR8 monomer in green, the second monomer in light gray, compound <b>11</b> in light blue; (b) top view, turned by 90°; (c) close-up view on one binding site showing amino acids within 5 Å of <b>11</b>, except for Phe261, which is not shown for clarity. Amino acids belonging to the green monomer were labeled with an asterisk. (d) Side view of the binding site only showing one monomer with surface representation and the 2<i>F</i><sub>o</sub> – <i>F</i><sub>c</sub> map contoured at 1.0 σ for the bound inhibitor.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0006.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Calculated lowest energy conformations of <b>28</b> and <b>27</b> in water at neutral pH and small-molecule crystal structure of <b>27</b> (CCDC 1979262). Orange lines indicate dihedral angles about the indazole–piperdine C–C bond.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0007.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Compound <b>27</b> inhibits TLR7-dependent IFNα secretion in mice <i>in vivo</i>. Exposure (blue squares) in blood and concentration of IFNα in serum (gray bars) at the indicated doses are shown. Data points for compound-treated groups represent means of <i>n</i> = 5 mice and for the vehicle-treated group means of <i>n</i> = 10 mice ± SD. Pooled data from two experiments. Horizontal dotted blue line represents <i>in vitro</i> TLR7 IC<sub>50</sub> of compound <b>27</b> in mouse whole blood (<a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a></a>). **, <i>p</i> < 0.01; ***, <i>p</i> < 0.001 for IFNα, analysis of variance (ANOVA) with Dunnett’s post test, compared to the vehicle group.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0008.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Synthesis of the Quinazoline Core Containing Compounds 3 and 4<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) LiAlH<sub>4</sub>, tetrahydrofuran (THF), 0 °C; 79%; (b) MnO<sub>2</sub>, dichloromethane (DCM), room temperature (RT); 91%; (c) urea, 180 °C; quant.; (d) POCl<sub>3</sub>, 110 °C; 50%; (e) <i>N</i>-methyl-2-pyrrolidinone (NMP), 150 °C; (f) PdCl<sub>2</sub>(dppf), aq. Na<sub>2</sub>CO<sub>3</sub>, 1,2-dimethoxyethane (DME), 80 °C.</p></p></figure><figure data-id="sch2" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0009.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. First-Generation Syntheses of Indazole-Core-Containing Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) Ag<sub>2</sub>SO<sub>4</sub>, I<sub>2</sub>, EtOH, RT; 67%; (b) NaNO<sub>2</sub>, AcOH, RT; 83%; (c) Cs<sub>2</sub>CO<sub>3</sub>, <i>N</i>,<i>N-</i>dimethylacetamide (DMA), 150 °C; (d) NaH, DMF, 100 °C; (e) 2-PrOH, 80 °C; then, PBu<sub>3</sub>, 80 °C; (f) CuI, phenanthroline, TMSCF<sub>3</sub>, KF, B(OMe)<sub>3</sub>, dimethyl sulfoxide (DMSO), 60 °C; (g) XPhos Pd G3, XPhos, B<sub>2</sub>(OH)<sub>4</sub>, KOAc, EtOH, 80 °C; (h) K<sub>2</sub>CO<sub>3</sub>, 80 °C; (i) trifluoroacetic acid (TFA) or HCl, DCM, RT; (j) formaldehyde, AcOH, NaBH(OAc)<sub>3</sub>, DCM; (k) 2-(dimethylamino)acetic acid, <i>O</i>-(7-azabenzotriazol-1-yl)-<i>N</i>,<i>N</i>,<i>N</i>′,<i>N</i>′-tetramethyluronium hexafluorophosphate (HATU), <i>N</i>,<i>N</i>-diisopropylethylamine (DIPEA), DMF, RT.</p></p></figure><figure data-id="sch3" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0010.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Second-Generation Synthesis of Indazole-Core-Containing Compounds<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) NBS, DCM, RT; 91%; (b) LiAlH<sub>4</sub>, THF, 0 °C; 72%; (c) MnO<sub>2</sub>, DCM, RT; 96%; (d) HCl, NaNO<sub>2</sub>, H<sub>2</sub>O, 0 °C to RT; then, NaN<sub>3</sub>, 0°C to RT; quant.; (e) RNH<sub>2</sub>, Cu<sub>2</sub>O, DCE, 80 °C; (f) XPhos Pd G3, XPhos, B<sub>2</sub>(OH)<sub>4</sub>, KOAc, EtOH, 80 °C; then, K<sub>2</sub>CO<sub>3</sub>, 80 °C; (g) TFA, DCM, RT; (h) <i>n</i>-BuLi, THF, −78°C; 47%; (i) 48% HBr, reflux, then NaOH; 98%; (j) NBS, DMF, RT; 42%.</p></p></figure><figure data-id="sch4" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/medium/jm0c00130_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0011.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Alternative Route with Late-Stage Introduction of Amine<sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2020/jmcmar.2020.63.issue-15/acs.jmedchem.0c00130/20200806/images/large/jm0c00130_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c00130&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>Reagents and conditions: (a) XPhos Pd G3, XPhos, B<sub>2</sub>(OH)<sub>4</sub>, KOAc, EtOH, 80 °C; then, K<sub>2</sub>CO<sub>3</sub>, 80 °C; 80%; (b) MnO<sub>2</sub>, DCM, RT; 91%; (c) HCl, NaNO<sub>2</sub>, H<sub>2</sub>O, 0 °C to RT; then, NaN<sub>3</sub>, 0 °C to RT; 87%; (d) Cu<sub>2</sub>O, DCE, 80 °C; (e) HCl, DCM, RT.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i76">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_62803" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_62803" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 31 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Junt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barchet, W.</span></span> <span> </span><span class="NLM_article-title">Translating Nucleic Acid-Sensing Pathways into Therapies</span>. <i>Nat. Rev. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">544</span>, <span class="refDoi"> DOI: 10.1038/nri3875</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1038%2Fnri3875" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=26292638" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtlOrtrjM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=529-544&author=T.+Juntauthor=W.+Barchet&title=Translating+Nucleic+Acid-Sensing+Pathways+into+Therapies&doi=10.1038%2Fnri3875"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Translating nucleic acid-sensing pathways into therapies</span></div><div class="casAuthors">Junt, Tobias; Barchet, Winfried</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Immunology</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">529-544</span>CODEN:
                <span class="NLM_cas:coden">NRIABX</span>;
        ISSN:<span class="NLM_cas:issn">1474-1733</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  Nucleic acid sensing by innate receptors initiates immune defences against viruses and other pathogens.  A hallmark of this response is the release of interferons (IFNs), which promote protective immunity by inducing IFN-stimulated genes (ISGs).  A similar ISG signature is found in autoinflammatory and autoimmune conditions, indicating that chronic activation of nucleic acid-sensing pathways may contribute to these diseases.  Here, we review how nucleic acid-sensing pathways are currently being targeted pharmacol. with both agonists and antagonists.  We discuss how an improved understanding of the biol. of these pathways is leading to novel therapies for infections, cancer, and autoimmune and autoinflammatory disorders, and how new therapeutics will, in turn, generate a deeper understanding of these complex diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGobYKnDGOTSvbVg90H21EOLACvtfcHk0ljWnCveNR32RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtlOrtrjM&md5=3afa98f84abcce81338604d3c3c5075c</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1038%2Fnri3875&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnri3875%26sid%3Dliteratum%253Aachs%26aulast%3DJunt%26aufirst%3DT.%26aulast%3DBarchet%26aufirst%3DW.%26atitle%3DTranslating%2520Nucleic%2520Acid-Sensing%2520Pathways%2520into%2520Therapies%26jtitle%3DNat.%2520Rev.%2520Immunol.%26date%3D2015%26volume%3D15%26spage%3D529%26epage%3D544%26doi%3D10.1038%2Fnri3875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lipard, G. B.</span>; <span class="NLM_string-name">Zepp, C. M.</span></span> <span> </span><span class="NLM_article-title">Quinazoline Derivative Useful as Toll-Like Receptor Antagonist</span>. <span class="NLM_patent">WO2008152471</span>, <span class="NLM_year">2008</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2008&author=G.+B.+Lipard&author=C.+M.+Zepp&title=Quinazoline+Derivative+Useful+as+Toll-Like+Receptor+Antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DLipard%26aufirst%3DG.%2BB.%26atitle%3DQuinazoline%2520Derivative%2520Useful%2520as%2520Toll-Like%2520Receptor%2520Antagonist%26date%3D2008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boivin, R.</span>; <span class="NLM_string-name">Carlson, E.</span>; <span class="NLM_string-name">Endo, A.</span>; <span class="NLM_string-name">Hansen, H.</span>; <span class="NLM_string-name">Hawkins, L. D.</span>; <span class="NLM_string-name">Ishizaka, S.</span>; <span class="NLM_string-name">Mackey, M.</span>; <span class="NLM_string-name">Narayan, S.</span>; <span class="NLM_string-name">Satoh, T.</span>; <span class="NLM_string-name">Schiller, S.</span></span> <span> </span><span class="NLM_article-title">Tetrahydropyrazolopyrimidine compounds</span>. <span class="NLM_patent">US20130324547</span>, <span class="NLM_year">2013</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2013&author=R.+Boivin&author=E.+Carlson&author=A.+Endo&author=H.+Hansen&author=L.+D.+Hawkins&author=S.+Ishizaka&author=M.+Mackey&author=S.+Narayan&author=T.+Satoh&author=S.+Schiller&title=Tetrahydropyrazolopyrimidine+compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoivin%26aufirst%3DR.%26atitle%3DTetrahydropyrazolopyrimidine%2520compounds%26date%3D2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Carlson, E.</span>; <span class="NLM_string-name">Hansen, H.</span>; <span class="NLM_string-name">Mackey, M.</span>; <span class="NLM_string-name">Schiller, S.</span>; <span class="NLM_string-name">Ogawa, C.</span>; <span class="NLM_string-name">Davis, H.</span></span> <span> </span><span class="NLM_article-title">Selectively Substituted Quinoline Compounds</span>. <span class="NLM_patent">WO2015057659 A1</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=E.+Carlson&author=H.+Hansen&author=M.+Mackey&author=S.+Schiller&author=C.+Ogawa&author=H.+Davis&title=Selectively+Substituted+Quinoline+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DCarlson%26aufirst%3DE.%26atitle%3DSelectively%2520Substituted%2520Quinoline%2520Compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boivin, R.</span>; <span class="NLM_string-name">Hansen, H.</span>; <span class="NLM_string-name">Ishizaka, S.</span>; <span class="NLM_string-name">Mackey, M.</span>; <span class="NLM_string-name">Schiller, S.</span>; <span class="NLM_string-name">Ogawa, C.</span>; <span class="NLM_string-name">Narayan, S.</span>; <span class="NLM_string-name">Bertinato, P.</span>; <span class="NLM_string-name">Burger, G.</span></span> <span> </span><span class="NLM_article-title">Selectively Substituted Quinoline Compounds</span>. <span class="NLM_patent">WO2015057655</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2015&author=R.+Boivin&author=H.+Hansen&author=S.+Ishizaka&author=M.+Mackey&author=S.+Schiller&author=C.+Ogawa&author=S.+Narayan&author=P.+Bertinato&author=G.+Burger&title=Selectively+Substituted+Quinoline+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBoivin%26aufirst%3DR.%26atitle%3DSelectively%2520Substituted%2520Quinoline%2520Compounds%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hawkins, L. D.</span></span> <i>E6887: A Novel and Selective Inhibitor of Toll-like Receptors 7 and 8</i>, Presented at the 252nd National Meeting, <span class="NLM_publisher-name">American Chemical Society</span>: <span class="NLM_publisher-loc">Philadelphia, PA</span>, MEDI 203, August 20–25, <span class="NLM_year">2016</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2016&author=L.+D.+Hawkins&title=E6887%3A+A+Novel+and+Selective+Inhibitor+of+Toll-like+Receptors+7+and+8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dconf-proc%26sid%3Dliteratum%253Aachs%26aulast%3DHawkins%26aufirst%3DL.%2BD.%26jtitle%3DE6887%253A%2520A%2520Novel%2520and%2520Selective%2520Inhibitor%2520of%2520Toll-like%2520Receptors%25207%2520and%25208%26pub%3DAmerican%2520Chemical%2520Society%26date%3D2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Padilla-Salinas, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaniwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nordeen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H. H.</span></span> <span> </span><span class="NLM_article-title">Discovery of Novel Inhibitors Targeting Toll-like Receptor 7 and 8</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">10221</span>– <span class="NLM_lpage">10244</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b01201</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b01201" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitV2hs7vF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=10221-10244&author=R.+Padilla-Salinasauthor=R.+Andersonauthor=K.+Sakaniwaauthor=S.+Zhangauthor=P.+Nordeenauthor=C.+Luauthor=T.+Shimizuauthor=H.+H.+Yin&title=Discovery+of+Novel+Inhibitors+Targeting+Toll-like+Receptor+7+and+8&doi=10.1021%2Facs.jmedchem.9b01201"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of Novel Small Molecule Dual Inhibitors Targeting Toll-Like Receptors 7 and 8</span></div><div class="casAuthors">Padilla-Salinas, Rosaura; Anderson, Rachel; Sakaniwa, Kentaro; Zhang, Shuting; Nordeen, Patrick; Lu, Chuanjun; Shimizu, Toshiyuki; Yin, Hang</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">10221-10244</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Endosomal toll-like receptors (TLRs) 7 and 8 recognize viral single-stranded RNAs, a class of imidazoquinoline compds., 8-oxo-adenosines, 8-aminobenzodiazepines, pyrimidines, and guanosine analogs.  Substantial evidence is present linking chronic inflammation mediated specifically by TLR7 to the progression of autoimmunity.  We identified a new TLR7/8 dual inhibitor (1) and a TLR8-specific inhibitor (2) based on our previous screen targeting TLR8.  Compd. 1, bearing a benzanilide scaffold, was found to inhibit TLR7 and TLR8 at low micromolar concns.  We envisioned making modifications on the benzanilide scaffold of 1 resulting in a class of highly specific TLR7 inhibitors.  Our efforts led to the discovery of a new TLR8 inhibitor (CU-115) and identification of a TLR7/8 dual inhibitor (CU-72), bearing a distinct di-Ph ether skeleton, with potential for TLR7 selectivity optimization.  Given the role of TLR8 in autoimmunity, we also optimized the potency of 2 and developed a new TLR8 inhibitor bearing a 1,3,4-oxadiazole motif.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr0h41ew98eKrVg90H21EOLACvtfcHk0lhSIAguc11cig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitV2hs7vF&md5=2c50f570c2837df4220f5c3f3847f518</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b01201&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b01201%26sid%3Dliteratum%253Aachs%26aulast%3DPadilla-Salinas%26aufirst%3DR.%26aulast%3DAnderson%26aufirst%3DR.%26aulast%3DSakaniwa%26aufirst%3DK.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DNordeen%26aufirst%3DP.%26aulast%3DLu%26aufirst%3DC.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DH.%2BH.%26atitle%3DDiscovery%2520of%2520Novel%2520Inhibitors%2520Targeting%2520Toll-like%2520Receptor%25207%2520and%25208%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D10221%26epage%3D10244%26doi%3D10.1021%2Facs.jmedchem.9b01201" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bou
Karroum, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moarbess, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guichou, J.-F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonnet, P.-A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patinote, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bourharoun-Tayoun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chamat, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cuq, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diab-Assaf, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kassab, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deleuze-Masquefa, C.</span></span> <span> </span><span class="NLM_article-title">Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]pyrazines, Imidazo[1,5-a]quinoxalines, and Pyrazolo[1,5-a]quinaxoline Series</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">7015</span>– <span class="NLM_lpage">7031</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b00411</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b00411" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtlamsbnN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=7015-7031&author=N.+Bou%0AKarroumauthor=G.+Moarbessauthor=J.-F.+Guichouauthor=P.-A.+Bonnetauthor=C.+Patinoteauthor=H.+Bourharoun-Tayounauthor=S.+Chamatauthor=P.+Cuqauthor=M.+Diab-Assafauthor=I.+Kassabauthor=C.+Deleuze-Masquefa&title=Novel+and+Selective+TLR7+Antagonists+among+the+Imidazo%5B1%2C2-a%5Dpyrazines%2C+Imidazo%5B1%2C5-a%5Dquinoxalines%2C+and+Pyrazolo%5B1%2C5-a%5Dquinaxoline+Series&doi=10.1021%2Facs.jmedchem.9b00411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Novel and Selective TLR7 Antagonists among the Imidazo[1,2-a]pyrazines, Imidazo[1,5-a]quinoxalines, and Pyrazolo[1,5-a]quinoxalines Series</span></div><div class="casAuthors">Bou Karroum, Nour; Moarbess, Georges; Guichou, Jean-Francois; Bonnet, Pierre-Antoine; Patinote, Cindy; Bouharoun-Tayoun, Hasnaa; Chamat, Soulaima; Cuq, Pierre; Diab-Assaf, Mona; Kassab, Issam; Deleuze-Masquefa, Carine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">7015-7031</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The Toll-like receptors (TLRs) 7 and 8 play an important role in the immune system activation, and their agonists may therefore serve as promising candidate vaccine adjuvants.  However, the chronic immune activation by excessive TLR stimulation is a hallmark of several clin. important infectious and autoimmune diseases, which warrants the search for TLR antagonists.  In this study, a variety of compds. belonging to three heterocyclic chem. series: imidazo[1,2-a]pyrazine, imidazo[1,5-a]quinoxaline, and pyrazolo[1,5-a]quinoxaline have been synthesized and characterized.  These compds. have been tested for their TLR7 or TLR8 agonistic and antagonistic activities.  Several of them are shown to be selective TLR7 antagonists without any TLR7 or TLR8 agonistic activity.  The selectivity was confirmed by a comparative ligand-docking study in TLR7 antagonist pocket.  Two compds. of the pyrazolo[1,5-a]quinoxaline series I [R = n-Bu, i-Bu] are potent selective TLR7 antagonists and may be considered as promising starting points for the development of new therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq3510Ht_ZHf7Vg90H21EOLACvtfcHk0lhSIAguc11cig"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtlamsbnN&md5=b9ffc17dcae442102245eb76face7394</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b00411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b00411%26sid%3Dliteratum%253Aachs%26aulast%3DBou%2BKarroum%26aufirst%3DN.%26aulast%3DMoarbess%26aufirst%3DG.%26aulast%3DGuichou%26aufirst%3DJ.-F.%26aulast%3DBonnet%26aufirst%3DP.-A.%26aulast%3DPatinote%26aufirst%3DC.%26aulast%3DBourharoun-Tayoun%26aufirst%3DH.%26aulast%3DChamat%26aufirst%3DS.%26aulast%3DCuq%26aufirst%3DP.%26aulast%3DDiab-Assaf%26aufirst%3DM.%26aulast%3DKassab%26aufirst%3DI.%26aulast%3DDeleuze-Masquefa%26aufirst%3DC.%26atitle%3DNovel%2520and%2520Selective%2520TLR7%2520Antagonists%2520among%2520the%2520Imidazo%255B1%252C2-a%255Dpyrazines%252C%2520Imidazo%255B1%252C5-a%255Dquinoxalines%252C%2520and%2520Pyrazolo%255B1%252C5-a%255Dquinaxoline%2520Series%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D7015%26epage%3D7031%26doi%3D10.1021%2Facs.jmedchem.9b00411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kužnik, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bencina, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Svajger, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeras, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rozman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jerla, R.</span></span> <span> </span><span class="NLM_article-title">Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>186</i></span>,  <span class="NLM_fpage">4794</span>– <span class="NLM_lpage">4804</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.1000702</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.4049%2Fjimmunol.1000702" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=21398612" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC3MXkt1Gqtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=186&publication_year=2011&pages=4794-4804&author=A.+Ku%C5%BEnikauthor=M.+Bencinaauthor=U.+Svajgerauthor=M.+Jerasauthor=B.+Rozmanauthor=R.+Jerla&title=Mechanism+of+Endosomal+TLR+Inhibition+by+Antimalarial+Drugs+and+Imidazoquinolines&doi=10.4049%2Fjimmunol.1000702"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Mechanism of Endosomal TLR Inhibition by Antimalarial Drugs and Imidazoquinolines</span></div><div class="casAuthors">Kuznik, Alenka; Bencina, Mojca; Svajger, Urban; Jeras, Matjaz; Rozman, Blaz; Jerala, Roman</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">186</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">4794-4804</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Endosomal TLRs play an important role in innate immune response as well as in autoimmune processes.  In the therapy of systemic lupus erythematosus, antimalarial drugs chloroquine, hydroxychloroquine, and quinacrine have been used for a long time.  Their suppression of endosomal TLR activation has been attributed to the inhibition of endosomal acidification, which is a prerequisite for the activation of these receptors.  We discovered that chloroquine inhibits only activation of endosomal TLRs by nucleic acids, whereas it augments activation of TLR8 by a small synthetic compd., R848.  We detected direct binding of antimalarials to nucleic acids by spectroscopic expts. and detd. their cellular colocalization.  Further anal. revealed that other nucleic acid-binding compds., such as propidium iodide, also inhibited activation of endosomal TLRs and colocalized with nucleic acids to endosomes.  We found that imidazoquinolines, which are TLR7/8 agonists, inhibit TLR9 and TLR3 even in the absence of TLR7 or TLR8, and their mechanism of inhibition is similar to the antimalarials.  In contrast to bafilomycin, none of the tested antimalarials and imidazoquinolines inhibited endosomal proteolysis or increased the endosomal pH, confirming that inhibition of pH acidification is not the underlying cause of inhibition.  We conclude that the direct binding of inhibitors to nucleic acids mask their TLR-binding epitope and may explain the efficiency of those compds. in the treatment of autoimmune diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp8R0z4GZpekbVg90H21EOLACvtfcHk0lgU37iZShZa0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXkt1Gqtr0%253D&md5=1d97c9b8ce92ff52546d6d5f0248bb99</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.1000702&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.1000702%26sid%3Dliteratum%253Aachs%26aulast%3DKu%25C5%25BEnik%26aufirst%3DA.%26aulast%3DBencina%26aufirst%3DM.%26aulast%3DSvajger%26aufirst%3DU.%26aulast%3DJeras%26aufirst%3DM.%26aulast%3DRozman%26aufirst%3DB.%26aulast%3DJerla%26aufirst%3DR.%26atitle%3DMechanism%2520of%2520Endosomal%2520TLR%2520Inhibition%2520by%2520Antimalarial%2520Drugs%2520and%2520Imidazoquinolines%26jtitle%3DJ.%2520Immunol.%26date%3D2011%26volume%3D186%26spage%3D4794%26epage%3D4804%26doi%3D10.4049%2Fjimmunol.1000702" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lamphier, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zheng, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Latz, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spyvee, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hansen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Genest, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaffer, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mempel, T. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rowbottom, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chow, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twine, N. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gusovsky, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishizaka, S.</span></span> <span> </span><span class="NLM_article-title">Novel Small Molecule Inhibitors of TLR7 and TLR9: Mechanism of Action and Efficacy in Vivo</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>85</i></span>,  <span class="NLM_fpage">429</span>– <span class="NLM_lpage">440</span>, <span class="refDoi"> DOI: 10.1124/mol.113.089821</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1124%2Fmol.113.089821" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=24342772" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlsVylu7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=85&publication_year=2014&pages=429-440&author=M.+Lamphierauthor=W.+Zhengauthor=E.+Latzauthor=M.+Spyveeauthor=H.+Hansenauthor=J.+Roseauthor=M.+Genestauthor=H.+Yangauthor=C.+Shafferauthor=Y.+Zhaoauthor=Y.+Shenauthor=C.+Liuauthor=D.+Liuauthor=T.+R.+Mempelauthor=C.+Rowbottomauthor=J.+Chowauthor=N.+C.+Twineauthor=M.+Yuauthor=F.+Gusovskyauthor=S.+Ishizaka&title=Novel+Small+Molecule+Inhibitors+of+TLR7+and+TLR9%3A+Mechanism+of+Action+and+Efficacy+in+Vivo&doi=10.1124%2Fmol.113.089821"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Novel small molecule inhibitors of TLR7 and TLR9: mechanism of action and efficacy in vivo</span></div><div class="casAuthors">Lamphier, Marc; Zheng, Wanjun; Latz, Eicke; Spyvee, Mark; Hansen, Hans; Rose, Jeffrey; Genest, Melinda; Yang, Hua; Shaffer, Christina; Zhao, Yan; Shen, Yongchun; Liu, Carrie; Liu, Diana; Mempel, Thorsten R.; Rowbottom, Christopher; Chow, Jesse; Twine, Natalie C.; Yu, Melvin; Gusovsky, Fabian; Ishizaka, Sally T.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmacology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">85</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">429-440, 31 pp.</span>CODEN:
                <span class="NLM_cas:coden">MOPMA3</span>;
        ISSN:<span class="NLM_cas:issn">1521-0111</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">The discovery that circulating nucleic acid-contg. complexes in the serum of autoimmune lupus patients can stimulate B cells and plasmacytoid dendritic cells via Toll-like receptors 7 and 9 suggested that agents that block these receptors might be useful therapeutics.  We identified two compds., AT791 {3-[4-(6-(3-(dimethylamino)propoxy)benzo[d]oxazol-2-yl)phenoxy]-N,N-dimethylpropan-1-amine} and E6446 {6-[3-(pyrrolidin-1-yl)propoxy)-2-(4-(3-(pyrrolidin-yl)propoxy)phenyl]benzo[d]oxazole}, that inhibit Toll-like receptor (TLR)7 and 9 signaling in a variety of human and mouse cell types and inhibit DNA-TLR9 interaction in vitro.  When administered to mice, these compds. suppress responses to challenge doses of cytidine-phosphate-guanidine (CpG)-contg. DNA, which stimulates TLR9.  When given chronically in spontaneous mouse lupus models, E6446 slowed development of circulating antinuclear antibodies and had a modest effect on anti-double-stranded DNA titers but showed no observable impact on proteinuria or mortality.  We discovered that the ability of AT791 and E6446 to inhibit TLR7 and 9 signaling depends on two properties: weak interaction with nucleic acids and high accumulation in the intracellular acidic compartments where TLR7 a nd 9 reside.  Binding of the compds. to DNA prevents DNA-TLR9 interaction in vitro and modulates signaling in vivo.  Our data also confirm an earlier report that this same mechanism may explain inhibition of TLR7 and 9 signaling by hydroxychloroquine (Plaquenil), a drug commonly prescribed to treat lupus.  Thus, very different structural classes of mols. can inhibit endosomal TLRs by essentially identical mechanisms of action, suggesting a general mechanism for targeting this group of TLRs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqIxcZmhieLrLVg90H21EOLACvtfcHk0lgU37iZShZa0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlsVylu7w%253D&md5=ad98c0ad97065795983540f5caa2b4a5</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1124%2Fmol.113.089821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.113.089821%26sid%3Dliteratum%253Aachs%26aulast%3DLamphier%26aufirst%3DM.%26aulast%3DZheng%26aufirst%3DW.%26aulast%3DLatz%26aufirst%3DE.%26aulast%3DSpyvee%26aufirst%3DM.%26aulast%3DHansen%26aufirst%3DH.%26aulast%3DRose%26aufirst%3DJ.%26aulast%3DGenest%26aufirst%3DM.%26aulast%3DYang%26aufirst%3DH.%26aulast%3DShaffer%26aufirst%3DC.%26aulast%3DZhao%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DY.%26aulast%3DLiu%26aufirst%3DC.%26aulast%3DLiu%26aufirst%3DD.%26aulast%3DMempel%26aufirst%3DT.%2BR.%26aulast%3DRowbottom%26aufirst%3DC.%26aulast%3DChow%26aufirst%3DJ.%26aulast%3DTwine%26aufirst%3DN.%2BC.%26aulast%3DYu%26aufirst%3DM.%26aulast%3DGusovsky%26aufirst%3DF.%26aulast%3DIshizaka%26aufirst%3DS.%26atitle%3DNovel%2520Small%2520Molecule%2520Inhibitors%2520of%2520TLR7%2520and%2520TLR9%253A%2520Mechanism%2520of%2520Action%2520and%2520Efficacy%2520in%2520Vivo%26jtitle%3DMol.%2520Pharmacol.%26date%3D2014%26volume%3D85%26spage%3D429%26epage%3D440%26doi%3D10.1124%2Fmol.113.089821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kaufmann, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krise, J. P.</span></span> <span> </span><span class="NLM_article-title">Lysosomal Sequestration of Amine-Containing Drugs: Analysis and Therapeutic Implications</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">729</span>– <span class="NLM_lpage">746</span>, <span class="refDoi"> DOI: 10.1002/jps.20792</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1002%2Fjps.20792" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=17117426" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BD2sXktVOjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2007&pages=729-746&author=A.+M.+Kaufmannauthor=J.+P.+Krise&title=Lysosomal+Sequestration+of+Amine-Containing+Drugs%3A+Analysis+and+Therapeutic+Implications&doi=10.1002%2Fjps.20792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Lysosomal sequestration of amine-containing drugs: analysis and therapeutic implications</span></div><div class="casAuthors">Kaufmann, Allyn M.; Krise, Jeffrey P.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmaceutical Sciences</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">729-746</span>CODEN:
                <span class="NLM_cas:coden">JPMSAE</span>;
        ISSN:<span class="NLM_cas:issn">0022-3549</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Liss, Inc.</span>)
        </div><div class="casAbstract">A review.  Amine-contg. drugs represent a very important class of therapeutic agents, with the majority of all drugs contg. at least one basic nitrogen.  For many decades, it has been known that weakly basic compds. can be sequestered into acidic organelles such as lysosomes.  Some amines can achieve very high concns. and induce a dramatic expansion (vacuolization) of the compartment.  In the early 70s, Nobel laureate and discoverer of lysosomes, Christian de Duve et al., wrote an elegant commentary describing the theor. basis for lysosomal sequestration of amines, referring to the process as pH-partitioning and the substrates as lysosomotropics.  Recently, a resurgence of interest in the intracellular distribution of drugs has occurred considering its therapeutic importance.  Specifically, lysosomal sequestration of amines has received considerable attention for reasons including its involvement in drug resistance, inducement of phospholipidosis, and its influence on whole body distribution/pharmacokinetics.  Moreover, the sequestration phenomenon has been recently exploited in the development of a novel drug targeting strategy.  This review will focus on these occurrences/developments and conclude with a commentary on the expected impact that knowledge regarding the intracellular distribution of drugs will likely have on future drug development processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqhcSM0IO68KbVg90H21EOLACvtfcHk0lgU37iZShZa0A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXktVOjtbk%253D&md5=2498515d01fa7e220e95a6c1fd623b97</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1002%2Fjps.20792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20792%26sid%3Dliteratum%253Aachs%26aulast%3DKaufmann%26aufirst%3DA.%2BM.%26aulast%3DKrise%26aufirst%3DJ.%2BP.%26atitle%3DLysosomal%2520Sequestration%2520of%2520Amine-Containing%2520Drugs%253A%2520Analysis%2520and%2520Therapeutic%2520Implications%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2007%26volume%3D96%26spage%3D729%26epage%3D746%26doi%3D10.1002%2Fjps.20792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span> <span> </span><span class="NLM_article-title">Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands</span>. <i>Science</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>339</i></span>,  <span class="NLM_fpage">1426</span>– <span class="NLM_lpage">1429</span>, <span class="refDoi"> DOI: 10.1126/science.1229159</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1126%2Fscience.1229159" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=23520111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC3sXktF2qsr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=2013&pages=1426-1429&author=H.+Tanjiauthor=U.+Ohtoauthor=T.+Shibataauthor=K.+Miyakeauthor=T.+Shimizu&title=Structural+Reorganization+of+the+Toll-Like+Receptor+8+Dimer+Induced+by+Agonistic+Ligands&doi=10.1126%2Fscience.1229159"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Reorganization of the Toll-Like Receptor 8 Dimer Induced by Agonistic Ligands</span></div><div class="casAuthors">Tanji, Hiromi; Ohto, Umeharu; Shibata, Takuma; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Science (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">339</span>
        (<span class="NLM_cas:issue">6126</span>),
    <span class="NLM_cas:pages">1426-1429</span>CODEN:
                <span class="NLM_cas:coden">SCIEAS</span>;
        ISSN:<span class="NLM_cas:issn">0036-8075</span>.
    
            (<span class="NLM_cas:orgname">American Association for the Advancement of Science</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) and TLR8 recognize single-stranded RNA and initiate innate immune responses.  Several synthetic agonists of TLR7-TLR8 display novel therapeutic potential; however, the mol. basis for ligand recognition and activation of signaling by TLR7 or TLR8 is largely unknown.  In this study, the crystal structures of unliganded and ligand-induced activated human TLR8 dimers were elucidated.  Ligand recognition was mediated by a dimerization interface formed by two protomers.  Upon ligand stimulation, the TLR8 dimer was reorganized such that the two C termini were brought into proximity.  The loop between leucine-rich repeat 14 (LRR14) and LRR15 was cleaved; however, the N- and C-terminal halves remained assocd. and contributed to ligand recognition and dimerization.  Thus, ligand binding induces reorganization of the TLR8 dimer, which enables downstream signaling processes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpzF-H0sxwN0rVg90H21EOLACvtfcHk0lgJyhPZigaFiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXktF2qsr4%253D&md5=13b8f32cd70dc59890820d03e88d62ab</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1126%2Fscience.1229159&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1126%252Fscience.1229159%26sid%3Dliteratum%253Aachs%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DStructural%2520Reorganization%2520of%2520the%2520Toll-Like%2520Receptor%25208%2520Dimer%2520Induced%2520by%2520Agonistic%2520Ligands%26jtitle%3DScience%26date%3D2013%26volume%3D339%26spage%3D1426%26epage%3D1429%26doi%3D10.1126%2Fscience.1229159" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krayukhina, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyake, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span> <span> </span><span class="NLM_article-title">Structural Analysis Reveals that Toll-like Receptor 7 is a Dual Receptor for Guanosine and Single-Stranded RNA</span>. <i>Immunity</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">737</span>– <span class="NLM_lpage">748</span>, <span class="refDoi"> DOI: 10.1016/j.immuni.2016.09.011</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1016%2Fj.immuni.2016.09.011" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=27742543" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC28Xhs1OgtLnI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2016&pages=737-748&author=Z.+Zhangauthor=U.+Ohtoauthor=T.+Shibataauthor=E.+Krayukhinaauthor=M.+Taokaauthor=Y.+Yamauchiauthor=H.+Tanjiauthor=T.+Isobeauthor=S.+Uchiyamaauthor=K.+Miyakeauthor=T.+Shimizu&title=Structural+Analysis+Reveals+that+Toll-like+Receptor+7+is+a+Dual+Receptor+for+Guanosine+and+Single-Stranded+RNA&doi=10.1016%2Fj.immuni.2016.09.011"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analysis Reveals that Toll-like Receptor 7 Is a Dual Receptor for Guanosine and Single-Stranded RNA</span></div><div class="casAuthors">Zhang, Zhikuan; Ohto, Umeharu; Shibata, Takuma; Krayukhina, Elena; Taoka, Masato; Yamauchi, Yoshio; Tanji, Hiromi; Isobe, Toshiaki; Uchiyama, Susumu; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Immunity</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">737-748</span>CODEN:
                <span class="NLM_cas:coden">IUNIEH</span>;
        ISSN:<span class="NLM_cas:issn">1074-7613</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) is a single-stranded RNA (ssRNA) sensor in innate immunity and also responds to guanosine and chem. ligands, such as imidazoquinoline compds.  However, TLR7 activation mechanism by these ligands remain largely unknown.  Here, we generated crystal structures of three TLR7 complexes, and found that all formed an activated m-shaped dimer with two ligand-binding sites.  The first site conserved in TLR7 and TLR8 was used for small ligand-binding essential for its activation.  The second site spatially distinct from that of TLR8 was used for a ssRNA-binding that enhanced the affinity of the first-site ligands.  The first site preferentially recognized guanosine and the second site specifically bound to uridine moieties in ssRNA.  Our structural, biochem., and mutagenesis studies indicated that TLR7 is a dual receptor for guanosine and uridine-contg. ssRNA.  Our findings have important implications for understanding of TLR7 function, as well as for therapeutic manipulation of TLR7 activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQskd1L0XeX7Vg90H21EOLACvtfcHk0lgJyhPZigaFiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xhs1OgtLnI&md5=194f87d5ea0e88009fd682c00e020f38</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2Fj.immuni.2016.09.011&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.immuni.2016.09.011%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DKrayukhina%26aufirst%3DE.%26aulast%3DTaoka%26aufirst%3DM.%26aulast%3DYamauchi%26aufirst%3DY.%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DIsobe%26aufirst%3DT.%26aulast%3DUchiyama%26aufirst%3DS.%26aulast%3DMiyake%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DStructural%2520Analysis%2520Reveals%2520that%2520Toll-like%2520Receptor%25207%2520is%2520a%2520Dual%2520Receptor%2520for%2520Guanosine%2520and%2520Single-Stranded%2520RNA%26jtitle%3DImmunity%26date%3D2016%26volume%3D45%26spage%3D737%26epage%3D748%26doi%3D10.1016%2Fj.immuni.2016.09.011" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibata, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Taoka, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yamauchi, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shukla, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">David, S. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isobe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span> <span> </span><span class="NLM_article-title">Structural Analyses of Toll-like Receptor 7 Reveal Detailed RNA Sequence Specificity and Recognition Mechanism of Agonistic Ligands</span>. <i>Cell Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">3371</span>– <span class="NLM_lpage">3381.e5</span>, <span class="refDoi"> DOI: 10.1016/j.celrep.2018.11.081</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1016%2Fj.celrep.2018.11.081" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=30566863" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC1cXisFKhsbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=3371-3381.e5&author=Z.+Zhangauthor=U.+Ohtoauthor=T.+Shibataauthor=M.+Taokaauthor=Y.+Yamauchiauthor=R.+Satoauthor=N.+M.+Shuklaauthor=S.+A.+Davidauthor=K.+Isobeauthor=T.+Shimizu&title=Structural+Analyses+of+Toll-like+Receptor+7+Reveal+Detailed+RNA+Sequence+Specificity+and+Recognition+Mechanism+of+Agonistic+Ligands&doi=10.1016%2Fj.celrep.2018.11.081"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Structural Analyses of Toll-like Receptor 7 Reveal Detailed RNA Sequence Specificity and Recognition Mechanism of Agonistic Ligands</span></div><div class="casAuthors">Zhang, Zhikuan; Ohto, Umeharu; Shibata, Takuma; Taoka, Masato; Yamauchi, Yoshio; Sato, Ryota; Shukla, Nikunj M.; David, Sunil A.; Isobe, Toshiaki; Miyake, Kensuke; Shimizu, Toshiyuki</div><div class="citationInfo"><span class="NLM_cas:title">Cell Reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3371-3381.e5</span>CODEN:
                <span class="NLM_cas:coden">CREED8</span>;
        ISSN:<span class="NLM_cas:issn">2211-1247</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Toll-like receptor 7 (TLR7) is an innate immune receptor for single-stranded RNA (ssRNA) and has important roles in infectious diseases.  We previously reported that TLR7 shows synergistic activation in response to two ligands, guanosine and ssRNA.  However, the specific ssRNA sequence preference, detailed recognition mode of TLR7 and its ligand, and mol. determinants of TLR7 and TLR8 selectivity remain unknown.  Here, we report on TLR7 from a large-scale crystallog. study combined with a multifaceted approach.  We reveal that successive uridine-contg. ssRNAs fully or moderately bind TLR7, whereas single uridine-contg. ssRNAs have reduced affinities.  We also reveal the detailed relationships between the chem. structures of ligands and their binding to TLR7.  We demonstrate that an engineered TLR8 mutant alters its responsiveness to TLR7-specific ligands.  Finally, we identify guanosine 2',3'-cyclic phosphate (2',3'-cGMP) as a possible endogenous ligand for TLR7 with greater affinity than guanosine.  The abundant structural information will facilitate future development of treatments targeting TLR7.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrSfIvVPXG7NbVg90H21EOLACvtfcHk0lgJyhPZigaFiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXisFKhsbvK&md5=2b8c37cd45a96e9298540bd87fb77faa</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1016%2Fj.celrep.2018.11.081&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.celrep.2018.11.081%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShibata%26aufirst%3DT.%26aulast%3DTaoka%26aufirst%3DM.%26aulast%3DYamauchi%26aufirst%3DY.%26aulast%3DSato%26aufirst%3DR.%26aulast%3DShukla%26aufirst%3DN.%2BM.%26aulast%3DDavid%26aufirst%3DS.%2BA.%26aulast%3DIsobe%26aufirst%3DK.%26aulast%3DShimizu%26aufirst%3DT.%26atitle%3DStructural%2520Analyses%2520of%2520Toll-like%2520Receptor%25207%2520Reveal%2520Detailed%2520RNA%2520Sequence%2520Specificity%2520and%2520Recognition%2520Mechanism%2520of%2520Agonistic%2520Ligands%26jtitle%3DCell%2520Rep.%26date%3D2018%26volume%3D25%26spage%3D3371%26epage%3D3381.e5%26doi%3D10.1016%2Fj.celrep.2018.11.081" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alper, P. B.</span>; <span class="NLM_string-name">Deane, J.</span>; <span class="NLM_string-name">Betschart, C.</span>; <span class="NLM_string-name">Buffet, D.</span>; <span class="NLM_string-name">Collignon Zipfel, G.</span>; <span class="NLM_string-name">Gordon, P.</span>; <span class="NLM_string-name">Hampton, J.</span>; <span class="NLM_string-name">Hawtin, S.</span>; <span class="NLM_string-name">Ibanez, M.</span>; <span class="NLM_string-name">Jiang, T.</span>; <span class="NLM_string-name">Junt, T.</span>; <span class="NLM_string-name">Knoepfel, T.</span>; <span class="NLM_string-name">Liu, B.</span>; <span class="NLM_string-name">Maginnis, J.</span>; <span class="NLM_string-name">McKeever, U.</span>; <span class="NLM_string-name">Michellys, P.-Y.</span>; <span class="NLM_string-name">Mutnick, D.</span>; <span class="NLM_string-name">Nayak, B.</span>; <span class="NLM_string-name">Niwa, S.</span>; <span class="NLM_string-name">Richmond, W.</span>; <span class="NLM_string-name">Rush, J. S.</span>; <span class="NLM_string-name">Syka, P.</span>; <span class="NLM_string-name">Zhang, Y.</span>; <span class="NLM_string-name">Zhu, X.</span></span> Discovery of Potent, Orally Bioavailable in Vivo Efficacious Antagonists of the TLR7/8 Pathway.  <i>Bioorg. Med. Chem. Lett</i>. [Online early access]. DOI: <span class="refDoi"> DOI: 10.1016/j.bmcl.2020.127366</span> . Published Online: June 24, <span class="NLM_year">2020</span>. <a href="https://www.sciencedirect.com/science/article/pii/S0960894X20304777" class="extLink">https://www.sciencedirect.com/science/article/pii/S0960894X20304777</a> (accessed June 24, <span class="NLM_year">2020</span>).</span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1016%2Fj.bmcl.2020.127366" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=32738975" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2020&author=P.+B.+Alper&author=J.+Deane&author=C.+Betschart&author=D.+Buffet&author=G.+Collignon+Zipfel&author=P.+Gordon&author=J.+Hampton&author=S.+Hawtin&author=M.+Ibanez&author=T.+Jiang&author=T.+Junt&author=T.+Knoepfel&author=B.+Liu&author=J.+Maginnis&author=U.+McKeever&author=P.-Y.+Michellys&author=D.+Mutnick&author=B.+Nayak&author=S.+Niwa&author=W.+Richmond&author=J.+S.+Rush&author=P.+Syka&author=Y.+Zhang&author=X.+Zhu&title=Bioorg.+Med.+Chem.+Lett"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2020.127366&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dsimple%26id%3Ddoi%3A10.1016%252Fj.bmcl.2020.127366%26sid%3Dliteratum%253Aachs%26aulast%3DAlper%26aufirst%3DP.%2BB.%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett%26doi%3D10.1016%2Fj.bmcl.2020.127366%26date%3D2020%26date%3D2020" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Arkin, M. R.</span>; <span class="NLM_string-name">Glicksman, M. A.</span>; <span class="NLM_string-name">Fu, H.</span>; <span class="NLM_string-name">Havel, J. J.</span>; <span class="NLM_string-name">Du, Y.</span></span> <span> </span><span class="NLM_article-title">Inhibition of Protein-Protein Interactions: Non-Cellular Assay Formats</span>. In  <i>Assay Guidance Manual [Online]</i>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sittampalam, G. S.</span>; <span class="NLM_string-name">Grossman, A.</span>; <span class="NLM_string-name">Brimacombe, K.</span></span>, Eds.; <span class="NLM_publisher-name">Eli Lilly & Company and the National Center for Advancing Translational Sciences</span>: <span class="NLM_publisher-loc">Bethesda (MD)</span>, <span class="NLM_year">2004</span>; <a href="https://www.ncbi.nlm.nih.gov/books/NBK92000/" class="extLink">https://www.ncbi.nlm.nih.gov/books/NBK92000/</a> (accessed June 3, 2020).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=M.+R.+Arkin&author=M.+A.+Glicksman&author=H.+Fu&author=J.+J.+Havel&author=Y.+Duauthor=G.+S.+Sittampalam&author=A.+Grossman&author=K.+Brimacombe&title=Assay+Guidance+Manual+%5BOnline%5D"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dbook%26sid%3Dliteratum%253Aachs%26aulast%3DArkin%26aufirst%3DM.%2BR.%26atitle%3DInhibition%2520of%2520Protein-Protein%2520Interactions%253A%2520Non-Cellular%2520Assay%2520Formats%26btitle%3DAssay%2520Guidance%2520Manual%2520%255BOnline%255D%26aulast%3DSittampalam%26aufirst%3DG.%2BS.%26pub%3DEli%2520Lilly%2520%2526%2520Company%2520and%2520the%2520National%2520Center%2520for%2520Advancing%2520Translational%2520Sciences%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span> <i>Glide</i>, version 2015.3; <span class="NLM_publisher-name">Schrödinger,
LLC</span>: <span class="NLM_publisher-loc">New York, NY</span>, <span class="NLM_year">2015</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Glide%2C+version+2015.3%3B+Schr%C3%B6dinger%2C%0ALLC%3A+New+York%2C+NY%2C+2015."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DGlide%26pub%3DSchr%25C3%25B6dinger%252C%250ALLC%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lovering, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bikker, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humblet, C.</span></span> <span> </span><span class="NLM_article-title">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">6752</span>– <span class="NLM_lpage">6756</span>, <span class="refDoi"> DOI: 10.1021/jm901241e</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm901241e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=6752-6756&author=F.+Loveringauthor=J.+Bikkerauthor=C.+Humblet&title=Escape+from+Flatland%3A+Increasing+Saturation+as+an+Approach+to+Improving+Clinical+Success&doi=10.1021%2Fjm901241e"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success</span></div><div class="casAuthors">Lovering, Frank; Bikker, Jack; Humblet, Christine</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">6752-6756</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The medicinal chem. community has become increasingly aware of the value of tracking calcd. phys. properties such as mol. wt., topol. polar surface area, rotatable bonds, and hydrogen bond donors and acceptors.  The authors hypothesized that the shift to high-throughput synthetic practices over the past decade may be another factor that may predispose mols. to fail by steering discovery efforts toward achiral, arom. compds.  The authors have proposed two simple and interpretable measures of the complexity of mols. prepd. as potential drug candidates.  The first is carbon bond satn. as defined by fraction Sp3 (Fsp3) where Fsp3 = (no. of Sp3 hybridized carbons/total carbon count).  The second is simply whether a chiral carbon exists in the mol.  The authors demonstrate that both complexity (as measured by Fsp3) and the presence of chiral centers correlate with success as compds. transition from discovery, through clin. testing, to drugs.  To explain these observations, the authors further demonstrate that satn. correlates with soly., an exptl. phys. property important to success in the drug discovery setting.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoC1f3Ed7nUBbVg90H21EOLACvtfcHk0lh8bShpNFqQyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1KjtLvN&md5=4ca92c30c17c53d77ad376719bad951e</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1021%2Fjm901241e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm901241e%26sid%3Dliteratum%253Aachs%26aulast%3DLovering%26aufirst%3DF.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DEscape%2520from%2520Flatland%253A%2520Increasing%2520Saturation%2520as%2520an%2520Approach%2520to%2520Improving%2520Clinical%2520Success%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D6752%26epage%3D6756%26doi%3D10.1021%2Fjm901241e" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Das, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaniwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule Inhibition of TLR8 through Stabilization of its Resting State</span>. <i>Nat. Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">58</span>– <span class="NLM_lpage">64</span>, <span class="refDoi"> DOI: 10.1038/nchembio.2518</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1038%2Fnchembio.2518" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=29155428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvVaksrjN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2018&pages=58-64&author=S.+Zhangauthor=Z.+Huauthor=H.+Tanjiauthor=S.+Jiangauthor=N.+Dasauthor=J.+Liauthor=K.+Sakaniwaauthor=J.+Jinauthor=Y.+Bianauthor=U.+Ohtoauthor=T.+Shimizuauthor=H.+Yin&title=Small-Molecule+Inhibition+of+TLR8+through+Stabilization+of+its+Resting+State&doi=10.1038%2Fnchembio.2518"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Small-molecule inhibition of TLR8 through stabilization of its resting state</span></div><div class="casAuthors">Zhang, Shuting; Hu, Zhenyi; Tanji, Hiromi; Jiang, Shuangshuang; Das, Nabanita; Li, Jing; Sakaniwa, Kentaro; Jin, Jin; Bian, Yanyan; Ohto, Umeharu; Shimizu, Toshiyuki; Yin, Hang</div><div class="citationInfo"><span class="NLM_cas:title">Nature Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">58-64</span>CODEN:
                <span class="NLM_cas:coden">NCBABT</span>;
        ISSN:<span class="NLM_cas:issn">1552-4450</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Endosomal Toll-like receptors (TLR3, TLR7, TLR8, and TLR9) are highly analogous sensors for various viral or bacterial RNA and DNA mol. patterns.  Nonetheless, few small mols. can selectively modulate these TLRs.  In this manuscript, we identified the first human TLR8-specific small-mol. antagonists via a novel inhibition mechanism.  Crystal structures of two distinct TLR8-ligand complexes validated a unique binding site on the protein-protein interface of the TLR8 homodimer.  Upon binding to this new site, the small-mol. ligands stabilize the preformed TLR8 dimer in its resting state, preventing activation.  As a proof of concept of their therapeutic potential, we have demonstrated that these drug-like inhibitors are able to suppress TLR8-mediated proinflammatory signaling in various cell lines, human primary cells, and patient specimens.  These results not only suggest a novel strategy for TLR inhibitor design, but also shed crit. mechanistic insight into these clin. important immune receptors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpPrewccnFLv7Vg90H21EOLACvtfcHk0lh8bShpNFqQyg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvVaksrjN&md5=1b43da16d6670324d77bb5e2c417cfe6</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1038%2Fnchembio.2518&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnchembio.2518%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DDas%26aufirst%3DN.%26aulast%3DLi%26aufirst%3DJ.%26aulast%3DSakaniwa%26aufirst%3DK.%26aulast%3DJin%26aufirst%3DJ.%26aulast%3DBian%26aufirst%3DY.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DSmall-Molecule%2520Inhibition%2520of%2520TLR8%2520through%2520Stabilization%2520of%2520its%2520Resting%2520State%26jtitle%3DNat.%2520Chem.%2520Biol.%26date%3D2018%26volume%3D14%26spage%3D58%26epage%3D64%26doi%3D10.1038%2Fnchembio.2518" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Forman, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rinna, A.</span></span> <span> </span><span class="NLM_article-title">Glutathione: Overview of its Roles, Measurement, and Biosynthesis</span>. <i>Mol. Aspects Med.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">1</span>– <span class="NLM_lpage">12</span>, <span class="refDoi"> DOI: 10.1016/j.mam.2008.08.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1016%2Fj.mam.2008.08.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=18796312" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BD1MXltFelurY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2009&pages=1-12&author=J.+H.+Formanauthor=H.+Zhangauthor=A.+Rinna&title=Glutathione%3A+Overview+of+its+Roles%2C+Measurement%2C+and+Biosynthesis&doi=10.1016%2Fj.mam.2008.08.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Glutathione: Overview of its protective roles, measurement, and biosynthesis</span></div><div class="casAuthors">Forman, Henry Jay; Zhang, Hongqiao; Rinna, Alessandra</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Aspects of Medicine</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">1-12</span>CODEN:
                <span class="NLM_cas:coden">MAMED5</span>;
        ISSN:<span class="NLM_cas:issn">0098-2997</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">This review is the introduction to a special issue concerning, glutathione (GSH), the most abundant low mol. wt. thiol compd. synthesized in cells.  GSH plays crit. roles in protecting cells from oxidative damage and the toxicity of xenobiotic electrophiles, and maintaining redox homeostasis.  Here, the functions and GSH and the sources of oxidants and electrophiles, the elimination of oxidants by redn. and electrophiles by conjugation with GSH are briefly described.  Methods of assessing GSH status in the cells are also described.  GSH synthesis and its regulation are addressed along with therapeutic approaches for manipulating GSH content that have been proposed.  The purpose here is to provide a brief overview of some of the important aspects of glutathione metab. as part of this special issue that will provide a more comprehensive review of the state of knowledge regarding this essential mol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrlWapNqV0GqLVg90H21EOLACvtfcHk0lhnnhztZon02Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXltFelurY%253D&md5=c1b1aa2b03389bf1434af0762df78fe1</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1016%2Fj.mam.2008.08.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mam.2008.08.006%26sid%3Dliteratum%253Aachs%26aulast%3DForman%26aufirst%3DJ.%2BH.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DRinna%26aufirst%3DA.%26atitle%3DGlutathione%253A%2520Overview%2520of%2520its%2520Roles%252C%2520Measurement%252C%2520and%2520Biosynthesis%26jtitle%3DMol.%2520Aspects%2520Med.%26date%3D2009%26volume%3D30%26spage%3D1%26epage%3D12%26doi%3D10.1016%2Fj.mam.2008.08.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pracht, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilcken, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Udvarhelyi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rodde, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grimme, S.</span></span> <span> </span><span class="NLM_article-title">High Accuracy Quantum-Chemistry-based Calculation and Blind Prediction of Macroscopic p<i>K</i><sub>a</sub> Values in the Context of the SAMPL6 Challenge</span>. <i>J. Comput.-Aided Mol. Des.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">1139</span>– <span class="NLM_lpage">1149</span>, <span class="refDoi"> DOI: 10.1007/s10822-018-0145-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1007%2Fs10822-018-0145-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=30141103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFyktL%252FK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2018&pages=1139-1149&author=P.+Prachtauthor=R.+Wilckenauthor=A.+Udvarhelyiauthor=S.+Roddeauthor=S.+Grimme&title=High+Accuracy+Quantum-Chemistry-based+Calculation+and+Blind+Prediction+of+Macroscopic+pKa+Values+in+the+Context+of+the+SAMPL6+Challenge&doi=10.1007%2Fs10822-018-0145-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">High accuracy quantum-chemistry-based calculation and blind prediction of macroscopic pKa values in the context of the SAMPL6 challenge</span></div><div class="casAuthors">Pracht, Philipp; Wilcken, Rainer; Udvarhelyi, Aniko; Rodde, Stephane; Grimme, Stefan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Computer-Aided Molecular Design</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1139-1149</span>CODEN:
                <span class="NLM_cas:coden">JCADEQ</span>;
        ISSN:<span class="NLM_cas:issn">0920-654X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Recent advances in the development of low-cost quantum chem. methods have made the prediction of conformational preferences and physicochem. properties of medium-sized drug-like mols. routinely feasible, with significant potential to advance drug discovery.  In the context of the SAMPL6 challenge, macroscopic pKa values were blindly predicted for a set of 24 of such mols.  In this paper we present two similar quantum chem. based approaches based on the high accuracy calcn. of std. reaction free energies and the subsequent detn. of those pKa values via a linear free energy relationship.  Both approaches use extensive conformational sampling and apply hybrid and double-hybrid d. functional theory with continuum solvation to calc. free energies.  The blindly calcd. macroscopic pKa values were in excellent agreement with the expt.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp114skroUQrLVg90H21EOLACvtfcHk0lhnnhztZon02Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFyktL%252FK&md5=51ee35b57e81d7a15e2874196babd43f</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1007%2Fs10822-018-0145-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10822-018-0145-7%26sid%3Dliteratum%253Aachs%26aulast%3DPracht%26aufirst%3DP.%26aulast%3DWilcken%26aufirst%3DR.%26aulast%3DUdvarhelyi%26aufirst%3DA.%26aulast%3DRodde%26aufirst%3DS.%26aulast%3DGrimme%26aufirst%3DS.%26atitle%3DHigh%2520Accuracy%2520Quantum-Chemistry-based%2520Calculation%2520and%2520Blind%2520Prediction%2520of%2520Macroscopic%2520pKa%2520Values%2520in%2520the%2520Context%2520of%2520the%2520SAMPL6%2520Challenge%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2018%26volume%3D32%26spage%3D1139%26epage%3D1149%26doi%3D10.1007%2Fs10822-018-0145-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morgenthaler, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schweizer, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoffmann-Röder, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Benini, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martin, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaeschke, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bendels, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zimmerli, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schneider, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diederich, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansy, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, K.</span></span> <span> </span><span class="NLM_article-title">Predicting and Tuning Physicochemical Properties in Lead Optimization: Amine Basicities</span>. <i>ChemMedChem</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">1100</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi"> DOI: 10.1002/cmdc.200700059</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1002%2Fcmdc.200700059" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=17530727" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2007&pages=1100-1115&author=M.+Morgenthalerauthor=E.+Schweizerauthor=A.+Hoffmann-R%C3%B6derauthor=F.+Beniniauthor=R.+E.+Martinauthor=G.+Jaeschkeauthor=B.+Wagnerauthor=H.+Fischerauthor=S.+Bendelsauthor=D.+Zimmerliauthor=J.+Schneiderauthor=F.+Diederichauthor=M.+Kansyauthor=K.+M%C3%BCller&title=Predicting+and+Tuning+Physicochemical+Properties+in+Lead+Optimization%3A+Amine+Basicities&doi=10.1002%2Fcmdc.200700059"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting and tuning physicochemical properties in lead optimization: amine basicities</span></div><div class="casAuthors">Morgenthaler, Martin; Schweizer, Eliane; Hoffmann-Roder, Anja; Benini, Fausta; Martin, Rainer E.; Jaeschke, Georg; Wagner, Bjorn; Fischer, Holger; Bendels, Stefanie; Zimmerli, Daniel; Schneider, Josef; Diederich, Francois; Kansy, Manfred; Muller, Klaus</div><div class="citationInfo"><span class="NLM_cas:title">ChemMedChem</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1100-1115</span>CODEN:
                <span class="NLM_cas:coden">CHEMGX</span>;
        ISSN:<span class="NLM_cas:issn">1860-7179</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">A review.  This review describes simple and useful concepts for predicting and tuning the pKa values of basic amine centers, a crucial step in the optimization of phys. and ADME properties of many lead structures in drug-discovery research.  The article starts with a case study of tricyclic thrombin inhibitors featuring a tertiary amine center with pKa values that can be tuned over a wide range, from the usual value of around 10 to below 2 by (remote) neighboring functionalities commonly encountered in medicinal chem.  Next, the changes in pKa of acyclic and cyclic amines upon substitution by fluorine, oxygen, nitrogen, and sulfur functionalities, as well as carbonyl and carboxyl derivs. are systematically analyzed, leading to the derivation of simple rules for pKa prediction.  Electronic and stereoelectronic effects in cyclic amines are discussed, and the emerging computational methods for pKa predictions are briefly surveyed.  The rules for tuning amine basicities should not only be of interest in drug-discovery research, but also to the development of new crop-protection agents, new amine ligands for organometallic complexes, and in particular, to the growing field of amine-based organocatalysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGodsWRMtrxWPbVg90H21EOLACvtfcHk0lhnnhztZon02Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXpsFemsbY%253D&md5=478b70744312c01d3a43cf435d9598de</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1002%2Fcmdc.200700059&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcmdc.200700059%26sid%3Dliteratum%253Aachs%26aulast%3DMorgenthaler%26aufirst%3DM.%26aulast%3DSchweizer%26aufirst%3DE.%26aulast%3DHoffmann-R%25C3%25B6der%26aufirst%3DA.%26aulast%3DBenini%26aufirst%3DF.%26aulast%3DMartin%26aufirst%3DR.%2BE.%26aulast%3DJaeschke%26aufirst%3DG.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DFischer%26aufirst%3DH.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DZimmerli%26aufirst%3DD.%26aulast%3DSchneider%26aufirst%3DJ.%26aulast%3DDiederich%26aufirst%3DF.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DM%25C3%25BCller%26aufirst%3DK.%26atitle%3DPredicting%2520and%2520Tuning%2520Physicochemical%2520Properties%2520in%2520Lead%2520Optimization%253A%2520Amine%2520Basicities%26jtitle%3DChemMedChem%26date%3D2007%26volume%3D2%26spage%3D1100%26epage%3D1115%26doi%3D10.1002%2Fcmdc.200700059" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gorden, K. K. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, X. X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Binsfeld, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vasilakos, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alkan, S. S.</span></span> <span> </span><span class="NLM_article-title">Cutting Edge: Activation of Murine TLR8 by a Combination of Imidazoquinoline Immune Response Modifiers and PolyT Oligodeoxynucleotides</span>. <i>J. Immunol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>177</i></span>,  <span class="NLM_fpage">6584</span>– <span class="NLM_lpage">6587</span>, <span class="refDoi"> DOI: 10.4049/jimmunol.177.10.6584</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.4049%2Fjimmunol.177.10.6584" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=17082568" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtFGrsbfF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=177&publication_year=2006&pages=6584-6587&author=K.+K.+B.+Gordenauthor=X.+X.+Qiuauthor=C.+C.+Binsfeldauthor=J.+P.+Vasilakosauthor=S.+S.+Alkan&title=Cutting+Edge%3A+Activation+of+Murine+TLR8+by+a+Combination+of+Imidazoquinoline+Immune+Response+Modifiers+and+PolyT+Oligodeoxynucleotides&doi=10.4049%2Fjimmunol.177.10.6584"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Cutting Edge: Activation of Murine TLR8 by a Combination of Imidazoquinoline Immune Response Modifiers and PolyT Oligodeoxynucleotides</span></div><div class="casAuthors">Gorden, Keith K. B.; Qiu, Xiaohong X.; Binsfeld, Christine C. A.; Vasilakos, John P.; Alkan, Sefik S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Immunology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">177</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">6584-6587</span>CODEN:
                <span class="NLM_cas:coden">JOIMA3</span>;
        ISSN:<span class="NLM_cas:issn">0022-1767</span>.
    
            (<span class="NLM_cas:orgname">American Association of Immunologists</span>)
        </div><div class="casAbstract">Synthetic immune response modifiers (IRM) such as imidazoquinolines can selectively activate human TLR7 or TLR8.  Although these endosomal TLRs are close relatives, TLR7-deficient mice are unresponsive to TLR8 agonist IRMs.  Similarly, natural ssRNA cannot activate murine TLR8, leading to the belief that murine TLR8 is nonfunctional.  In this study, the authors transfected HEK293 cells with murine TLR8 and NF-κB reporter constructs and stimulated them with combinations of IRM and oligodeoxynucleotides (ODNs).  When stimulated with TLR7 or TLR8 agonists alone, no NF-κB response was obsd.  However, a combination of polyT ODN plus the TLR8 agonist activated NF-κB, whereas polyT ODN plus the TLR7 agonist did not activate.  Primary mouse cells responded to the IRM/polyT ODN by secreting TNF.  Cells from TLR7-/- and TLR9-/- mice responded to the IRM/polyT ODN combination, whereas MyD88-/- cells did not respond.  In conclusion, this study demonstrates for the first time that mouse TLR8 is functional.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQ5dlXy-S_ZrVg90H21EOLACvtfcHk0lhUQjWg0_X2WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtFGrsbfF&md5=a8d9515e52adc901902daa716e01c64b</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.4049%2Fjimmunol.177.10.6584&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4049%252Fjimmunol.177.10.6584%26sid%3Dliteratum%253Aachs%26aulast%3DGorden%26aufirst%3DK.%2BK.%2BB.%26aulast%3DQiu%26aufirst%3DX.%2BX.%26aulast%3DBinsfeld%26aufirst%3DC.%2BC.%26aulast%3DVasilakos%26aufirst%3DJ.%2BP.%26aulast%3DAlkan%26aufirst%3DS.%2BS.%26atitle%3DCutting%2520Edge%253A%2520Activation%2520of%2520Murine%2520TLR8%2520by%2520a%2520Combination%2520of%2520Imidazoquinoline%2520Immune%2520Response%2520Modifiers%2520and%2520PolyT%2520Oligodeoxynucleotides%26jtitle%3DJ.%2520Immunol.%26date%3D2006%26volume%3D177%26spage%3D6584%26epage%3D6587%26doi%3D10.4049%2Fjimmunol.177.10.6584" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guiducci, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cepika, A.-M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tripodo, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bennett, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Crain, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Quartier, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cush, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pascual, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Coffman, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barrat, F. J.</span></span> <span> </span><span class="NLM_article-title">RNA Recognition by Human TLR8 Can Lead to Autoimmune Inflammation</span>. <i>J. Exp. Med.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>210</i></span>,  <span class="NLM_fpage">2903</span>– <span class="NLM_lpage">2919</span>, <span class="refDoi"> DOI: 10.1084/jem.20131044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1084%2Fjem.20131044" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=24277153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhvFynur3L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=210&publication_year=2013&pages=2903-2919&author=C.+Guiducciauthor=M.+Gongauthor=A.-M.+Cepikaauthor=Z.+Xuauthor=C.+Tripodoauthor=L.+Bennettauthor=C.+Crainauthor=P.+Quartierauthor=J.+J.+Cushauthor=V.+Pascualauthor=R.+L.+Coffmanauthor=F.+J.+Barrat&title=RNA+Recognition+by+Human+TLR8+Can+Lead+to+Autoimmune+Inflammation&doi=10.1084%2Fjem.20131044"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">RNA recognition by human TLR8 can lead to autoimmune inflammation</span></div><div class="casAuthors">Guiducci, Cristiana; Gong, Mei; Cepika, Alma-Martina; Xu, Zhaohui; Tripodo, Claudio; Bennett, Lynda; Crain, Chad; Quartier, Pierre; Cush, John J.; Pascual, Virginia; Coffman, Robert L.; Barrat, Franck J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental Medicine</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">210</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">2903-2919</span>CODEN:
                <span class="NLM_cas:coden">JEMEAV</span>;
        ISSN:<span class="NLM_cas:issn">0022-1007</span>.
    
            (<span class="NLM_cas:orgname">Rockefeller University Press</span>)
        </div><div class="casAbstract">Studies on the role of the RNA receptor TLR8 in inflammation have been limited by its different function in human vs. rodents.  We have generated multiple lines of transgenic mice expressing different levels of human TLR8.  The high copy no. chimeras were unable to pass germline; developed severe inflammation targeting the pancreas, salivary glands, and joints; and the severity of the specific phenotypes closely correlated with the huTLR8 expression levels.  Mice with relatively low expression levels survived and bred successfully but had increased susceptibility to collagen-induced arthritis, and the levels of huTLR8 correlated with proinflammatory cytokines in the joints of the animals.  At the cellular level, huTLR8 signaling exerted a DC-intrinsic effect leading to up-regulation of co-stimulatory mols. and subsequent T cell activation.  A pathogenic role for TLR8 in human diseases was suggested by its increased expression in patients with systemic arthritis and the correlation of TLR8 expression with the elevation of IL-1β levels and disease status.  We found that the consequence of self-recognition via TLR8 results in a constellation of diseases, strikingly distinct from those related to TLR7 signaling, and points to specific inflammatory diseases that may benefit from inhibition of TLR8 in humans.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqrr_1JT3fWY7Vg90H21EOLACvtfcHk0lhUQjWg0_X2WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhvFynur3L&md5=133370bf5dd6c76dedd8470091446e45</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1084%2Fjem.20131044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1084%252Fjem.20131044%26sid%3Dliteratum%253Aachs%26aulast%3DGuiducci%26aufirst%3DC.%26aulast%3DGong%26aufirst%3DM.%26aulast%3DCepika%26aufirst%3DA.-M.%26aulast%3DXu%26aufirst%3DZ.%26aulast%3DTripodo%26aufirst%3DC.%26aulast%3DBennett%26aufirst%3DL.%26aulast%3DCrain%26aufirst%3DC.%26aulast%3DQuartier%26aufirst%3DP.%26aulast%3DCush%26aufirst%3DJ.%2BJ.%26aulast%3DPascual%26aufirst%3DV.%26aulast%3DCoffman%26aufirst%3DR.%2BL.%26aulast%3DBarrat%26aufirst%3DF.%2BJ.%26atitle%3DRNA%2520Recognition%2520by%2520Human%2520TLR8%2520Can%2520Lead%2520to%2520Autoimmune%2520Inflammation%26jtitle%3DJ.%2520Exp.%2520Med.%26date%3D2013%26volume%3D210%26spage%3D2903%26epage%3D2919%26doi%3D10.1084%2Fjem.20131044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Genung, N. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aspnes, G. E.</span></span> <span> </span><span class="NLM_article-title">Regioselective Synthesis of 2H-Indazoles Using a Mild, One-Pot Condensation–Cadogan Reductive Cyclization</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">3114</span>– <span class="NLM_lpage">3117</span>, <span class="refDoi"> DOI: 10.1021/ol5012423</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol5012423" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC2cXosVOgu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2014&pages=3114-3117&author=N.+E.+Genungauthor=L.+Weiauthor=G.+E.+Aspnes&title=Regioselective+Synthesis+of+2H-Indazoles+Using+a+Mild%2C+One-Pot+Condensation%E2%80%93Cadogan+Reductive+Cyclization&doi=10.1021%2Fol5012423"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Regioselective Synthesis of 2H-Indazoles Using a Mild, One-Pot Condensation-Cadogan Reductive Cyclization</span></div><div class="casAuthors">Genung, Nathan E.; Wei, Liuqing; Aspnes, Gary E.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3114-3117</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">An operationally simple and efficient one-pot synthesis of 2H-indazoles e. g., I, from com. available reagents is reported.  Ortho-imino-nitrobenzene substrates, generated via condensation, undergo reductive cyclization promoted by tri-n-butylphosophine to afford substituted 2H-indazoles under mild reaction conditions.  A variety of electronically diverse ortho-nitrobenzaldehydes and anilines were examd.  To further extend the scope of the transformation, aliph. amines were also employed to form N2-alkyl indazoles selectively under the optimized reaction conditions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGosMGOKkDGlbrVg90H21EOLACvtfcHk0lhUQjWg0_X2WQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXosVOgu7Y%253D&md5=59630646dc650deaf94f10a3aeabdaac</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1021%2Fol5012423&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol5012423%26sid%3Dliteratum%253Aachs%26aulast%3DGenung%26aufirst%3DN.%2BE.%26aulast%3DWei%26aufirst%3DL.%26aulast%3DAspnes%26aufirst%3DG.%2BE.%26atitle%3DRegioselective%2520Synthesis%2520of%25202H-Indazoles%2520Using%2520a%2520Mild%252C%2520One-Pot%2520Condensation%25E2%2580%2593Cadogan%2520Reductive%2520Cyclization%26jtitle%3DOrg.%2520Lett.%26date%3D2014%26volume%3D16%26spage%3D3114%26epage%3D3117%26doi%3D10.1021%2Fol5012423" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Molander, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trice, S. L. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kennedy, S. M.</span></span> <span> </span><span class="NLM_article-title">Scope of the Two-Step, One-Pot Palladium-Catalyzed Borylation/Suzuki Cross-Coupling Reaction Utilizing Bis-Boronic Acid</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>77</i></span>,  <span class="NLM_fpage">8678</span>– <span class="NLM_lpage">8688</span>, <span class="refDoi"> DOI: 10.1021/jo301642v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo301642v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC38XhtlygtLjO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=77&publication_year=2012&pages=8678-8688&author=G.+A.+Molanderauthor=S.+L.+J.+Triceauthor=S.+M.+Kennedy&title=Scope+of+the+Two-Step%2C+One-Pot+Palladium-Catalyzed+Borylation%2FSuzuki+Cross-Coupling+Reaction+Utilizing+Bis-Boronic+Acid&doi=10.1021%2Fjo301642v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Scope of the Two-Step, One-Pot Palladium-Catalyzed Borylation/Suzuki Cross-Coupling Reaction Utilizing Bis-Boronic Acid</span></div><div class="casAuthors">Molander, Gary A.; Trice, Sarah L. J.; Kennedy, Steven M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">77</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8678-8688</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The use of bis-boronic acid for the direct synthesis of boronic acids has greatly facilitated the two-step, one-pot borylation/Suzuki cross-coupling reaction between aryl and heteroaryl halides.  With use of Buchwald's second-generation XPhos preformed catalyst, high yields of cross-coupled products were obtained for most substrates.  The method also allows an efficient two-step, one-pot synthesis, providing access to three distinct cross-coupled products after column chromatog.  The method also provides a rapid and convenient route to teraryl compds.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDMxPPa0A15rVg90H21EOLACvtfcHk0lirg-SsM26oHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XhtlygtLjO&md5=80b369825dd060e4e3d243d3c85a9354</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjo301642v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo301642v%26sid%3Dliteratum%253Aachs%26aulast%3DMolander%26aufirst%3DG.%2BA.%26aulast%3DTrice%26aufirst%3DS.%2BL.%2BJ.%26aulast%3DKennedy%26aufirst%3DS.%2BM.%26atitle%3DScope%2520of%2520the%2520Two-Step%252C%2520One-Pot%2520Palladium-Catalyzed%2520Borylation%252FSuzuki%2520Cross-Coupling%2520Reaction%2520Utilizing%2520Bis-Boronic%2520Acid%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D2012%26volume%3D77%26spage%3D8678%26epage%3D8688%26doi%3D10.1021%2Fjo301642v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, Y.</span></span> <span> </span><span class="NLM_article-title">A General and Efficient Approach to 2H-Indazoles and 1H-Pyrazoles through Copper-Catalyzed Intramolecular N–N Bond Formation under Mild Conditions</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">10133</span>– <span class="NLM_lpage">10135</span>, <span class="refDoi"> DOI: 10.1039/c1cc13908h</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1039%2Fc1cc13908h" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=21826369" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhtV2htrbM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=10133-10135&author=J.+Huauthor=Y.+Chengauthor=Y.+Yangauthor=Y.+Rao&title=A+General+and+Efficient+Approach+to+2H-Indazoles+and+1H-Pyrazoles+through+Copper-Catalyzed+Intramolecular+N%E2%80%93N+Bond+Formation+under+Mild+Conditions&doi=10.1039%2Fc1cc13908h"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">A general and efficient approach to 2H-indazoles and 1H-pyrazoles through copper-catalyzed intramolecular N-N bond formation under mild conditions</span></div><div class="casAuthors">Hu, Jiantao; Cheng, Yongfeng; Yang, Yiqing; Rao, Yu</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">36</span>),
    <span class="NLM_cas:pages">10133-10135</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A new efficient copper-catalyzed intramol. amination reaction has been developed to readily synthesize a wide variety of multi-substituted 2H-indazole, e.g., I, and 1H-pyrazole, e.g., II,derivs. from easily accessible starting materials under mild conditions.  A highly selective ligand for estrogen receptor β was prepd. in three steps by employing this method.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhIxwFyyNUcLVg90H21EOLACvtfcHk0lirg-SsM26oHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhtV2htrbM&md5=893bc3aa9ea23c4150fbff16cd39ebe9</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1039%2Fc1cc13908h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1cc13908h%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DCheng%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DRao%26aufirst%3DY.%26atitle%3DA%2520General%2520and%2520Efficient%2520Approach%2520to%25202H-Indazoles%2520and%25201H-Pyrazoles%2520through%2520Copper-Catalyzed%2520Intramolecular%2520N%25E2%2580%2593N%2520Bond%2520Formation%2520under%2520Mild%2520Conditions%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D10133%26epage%3D10135%26doi%3D10.1039%2Fc1cc13908h" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharghi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aberi, M.</span></span> <span> </span><span class="NLM_article-title">Ligand-Free Copper(I) Oxide Nanoparticle Catalyzed Three-Component Synthesis of 2H-Indazole Derivatives from 2-Halobenzaldehydes, Amines and Sodium Azide in Polyethylene Glycol as a Green Solvent</span>. <i>Synlett</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1111</span>– <span class="NLM_lpage">1115</span>, <span class="refDoi"> DOI: 10.1055/s-0033-1340979</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1055%2Fs-0033-1340979" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhslSrtbrP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2014&pages=1111-1115&author=H.+Sharghiauthor=M.+Aberi&title=Ligand-Free+Copper%28I%29+Oxide+Nanoparticle+Catalyzed+Three-Component+Synthesis+of+2H-Indazole+Derivatives+from+2-Halobenzaldehydes%2C+Amines+and+Sodium+Azide+in+Polyethylene+Glycol+as+a+Green+Solvent&doi=10.1055%2Fs-0033-1340979"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand-free copper(I) oxide nanoparticle catalyzed three-component synthesis of 2H-indazole derivatives from 2-halobenzaldehydes, amines and sodium azide in polyethylene glycol as a green solvent</span></div><div class="casAuthors">Sharghi, Hashem; Aberi, Mahdi</div><div class="citationInfo"><span class="NLM_cas:title">Synlett</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1111-1115, 5 pp.</span>CODEN:
                <span class="NLM_cas:coden">SYNLES</span>;
        ISSN:<span class="NLM_cas:issn">0936-5214</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">An efficient synthesis of 2H-indazole derivs., e.g., I, based on the one-pot three-component reaction of 2-chloro- and 2-bromobenzaldehydes, primary amines and sodium azide is described.  The reaction is catalyzed by copper(I) oxide nanoparticles under ligand-free conditions in polyethylene glycol as a green solvent.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzl_ugHCwvg7Vg90H21EOLACvtfcHk0lirg-SsM26oHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhslSrtbrP&md5=f85b0d19dbbf8ead661706da0b0463f8</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1055%2Fs-0033-1340979&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-0033-1340979%26sid%3Dliteratum%253Aachs%26aulast%3DSharghi%26aufirst%3DH.%26aulast%3DAberi%26aufirst%3DM.%26atitle%3DLigand-Free%2520Copper%2528I%2529%2520Oxide%2520Nanoparticle%2520Catalyzed%2520Three-Component%2520Synthesis%2520of%25202H-Indazole%2520Derivatives%2520from%25202-Halobenzaldehydes%252C%2520Amines%2520and%2520Sodium%2520Azide%2520in%2520Polyethylene%2520Glycol%2520as%2520a%2520Green%2520Solvent%26jtitle%3DSynlett%26date%3D2014%26volume%3D25%26spage%3D1111%26epage%3D1115%26doi%3D10.1055%2Fs-0033-1340979" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, E. W.</span></span> <span> </span><span class="NLM_article-title">Synthesis of Indolizinones and a Pyridoazepinone: A New Method for the Annulation of Pyridinones</span>. <i>J. Org. Chem.</i> <span class="NLM_year" style="font-weight: bold;">1986</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">2184</span>– <span class="NLM_lpage">2191</span>, <span class="refDoi"> DOI: 10.1021/jo00362a006</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jo00362a006" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADyaL28XktVKgu78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1986&pages=2184-2191&author=E.+W.+Thomas&title=Synthesis+of+Indolizinones+and+a+Pyridoazepinone%3A+A+New+Method+for+the+Annulation+of+Pyridinones&doi=10.1021%2Fjo00362a006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis of indolizinones and a pyridoazepinone:  a new method for the annulation of pyridinones</span></div><div class="casAuthors">Thomas, Edward W.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Organic Chemistry</span>
        (<span class="NLM_cas:date">1986</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">2184-91</span>CODEN:
                <span class="NLM_cas:coden">JOCEAH</span>;
        ISSN:<span class="NLM_cas:issn">0022-3263</span>.
    </div><div class="casAbstract">Annulated pyridines I (n = 1-3) were prepd. via regiospecific addn. of LiCH2(CH2)nCH2OTHP (THP = tetrahydro-2H-pyran-2-yl) to C-6 of 2-methoxypyridine.  The resulting lactims were oxidized to 2,6-disubstituted pyridines II.  Under acidic conditions, II (n = 1, 2) afford I (n = 1, 2), resp., but II (n = 3) does not afford I (n = 3), but is converted to the bromide III by HBr, which under basic conditions cyclizes to I (n = 3).  In addn., examples of the synthesis of substituted indolizinones IV (R = H, Et) are presented.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqt7iXg6J8GarVg90H21EOLACvtfcHk0lirg-SsM26oHw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaL28XktVKgu78%253D&md5=831659a3eb98832c89bd0a40a9843ada</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fjo00362a006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjo00362a006%26sid%3Dliteratum%253Aachs%26aulast%3DThomas%26aufirst%3DE.%2BW.%26atitle%3DSynthesis%2520of%2520Indolizinones%2520and%2520a%2520Pyridoazepinone%253A%2520A%2520New%2520Method%2520for%2520the%2520Annulation%2520of%2520Pyridinones%26jtitle%3DJ.%2520Org.%2520Chem.%26date%3D1986%26volume%3D51%26spage%3D2184%26epage%3D2191%26doi%3D10.1021%2Fjo00362a006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McComas, C. C.</span>; <span class="NLM_string-name">Kuduk, S. D.</span>; <span class="NLM_string-name">Reger, T. S.</span></span> <span> </span><span class="NLM_article-title">Substituted Pyridone Derivatives as PDE10 Inhibitors</span>. <span class="NLM_patent">WO201481617</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=C.+C.+McComas&author=S.+D.+Kuduk&author=T.+S.+Reger&title=Substituted+Pyridone+Derivatives+as+PDE10+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DMcComas%26aufirst%3DC.%2BC.%26atitle%3DSubstituted%2520Pyridone%2520Derivatives%2520as%2520PDE10%2520Inhibitors%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanji, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koo, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakaniwa, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohto, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Candia, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yin, H.</span></span> <span> </span><span class="NLM_article-title">Small-Molecule TLR8 Antagonists via Structure-Based Rational Design</span>. <i>Cell Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1286</span>– <span class="NLM_lpage">1291</span>, <span class="refDoi"> DOI: 10.1016/j.chembiol.2018.07.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=10.1016%2Fj.chembiol.2018.07.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=30100350" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsVOksr3F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2018&pages=1286-1291&author=Z.+Huauthor=H.+Tanjiauthor=S.+Jiangauthor=S.+Zhangauthor=K.+Kooauthor=J.+Chanauthor=K.+Sakaniwaauthor=U.+Ohtoauthor=A.+Candiaauthor=T.+Shimizuauthor=H.+Yin&title=Small-Molecule+TLR8+Antagonists+via+Structure-Based+Rational+Design&doi=10.1016%2Fj.chembiol.2018.07.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit31R"><div class="casContent"><span class="casTitleNuber">31</span><div class="casTitle"><span class="NLM_cas:atitle">Small-Molecule TLR8 Antagonists via Structure-Based Rational Design</span></div><div class="casAuthors">Hu, Zhenyi; Tanji, Hiromi; Jiang, Shuangshuang; Zhang, Shuting; Koo, Kyoin; Chan, Jean; Sakaniwa, Kentaro; Ohto, Umeharu; Candia, Albert; Shimizu, Toshiyuki; Yin, Hang</div><div class="citationInfo"><span class="NLM_cas:title">Cell Chemical Biology</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1286-1291.e3</span>CODEN:
                <span class="NLM_cas:coden">CCBEBM</span>;
        ISSN:<span class="NLM_cas:issn">2451-9448</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">Rational design of drug-like small-mol. ligands based on structural information of proteins remains a significant challenge in chem. biol.  In particular, designs targeting protein-protein interfaces have met little success given the dynamic nature of the protein surfaces.  Herein, we utilized the structure of a small-mol. ligand in complex with Toll-like receptor 8 (TLR8) as a model system due to TLR8's clin. relevance.  Overactivation of TLR8 has been suggested to play a prominent role in the pathogenesis of various autoimmune diseases; however, there are still few small-mol. antagonists available, and our rational designs led to the discovery of six exceptionally potent compds. with ∼picomolar IC50 values.  Two X-ray crystallog. structures validated the contacts within the binding pocket.  A variety of biol. evaluations in cultured cell lines, human peripheral blood mononuclear cells, and splenocytes from human TLR8-transgenic mice further demonstrated these TLR8 inhibitors' high efficacy, suggesting strong therapeutic potential against autoimmune disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr97vmMOWWiELVg90H21EOLACvtfcHk0ljxlOVjeItT4Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsVOksr3F&md5=29acde5f0074c71209789154399a8119</span></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1016%2Fj.chembiol.2018.07.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.chembiol.2018.07.004%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DTanji%26aufirst%3DH.%26aulast%3DJiang%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DKoo%26aufirst%3DK.%26aulast%3DChan%26aufirst%3DJ.%26aulast%3DSakaniwa%26aufirst%3DK.%26aulast%3DOhto%26aufirst%3DU.%26aulast%3DCandia%26aufirst%3DA.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DYin%26aufirst%3DH.%26atitle%3DSmall-Molecule%2520TLR8%2520Antagonists%2520via%2520Structure-Based%2520Rational%2520Design%26jtitle%3DCell%2520Chem.%2520Biol.%26date%3D2018%26volume%3D25%26spage%3D1286%26epage%3D1291%26doi%3D10.1016%2Fj.chembiol.2018.07.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TY5" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TY5','PDB','6TY5'); return false;">PDB: 6TY5</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i71"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00130">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_02672"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c00130?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c00130</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">X-ray crystal data and structure refinement details, sequence alignment for TLRs, glutathione stability data for compound <b>24</b>, synthesis procedure and spectral data for probe compound <b>2</b> (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings including assay data (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_002.csv">CSV</a>)</p></li><li><p class="inline">Binding model of compound <b>3</b> to TLR8 (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_003.pdb">PDB</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_001.pdf">jm0c00130_si_001.pdf (933.85 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_002.csv">jm0c00130_si_002.csv (2.37 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c00130/suppl_file/jm0c00130_si_003.pdb">jm0c00130_si_003.pdb (130.17 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB code for the X-ray cocrystal structure of TLR8 ECD in complex with compound <b>11</b> is <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TY5">6TY5</a>. CCDC deposition number for the small-molecule crystal structure for compound <b>27</b> is 1979262. The authors will release the atomic coordinates and experimental data upon publication of the article.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c00130&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2020.63.issue-15%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c00130%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c00130" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                7MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679932703b693cdc","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
